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Abstract	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Abstract	  
As	  an	  element	  which	  occurs	   in	  the	  body	   in	  comparatively	  high	  concentrations,	  
magnesium	  attracts	  considerable	  interest	  as	  a	  component	  in	  biomaterials.	  This	  
is	  true	  for	  the	  pure	  metal,	  some	  of	  its	  alloys	  as	  well	  as	  for	  magnesium-­‐containing	  
compounds.	  This	  thesis	  addresses	  the	  degradation	  behavior	  of	  pure	  magnesium	  
and	   its	   ZEK100	   alloy	   as	   well	   as	   the	   properties	   of	   magnesium	   hydroxide	   and	  
magnesium-­‐containing	   layered	   double	   hydroxides	   (LDHs).	   For	   these	  
investigations,	   the	   magnesium	   hydroxide	   compounds	   were	   processed	   to	  
powder	   pellets	   and	   coatings.	   Processing	   and	   degradation	   behavior	   are	  
discussed	   in	   context	   of	   in	  vitro	   and	   in	  vivo	   studies	   with	   regard	   to	   medical	  
applications.	   In	   particular,	   osteoinductive	   properties	   are	   of	   interest	   for	  
orthopedic	   applications	   and	   implant-­‐directed	   drug	   delivery	   is	   of	   interest	   for	  
otolaryngology.	  The	  results	  part	  of	  the	  thesis	  consists	  of	  three	  parts	  wherein	  the	  
results	  are	  presented	  as	  publications	  or	  manuscripts	  for	  publications.	  
The	  examination	  of	  the	  corrosion	  behavior	  of	  magnesium	  and	  its	  ZEK100	  alloy	  
is	  in	  the	  focus	  of	  the	  first	  part.	  For	  the	  estimation	  of	  magnesium	  corrosion	  rates	  
and	  products,	  discs	  made	  of	  pure	  magnesium	  were	  exposed	   to	   three	  different	  
aqueous	   fluids	   under	   physiological	   conditions.	   For	   the	   examination	   of	   the	  
influence	   of	   proteins,	   further	   corrosion	   experiments	   were	   performed	   in	   their	  
presence.	   X-­‐ray	   diffraction	   examination	   of	   the	   corrosion	   layer	   revealed	   the	  
presence	   of	   nesquehonite,	   Mg(HCO3)(OH)∙2H2O,	   as	   the	   dominant	   corrosion	  
product	   formed	   in	  all	   test	  series,	  whereas	  magnesium	  hydroxide	  was	   found	  to	  
have	   formed	  only	   under	   lowly	   buffered	   conditions.	   The	   corrosion	   behavior	   of	  
ZEK100	  plates	  was	  examined	  by	  using	  a	   test	   setup	   featuring	   the	  possibility	  of	  
applying	   the	  medium	   in	   flow	  mode.	   In	   this	   study,	  magnesium	   hydroxide	  was	  
found	  as	  the	  prevalent	  corrosion	  product.	  The	  results	  of	  the	  studies	  emphasize	  
that	  the	  formation	  of	  different	  magnesium	  compounds	  strongly	  depends	  on	  the	  
conditions,	   and	   hence	   has	   to	   be	   considered	   for	   further	   studies	   in	   order	   to	  
increase	  the	  predictive	  power	  of	  in	  vitro	  corrosion	  studies.	  
Studies	   in	   the	   second	   part	   aimed	   at	   the	   evaluation	   of	   magnesium-­‐containing	  
LDHs	   as	   a	   class	   of	   variable	   magnesium	   compounds	   with	   regard	   to	   their	  
potential	   use	   as	   coating	  materials	   for	   bone	   implant.	   The	   release	   of	  Mg2+	   from	  
Mg(OH)2	  coatings	  and	  from	  LDH	  coatings	  with	  different	  Mg2+:Al3+	  cation	  ratios	  
was	  examined	  by	  exposing	  the	  samples	  to	  aqueous	  conditions	  and	  determining	  
the	  Mg2+	  concentration.	  Varying	  stabilities	  of	  the	  coatings	  were	  also	  tracked	  by	  
SEM	  and	  XRD	   investigations.	  Pellets	  made	  of	  Mg(OH)2,	  Mg-­‐Al-­‐LDH	  and	  Mg-­‐Fe-­‐
LDH	   powders	   were	   also	   examined	   in	  vitro	   and	   in	  vivo.	   Very	   good	   cytocompa-­‐
tibility	  was	  assessed	   for	  NIH3T3	  and	  MG63	  cells.	  The	   in	   vivo	   study	  comprised	  
implantation	  into	  femur	  condyles	  of	  rabbits	  and	  subsequent	  µCT	  and	  histology	  
examination	   and	   showed	   a	   favourable	   host	   response.	   The	   Mg-­‐Al-­‐LDH	   system	  
was	  thus	  found	  to	  be	  a	  promising	  material	  for	  orthopedic	  implant	  coatings.	  	  
In	  the	  third	  part,	  Mg-­‐Al-­‐LDHs	  are	  assessed	  with	  regard	  to	  their	  applicability	  as	  
key	  components	   in	  drug	  delivery	  systems,	  especially	   in	  view	  of	  applications	   in	  
the	  middle	  ear.	  The	  in	  vivo	  stability	  and	  biocompatibility	  of	  pristine	  Mg-­‐Al-­‐LDH	  
coatings	   in	   this	   unique	   site	  were	   tested	   in	   the	   rabbit	  middle	   ear	   using	   coated	  
middle	  ear	  prostheses.	  Suspensions	  of	  LDH	  nanoparticles	  were	  synthesized	  and	  
spray-­‐coating	   techniques	   were	   established	   in	   order	   to	   coat	   the	   middle	   ear	  
prostheses	   for	   this	  study.	  Degradation	  was	  evaluated	   indirectly	  by	  ex	  vivo	  EDX	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measurements	   of	   explanted	   specimens.	   The	   absence	   of	   harmful	   effects	   on	   the	  
animals	   and	   a	   distinctive	   stability	   of	   the	   LDH	   coatings	   were	   found.	   For	   drug	  
delivery	   studies,	   LDH	   nanosuspensions	   were	   mixed	   with	   ciprofloxacin	   and	  
applied	   as	   coatings	   on	   middle	   ear	   prostheses	   in	   rabbits.	   These	   implants	  
successfully	  curbed	  bacterial	  infections	  triggered	  during	  and	  subsequent	  to	  the	  
implantation.	  Additionally,	  prolongation	  of	  the	  in	  vitro	  drug	  release	  and	  efficacy	  
against	   bacteria	   were	   shown	   for	   titanium	   alloy	   discs	   coated	   with	  
ciprofloxacin/LDH	   coatings.	   Excellent	   cell	   compatibility	   was	   observed	   for	  
NIH3T3	   cells.	   Furthermore,	   these	   coatings	   were	   also	   shown	   to	   feature	  
antibacterial	   effects	   for	   extended	   periods	   of	   time	   when	   subcutaneously	  
implanted	   into	  white	  mice.	   In	   these	  studies,	   intercalation	  of	   the	  antibiotic	   into	  
the	   interlayers	  of	   the	  LDH	  materials	  appeared	   to	  be	  not	  necessary	   in	  order	   to	  
combat	   bacteria.	   Biocompatibility	   and	   processability	   make	   LDHs	   a	   promising	  
class	   of	   biomaterials	   for	   future	   drug	   delivery	   systems	   based	   on	   simple	  
drug/LDH	  mixtures.	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Kurzzusammenfassung	  
Als	  ein	  Element,	  welches	  in	  vergleichsweise	  hohen	  Konzentrationen	  im	  Körper	  
vorkommt,	   zieht	   Magnesium	   großes	   Interesse	   als	   Komponente	   in	  
Biomaterialien	   auf	   sich.	   Dies	   gilt	   für	   das	   reine	   Metall	   ebenso	   wie	   für	   einige	  
seiner	   Legierungen	   als	   auch	   für	   Magnesium-­‐haltige	   Verbindungen.	   Diese	  
Dissertation	  behandelt	  das	  Degradationsverhalten	  von	  reinem	  Magnesium	  und	  
seiner	   Legierung	   ZEK100	  und	  die	   Eigenschaften	   von	  Magnesiumhydroxid	   und	  
Magnesium-­‐haltigen	   Doppelhydroxiden	   mit	   Schichtstruktur	   (LDHs).	   Für	   diese	  
Untersuchungen	   wurden	   die	   Magnesiumhydroxid-­‐Verbindungen	   zu	  
Pulverpresslingen	   und	   Beschichtungen	   verarbeitet.	   Verarbeitung	   und	  
Abbauverhalten	   werden	   im	   Kontext	   von	   in	  vitro-­‐	   und	   in	  vivo-­‐Studien	   mit	  
Hinsicht	   auf	   medizinische	   Anwendungen	   diskutiert.	   Insbesondere	   sind	  
osteoinduktive	   Eigenschaften	   von	   Interesse	   für	   orthopädische	   Anwendungen,	  
und	   die	   implantat-­‐basierte	   Wirkstofffreisetzung	   für	   die	   Otolaryngologie.	   Der	  
Ergebnisteil	  der	  Dissertation	  besteht	  aus	  drei	  Teilen,	  in	  denen	  die	  Ergebnisse	  in	  
Form	   von	   Publikationen	   oder	   Manuskripten	   für	   Publikationen	   präsentiert	  
werden.	  	  
Die	   Untersuchung	   des	   Korrosionsverhaltens	   von	   Magnesium	   und	   seiner	  
Legierung	   ZEK100	   steht	   im	   Fokus	   des	   ersten	   Teils.	   Zur	   Bestimmung	   der	  
Korrosionsraten	   und–produkte	   von	   Magnesium	   wurden	   Scheiben	   aus	   reinem	  
Magnesium	   unter	   physiologischen	   Bedingungen	   drei	   unterschiedlichen	  
wässrigen	  Medien	   ausgesetzt.	   Zur	  Untersuchung	   des	   Einflusses	   von	  Proteinen	  
wurden	   weitere	   Experimente	   in	   deren	   Gegenwart	   durchgeführt.	  
Röntgenbeugungsuntersuchungen	   an	   den	   Korrosionsschichten	   zeigten	  
Nesquehonit,	   Mg(HCO3)(OH)∙2H2O,	   als	   das	   in	   allen	   Versuchsreihen	  
dominierende	   Korrosionsprodukt	   an,	   während	   die	   Bildung	   von	  
Magnesiumhydroxid	   nur	   unter	   schwach	   gepufferten	   Bedingungen	   festgestellt	  
wurde.	   Das	   Korrosionsverhalten	   von	   Platten	   aus	   ZEK100	  wurde	  mittels	   eines	  
Versuchsstandes	   untersucht,	   welcher	   die	   Möglichkeit	   bietet	   das	   Medium	   im	  
Durchfluss	   anzuwenden.	   In	   dieser	   Studie	   wurde	   Magnesiumhydroxid	   als	   das	  
vorherrschende	   Korrosionsprodukt	   gefunden.	   Die	   Ergebnisse	   der	   Studien	  
zeigen,	   dass	   die	  Bildung	  unterschiedlicher	  Magnesiumverbindungen	   stark	   von	  
den	   Bedingungen	   abhängen,	   und	   demnach	   für	   weitere	   Studien	   berücksichtigt	  
werden	   müssen,	   um	   die	   Vorhersagekraft	   von	   in	  vitro-­‐Korrosionsstudien	   zu	  
vergrößern.	  	  
Die	  Studien	  im	  zweiten	  Teil	  zielten	  auf	  die	  Evaluierung	  von	  magnesiumhaltigen	  
LDHs	  als	  eine	  variierbare	  Klasse	  von	  Magnesium-­‐Verbindungen	  mit	  Hinblick	  auf	  
ihre	  potentielle	  Verwendung	  als	  Beschichtungsmaterial	  für	  Knochenimplantate.	  
Die	   Freisetzung	   von	   Mg2+	   aus	   Mg(OH)2-­‐Beschichtungen	   und	   aus	   LDH-­‐
Beschichtungen	   mit	   unterschiedlichen	   Mg2+:Al3+-­‐Kationenverhältnissen	   wurde	  
untersucht,	  indem	  die	  Proben	  wässrigen	  Bedingungen	  ausgesetzt	  und	  die	  Mg2+-­‐
Konzentrationen	   bestimmt	   wurden.	   Variierende	   Stabilitäten	   der	  
Beschichtungen	   wurden	   	   durch	   REM-­‐	   und	   XRD-­‐Untersuchungen	   erfasst.	  
Presslinge	   aus	   Mg(OH)2-­‐,	   Mg-­‐Al-­‐LDH-­‐	   und	   Mg-­‐Fe-­‐LDH-­‐Pulvern	   wurden	   des	  
weiteren	   in	  vitro	   und	   in	  vivo	   untersucht.	   Die	   Cytokompatibilität	   mit	   NIH3T3-­‐	  
und	  MG63-­‐Zellen	  wurde	  als	   sehr	  gut	  bewertet.	  Die	   in	  vivo-­‐Studie	  umfasste	  die	  
Implantation	  in	  Femurkondylen	  von	  Kaninchen	  und	  die	  anschließende	  µCT-­‐	  und	  
histologische	  Untersuchung	   und	   zeigte	   eine	   günstige	  Wirtantwort.	   Das	  Mg-­‐Al-­‐
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LDH-­‐System	   wurde	   dementsprechend	   als	   vielversprechendes	   Material	   für	  
orthopädische	  Implantatbeschichtungen	  befunden.	  	  
Im	   dritten	   Teil	   werden	   Mg-­‐Al-­‐LDHs	   im	   Hinblick	   auf	   ihre	   Anwendbarkeit	   als	  
Schlüsselkomponenten	   in	   Wirkstofffreisetzungs-­‐Systemen	   bewertet,	  
insbesondere	   für	   Anwendungen	   im	   Mittelohr.	   Die	   in	  vivo-­‐Stabilität	   und	  
-­‐Biokompatibilität	   von	   reinen	   Mg-­‐Al-­‐LDH-­‐Beschichtungen	   in	   der	   besonderen	  
Umgebung	   des	   Kaninchen-­‐Mittelohrs	   wurden	   unter	   Verwendung	   von	  
entsprechend	   beschichteten	   Mittelohrprothesen	   getestet.	   LDH-­‐
Nanosuspensionen	   wurden	   synthetisiert	   und	   Sprühbeschichtungsverfahren	  
wurden	   etabliert,	   um	   die	  Mittelohrprothesen	   für	   diese	   Studie	   zu	   beschichten.	  
Die	  Degradation	  wurde	  indirekt	  durch	  ex	  vivo-­‐EDX-­‐Messungen	  an	  explantierten	  
Proben	   bewertet.	   Dabei	   wurde	   gefunden,	   dass	   es	   zu	   keinerlei	   schädlichen	  
Wirkungen	   auf	   die	   Tiere	   kam	   und	   dass	   die	   LDH-­‐Beschichtungen	   eine	  
ausgeprägte	  Stabilität	  zeigten.	  Für	  Wirkstofffreisetzungs-­‐Studien	  wurden	  LDH-­‐
Nanosuspensionen	   mit	   Ciprofloxacin	   gemischt	   und	   als	   Beschichtungen	   auf	  
Mittelohrprothesen	   in	   Kaninchen	   eingesetzt.	   Diese	   Implantate	   konnten	  
erfolgreich	   bakterielle	   Infektionen	   hemmen,	   die	   während	   oder	   nach	   der	  
Implantation	   ausgelöst	   wurden.	   Zusätzlich	   wurde	   eine	   Verlängerung	   der	  
in	  vitro-­‐Wirkstofffreisetzung	  und	  der	  Wirksamkeit	  gegenüber	  Bakterien	  für	  mit	  
Ciprofloxacin/LDH	   beschichtete	   Scheiben	   aus	   einer	   Titanlegierung	   gezeigt.	  
Gegenüber	   NIH3T3-­‐Zellen	   zeigten	   diese	   Proben	   eine	   ausgezeichnete	  
Zellkompatibilität.	   Weiterhin	   wurde	   durch	   subkutane	   Implantation	   in	   Mäuse	  
gezeigt,	   dass	   sich	   diese	   Beschichtungen	   durch	   eine	   länger	   anhaltende	  
antibakterielle	  Wirkung	   auszeichneten.	  Gemäß	  dieser	   Studien	   scheint	   es	   nicht	  
notwendig	   zu	   sein,	   das	   Antibiotikum	   in	   die	   Zwischenschichten	   der	   LDH-­‐
Materialien	   zu	   intercalieren,	   um	   Bakterien	   zu	   bekämpfen.	   Ihre	   gute	  
Biokompatibilität	   und	   Verarbeitbarkeit	   machen	   LDHs	   zu	   einer	  
vielversprechenden	   Klasse	   von	   Biomaterialien	   für	   zukünftige	  
Wirkstofffreisetzung-­‐Systeme,	   die	   auf	   einfachen	   Wirkstoff/LDH-­‐Mischungen	  
basieren.	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1	   Introduction	  
Magnesium	  and	   its	   alloys	  have	  a	   long	   standing	  history	   in	   the	   fields	  of	   various	  
applications.	  Over	  the	  years,	  numerous	  magnesium	  alloys	  were	  processed	   into	  
magnesium	   based	   workpieces	   for	   various	   applications,	   in	   particular	   in	  
automotive	   and	   biomedical	   applications	   [1,2].	   The	   first	   mentioned	   field	   in	  
particular	  exploits	  the	  low	  density	  of	  magnesium	  alloys,	  whereas	  the	  latter	  field	  
benefits	  from	  moderate	  mechanical	  stabilities.	  The	  pronounced	  susceptibility	  to	  
corrosion	  is	  a	  major	  challenge	  as	  well	  as	  an	  opportunity	  for	  further	  application	  
of	   magnesium	   and	   its	   alloys.	   Mostly	   deceleration	   of	   the	   corrosion	   is	   desired,	  
hence	   a	   set	   of	   anticorrosion	   strategies	   such	   as	   the	   targeted	   supplementation	  
with	  alloying	  elements	  and	   the	   shielding	  of	   the	   substrates	   surfaces	  by	   coating	  
were	   developed	   [3,4].	   On	   the	   other	   hand,	   controlled	   degradation	   can	   be	  
beneficial	  in	  the	  field	  of	  biodegradable	  biomaterials.	  
With	   regard	   to	  both	   fields	  of	   applications,	   the	   choice	  of	   examination	   setups	   is	  
crucial	  for	  the	  course	  of	  corrosion	  and	  its	  tracking.	  Of	  course,	  the	  setups	  should	  
be	   adjustable	   with	   regard	   to	   the	   conditions	   of	   exposure	   of	   the	   respective	  
applications.	  By	  the	  employment	  of	  sophisticated	  and	  combinatory	  analyses	  the	  
predictive	  power	  of	  the	  test	  setups	  might	  be	  increased.	  To	  this	  end,	  choice	  and	  
variation	  of	  flow	  rate	  of	  the	  corrosion	  medium	  has	  been	  frequently	  in	  the	  focus	  
of	   in	  vitro	   corrosion	   analyses.	   Depending	   on	   the	   parameters	   of	   the	   corrosion	  
setups,	   different	   magnesium	   compounds	   were	   reported	   to	   form	   in	   course	   of	  
magnesium	   corrosion	   [5,6].	   In	   turn,	   identification	   of	   these	   is	   crucial	   for	   the	  
deciphering	  of	  magnesium	  corrosion	  pathways.	  
Whereas	  the	  corrosion	  frequently	  occurs	  as	  a	  problem	  in	  the	  fields	  of	  technical	  
applications,	  the	  biodegradability	  of	  magnesium	  offers	  various	  opportunities	  in	  
medical	  fields.	  Implants	  made	  of	  magnesium	  are,	  ideally,	  expected	  to	  fulfill	  their	  
designation	   as	   long	   as	   intended	   and	   to	   be	  decomposed	   afterwards,	   neglecting	  
the	  necessities,	  risks	  and	  costs	  of	  retrieving	  surgeries	  [1,7,8].	  Hence,	  a	  thorough	  
understanding	  of	  the	  corrosion	  is	  desired	  in	  order	  to	  either	  prevent	  or	  to	  exploit	  
the	  corrosion.	  
Implants	  made	  of	  magnesium	  and	  some	  of	  its	  alloys	  were	  frequently	  reported	  to	  
enhance	  bone	  growth	  adjacent	  to	  the	  implant	  [9,10].	  This	  is	  of	  interest,	  since	  the	  
need	   for	  orthopedic	   implants,	   in	  particular	  hip	  prostheses,	  has	   increased	  over	  
the	  last	  years	  as	  did	  the	  number	  and	  percentage	  of	  revision	  surgeries,	  and	  both	  
are	   expected	   to	   increase	   further	   as	   a	   consequence	   of	   the	   ageing	   population	  
[11,12].	   Hence,	   biocompatible	   materials	   are	   needed	   that	   promote	   implant	  
incorporation.	   However,	   the	   application	   of	   load-­‐bearing	   prostheses	   as	   hip	  
prostheses	  made	   entirely	   from	  metal	  magnesium	   is	   not	   promising,	   due	   to	   the	  
expected	  functional	  loss	  in	  the	  course	  of	  decomposition.	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Besides	   for	  metallic	  magnesium	  and	   its	   alloys,	  osteoinductive	  properties	  were	  
also	   reported	   for	   magnesium	   hydroxide	   (which	   may	   form	   on	   metallic	  
magnesium	  surfaces	  in	  the	  course	  of	  corrosion).	  Hence,	  a	  magnesium	  hydroxide	  
coating	   on	   a	   permanent	   implant	   could	   also	   be	   expected	   to	   promote	   implant	  
integration.	   The	   osteoinductive	   effect	   of	  magnesium	   or	  magnesium	  hydroxide	  
has	  not	  been	  explained	  entirely	  yet.	   In	  different	  proposals,	   it	  was	  attributed	  to	  
increased	   Mg2+	   concentrations	   or	   to	   mildly	   alkaline	   effect	   adjacent	   to	   the	  
implant	  [13].	  	  
As	   a	   single	   compound,	   magnesium	   hydroxide	   is	   fixed	   in	   its	   composition	   and	  
most	  of	   its	  properties,	  significantly	  also	   the	  solubility	  and	  the	  dissolution	  rate.	  
By	  replacing	  a	  certain	  amount	  of	  bivalent	  Mg2+	  ions	  with	  trivalent	  metal	  cations	  
in	   the	   layered	  structure	  of	  magnesium	  hydroxide	  and	  balancing	   the	  additional	  
positive	  charges	  with	  anions,	  which	  are	  placed	  (together	  with	  water	  molecules)	  
in	   the	   galleries	   between	   the	   layers,	   magnesium-­‐containing	   layered	   double	  
hydroxides	   (LDHs)	   can	   be	   derived	   from	   magnesium	   hydroxide.	   The	  
compositions	   of	   the	   respective	   LDHs	   can	   be	   varied	  within	  wide	   ranges	  while	  
maintaining	  the	  basic	  LDH	  structure.	  Variations	  of	  the	  composition	  includes	  the	  
choice	   of	   trivalent	   cations,	   in	   particular	   Al3+	   and	   Fe3+,	   the	   metal	   cation	   ratio	  
MII:MIII	   and	   the	   choice	  of	   anion	   [14].	  Over	   the	  years,	   a	  wide	   selection	  of	  LDHs	  
with	   varied	   relative	   stabilities	   was	   reported.	   With	   regard	   to	   various	  
applications,	   in	   particular	   medical	   ones,	   variability	   in	   the	   composition	   and	  
properties	  of	  magnesium-­‐containing	  compounds	  are	  of	  high	  interest.	  
Various	   conventional	   and	   sophisticated	   approaches	   were	   developed	   and	  
employed	   for	   the	   synthesis	   of	   LDH	   materials.	   In	   particular,	   the	   inherent	  
capability	   for	   anion	   exchange	   reactions	   [15]	   and	   a	   structural	   memory	   effect	  
allowing	   recrystallization	   of	   LDHs	   amorphized	   by	   thermal	   treatment	   [16],	  
highlight	   the	  promise	  of	   LDH	  materials	   to	  be	   vastly	   adaptable.	  Tuning	  of	   LDH	  
materials	   furthermore	   includes	   variation	   of	   particle	  morphologies.	   Especially,	  
the	   synthesis	   of	   suspensions	   of	   LDH	   nanoparticles	   [17,18]	   allows	   the	  
application	   of	   post-­‐synthesis	   fabrication	   protocols,	   for	   example	   coating	  
techniques	  for	  different	  substrates.	  
An	  established	  application	  of	  LDHs	  is	  the	  supplementation	  of	  LDHs	  as	  fillers	  to	  
polymers	   which	   endows	   the	   composite	   materials	   with	   high	   heat	   resistance	  
[19,20].	   Also	   the	   catalytic	   activity	   of	   some	   LDH	   systems	   towards	   organic	  
reactions	  is	  employed	  [21].	  An	  established	  medical	  use	  relies	  on	  the	  mildly	  basic	  
properties	   of	   LDHs,	   namely	   their	   use	   as	   antacids	   [22].	   The	   incorporation	   of	   a	  
variety	   of	   functional	   anions	   into	   the	   LDH	   materials	   widens	   the	   spectrum	   of	  
potential	  applications.	   In	  particular,	  a	  vast	  variety	  of	  biologically	  active	  anions	  
can	  be	  combined	  with	  LDHs	  and	  was	  examined	  in	  the	  course	  of	  various	  in	  vitro	  
1	  Introduction	   	   	   3	  
	  
and	   in	  vivo	   studies.	   The	   LDH	   host	   material	   proves	   valuable	   in	   stabilizing	   the	  
interlayer	  anions	  and	  in	  promoting	  cellular	  uptake	  [23,24].	  Whereas	  most	  of	  the	  
studies	   employed	  drug-­‐LDH	   intercalation	   compounds,	   drug/LDH	  mixtures	   are	  
also	   in	   the	   focus	  of	  recent	  research.	  The	  application	  of	  mixtures	  appears	   to	  be	  
promising,	   since	   intercalation	   is	   a	   labor-­‐intensive	   process,	   whereas	   mixtures	  
are	   more	   simply	   prepared,	   while	   the	   tunability	   of	   LDH	  materials	   can	   still	   be	  
exploited.	  	  
According	   to	   the	   respective	   medical	   situations,	   LDHs	   could	   be	   of	   interest	   as	  
adaptable	   magnesium	   hydroxide	   derivates	   and	   as	   key	   components	   in	   drug	  
delivery	   systems	   for	   the	   coating	   of	   medical	   implants.	   The	   application	   of	   Mg-­‐
LDHs	   as	   magnesium-­‐containing	   coating	   materials	   could	   contribute	   to	   the	  
development	   of	   osteoinductive	   coatings	   that	   promote	   implant	   incorporation.	  
Drug-­‐loaded	  coatings	  on	  middle	  ear	  implants	  could	  combat	  infections	  triggered	  
during	   or	   subsequent	   to	   surgery.	  With	   regard	   to	   both	   fields,	   orthopedics	   and	  
otolaryngology,	  biocompatible	  and	  variably	  degradable	   implant	   coatings	  could	  
enhance	  success	  rates	  of	  the	  respective	  medical	  implants.	  For	  the	  development	  
of	  these,	  knowledge	  on	  the	  degradation	  behavior	  appears	  to	  be	  crucial.	  
The	   scientific	  background	  of	   the	   topics	  mentioned	  above	   is	  discussed	   in	  more	  
detail	  in	  chapter	  2,	  concluded	  by	  the	  bibliography	  (section	  2.3).	  The	  results	  are	  
summarized	  in	  seven	  articles,	  which	  are	  presented	  in	  chapters	  3	  to	  5.	  Chapter	  3	  
addresses	   the	   examination	   of	   the	   corrosion	   behavior	   of	   pure	  magnesium	   and	  
magnesium	   alloy	   ZEK100	   under	   physiological	   conditions	   by	   employing	  
comprehensive	   testing	   setups.	   In	   the	   course	   of	   the	   in	  vitro	   examinations,	  
physiological	  media	  were	   used	   and	   the	   crystalline	   corrosion	   products	   formed	  
were	   identified.	   The	   scientific	   background	   for	   chapter	  3	   is	   for	   the	   most	   part	  
given	  in	  section	  2.1.	  With	  regard	  to	  their	  resemblance	  to	  magnesium	  hydroxide,	  
the	  evaluation	  of	  Mg-­‐LDHs	  as	  biocompatible,	  versatile	  implant	  coating	  materials	  
for	   orthopedics	   is	   given	   in	   chapter	  4.	   The	   evaluation	   focuses	   on	   the	   in	  vitro	  
stability	  of	  Mg-­‐Al-­‐LDHs	  and	   the	   in	  vitro	   and	   in	  vivo	   examination	  of	  Mg-­‐Al-­‐	   and	  
Mg-­‐Fe-­‐LDHs.	   Both	   studies	   were	   performed	   in	   comparison	   with	   magnesium	  
hydroxide.	  In	  chapter	  5,	  the	  efficacy	  and	  biocompatibility	  of	  Mg-­‐Al-­‐LDHs	  as	  key	  
components	   in	  drug	  delivery	  systems,	  based	  on	  mixtures	  of	  an	  antibiotic	  drug	  
and	  an	  LDH,	  are	  evaluated.	  The	  studies	  comprised	  in	  vitro	  and	  in	  vivo	  assays	  and	  
were	  performed	  with	  regard	  to	  the	  application	  in	  the	  middle	  ear.	  The	  scientific	  
background	  for	  chapters	  4	  and	  5	  is	  for	  the	  most	  part	  given	  in	  section	  2.2.	  
For	   four	   of	   the	   seven	   articles,	   the	   author	   of	   this	   thesis	   is	   the	   first	   author	  
(including	  three	  shared	  first	  authorships)	  and	  for	  a	  further	  three	  articles	  he	  is	  a	  
co-­‐author.	  The	  work	  presented	   in	   this	   thesis	  was	   for	   the	  most	  part	  performed	  
within	   the	   collaborative	   research	   centre	   SFB	  599	   “Sustainable	   bioresorbable	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and	   permanent	   implants	   of	   metal	   and	   ceramic	   materials”,	   funded	   by	   the	  
Deutsche	   Forschungsgemeinschaft	   (DFG).	   Cooperating	   institutions	   come	   from	  
the	   Hannover	   Medical	   School	   (MHH),	   specifically	   the	   Departments	   for	  
Orthopedics	   and	   for	   Otorhinolaryngology,	   the	   Helmholtz	   Centre	   for	   Infection	  
Research	  (HZI)	  in	  Braunschweig,	  several	  institutes	  from	  the	  Leibniz	  University	  
Hannover	  (LUH),	  and	  the	  University	  of	  Veterinary	  Medicine	  in	  Hannover	  (TiHo).	  
Further	  cooperation	  was	  maintained	  with	  the	  Institute	  for	  Materials	  Research	  of	  
the	   Helmholtz-­‐Zentrum	   Geesthacht	   (HZG).	   To	   a	   minor	   part,	   this	   work	   also	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2	   General	  Principles	  
This	   chapter	   contains	   a	   brief	   overview	   on	   the	   scientific	   background	   for	   the	  
publications	  presented	  in	  chapters	  three	  to	  five.	  In	  section	  2.1	  techniques	  for	  the	  
examination	   of	   magnesium	   corrosion	   and	   the	   importance	   of	   a	   thorough	  
understanding	  of	  magnesium	  corrosion	  are	  discussed.	  Section	  2.2	  comprises	  the	  
topics	  of	  versatility	  and	  applicability	  of	  layered	  double	  hydroxides	  (LDHs).	  	  
	  
2.1	  	   Corrosion	  of	  magnesium	  and	  its	  alloys	  
In	   the	   following	   subsections	   the	   corrosion	   properties	   of	   magnesium	   and	   its	  
alloys	  are	  discussed	  with	  regard	  to	  technical	  and	  biomedical	  applications.	  Also,	  
an	   overview	   on	   different	   techniques	   for	   the	   examination	   of	   the	   degradation	  
process	   is	   given.	   Furthermore,	   formation	   and	   identification	   of	   degradation	  
products	  found	  in	  the	  course	  of	  magnesium	  degradation	  are	  addressed.	  	  
	  
2.1.1	  	   Properties	  and	  application	  of	  magnesium	  and	  its	  alloys	  
Magnesium	   features	   various	   advantages	   such	   as	   light	   weight,	   moderate	  
mechanical	  stability	  and	  the	  capacity	  to	  fuse	  into	  various	  alloys.	  However,	  their	  
high	   susceptibility	   to	   corrosion	   limits	   the	   number	   of	   further	   technical	  
applications.	   In	   order	   to	   overcome	   this	   limitation,	   effort	   concentrated	   on	   the	  
development	   of	   anticorrosion	   strategies.	   Whereas	   corrosion	   of	   metallic	  
magnesium	  is	  a	  key	  problem	  in	  the	  fields	  of	   technological	  applications,	   it	   is	  an	  
opportunity	   in	   the	   fields	   of	   biomedical	   applications.	  Magnesium	  and	   its	   alloys	  
were	  applied	  in	  degradable	  implants	  and	  showed	  osteoconductive	  properties.	  	  
	  
Technical	  aspects	  and	  alloying	  
Magnesium	   has	   been	   widely	   available	   since	   it	   was	   identified	   1808	   by	   Sir	  
Humphry	   Davy,	   whose	   assistant,	   Michael	   Faraday,	   obtained	   it	   in	   1833	   by	  
electrolysis	   [1].	   Nowadays,	  most	  metallic	  magnesium	   is	   obtained	   in	   China	   via	  
the	   Pidgeon	   process	   (700	  000	  tons	   in	   2006	   and	   550	  000	  tons	   in	   2007).	   As	  
magnesium	   sources	   various	   minerals	   are	   being	   used,	   e.g.	   dolomite	   and	  
magnesite	  [25,26].	  	  
Magnesium	  is,	  amongst	  other	  properties,	  characterized	  by	  a	  moderate	  Young’s	  
modulus	   (45	  GPa)	   and	   a	   low	   density	   (1.75	  g·cm−3)	   [27].	   The	   first	   mentioned	  
property	  makes	  implants	  made	  of	  magnesium	  interesting	  for	  the	  application	  in	  
orthopedics	  and	  trauma	  surgery.	  Implants	  with	  elastic	  moduli	  similar	  to	  the	  one	  
of	   human	   bone	   are	   expected	   to	   provide	   mechanical	   stability	   without	   stress-­‐
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shielding	   [28].	   In	   addition,	   the	   biodegradability	   of	   magnesium	   and	   its	   alloys	  
allows	   for	   the	  application	  as	   temporary	   implants	   [29].	  Due	   to	   the	   low	  density,	  
magnesium	  is	  of	  interest	  for	  applications	  in	  which	  weight	  reduction	  are	  crucial.	  
Hence,	   magnesium	   is	   a	   favorable	   metal	   in	   automobile	   manufacturing	   [2,30].	  
However,	   magnesium’s	   applicability	   is	   limited	   by	   its	   vast	   susceptibility	   to	  
corrosion.	  	  
With	   regard	   to	   both	   types	   of	   application,	   magnesium	   was	   fused	   into	   various	  
alloys.	   Alloying	   elements	  were	   shown	   to	   influence	   the	   corrosion	   resistance	   of	  
the	   respective	   alloys	  depending	  on	   the	   choice,	   percentage	  and	   combination	  of	  
the	  elements	   fused	   into	   the	   respective	  magnesium	  alloy	   [31,32].	  Furthermore,	  
mechanical	  properties	   could	  be	  enhanced	  by	  alloying	   [33].	   In	  order	   to	   further	  
improve	   the	  mechanical	   properties,	   e.g.	   by	   grain	   refinement,	   a	   set	   of	   thermo-­‐
mechanical	  techniques,	  e.g.	  extrusion	  techniques,	  was	  established	  over	  the	  years	  
that	   work	   for	   pure	   magnesium	   and	   its	   alloys	   [34].	   With	   regard	   to	   medical	  
applications,	   biocompatibility	   and	  potential	   toxicity	   of	   the	   elements	   employed	  
have	  to	  be	  considered.	  In	  general,	  elemental	  components	  were	  found	  to	  be	  non-­‐
toxic;	  however,	  risks	  and	  compatibility	  problems	  with	  some	  elements,	  e.g.	  nickel	  
and	  vanadium,	  have	  also	  been	  reported	  [29].	  
Amongst	  other	  elements,	  aluminium,	  zirconium,	  zinc	  and	  rare	  earth	  metals	  are	  
of	  central	  interest	  for	  the	  casting	  of	  magnesium	  alloys.	  In	  particular,	  aluminium	  
and	   its	   alloys	   themselves	   are	   used	   in	   automobile	   manufacturing	   [30]	   and	   in	  
airplane	  construction	  [35].	  Commonly,	  the	  alloys	  designations	  allow	  for	  a	  quick	  
overview	  on	  the	  elements	  contained.	  Supplemented	  metals	  are	  abbreviated	  (e.g.	  
Al:	  A,	  K:	  Zr,	   Z:	  Zn,	  RE/E:	  rare	   earth	   elements)	   and	   the	   approximate	  percentage	  
contributions	  to	  the	  alloy	  are	  stated	  with	  a	  single-­‐digit	   in	  the	  same	  order	  [31].	  
Exemplarily,	   a	   ZEK100	   alloy	   contains	   about	   1%	   Zn	   and	   each	   <1%	   rare	   earth	  
metals	  and	  Zr,	  respectively.	  However,	  this	  designation	  system	  is	  not	  obligatory;	  
hence,	  variation	  in	  nomenclature	  and	  the	  use	  of	  trade	  names	  are	  frequently	  met.	  
Samples	  made	  of	  pure	  magnesium	  were	  in	  the	  focus	  of	  corrosion	  examinations	  
as	   described	   in	   section	  3.2,	   whereas	   magnesium	   alloy	   ZEK100	   samples	   were	  
examined	  as	  described	  in	  section	  3.3.	  
Magnesium	   is	   an	   available	   and	  extensively	   studied	  metal	   that	   allows	   for	   large	  
scale	  production	  and	  modification	  by	  alloying	  and	  processing.	  Due	  to	  their	  light	  
weight,	  magnesium	  and	   its	   alloys	   have	  proven	   their	   potential	   for	   technical,	   in	  
particular	   automotive,	   application.	   Their	   moderate	   mechanical	   stability	   was	  
shown	   to	   be	   of	   promise	   for	   application	   in	   biomedical	   fields.	   The	   strong	  
susceptibility	   of	   magnesium	   and	   its	   alloys	   to	   corrosion	   was	   shown	   to	   be	   a	  
challenge	   with	   regard	   to	   technical	   application	   and	   a	   chance	   with	   regard	   to	  
biomedical	  application.	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Corrosion	  as	  a	  challenge	  for	  technical	  use	  
The	  susceptibility	  of	  magnesium	   to	   corrosion	   is	  a	  key	  problem	   in	   the	   fields	  of	  
technical	  applications	  and	  efforts	  have	  been	  made	  to	  delay	  and	  to	  decelerate	  the	  
corrosion.	   A	   key	   challenge	   in	   order	   to	   answer	   this	   issue	   is	   the	   avoidance	   of	  
impurities	   which	   might	   act	   as	   cathodes	   and	   cause	   galvanic	   corrosion	   [3].	  
However,	   supplementation	   with	   aluminium	   in	   magnesium-­‐aluminium	   alloys	  
was	  shown	  to	  enhance	  the	  corrosion	  resistance	  by	  the	   formation	  of	  protective	  
aluminium	  oxide	  films	  on	  the	  surface	  [4].	  Furthermore,	  the	  addition	  of	  a	  certain	  
amount	   of	   manganese	   to	   a	   magnesium-­‐iron	   alloy	   improved	   its	   corrosion	  
resistance	  by	  manganese	  atoms	  surrounding	  the	  iron	  atoms	  and	  acting	  as	  local	  
cathodes	  [33].	  
Another	  principle	   to	   hinder	   corrosion	   is	   to	   shield	   the	   substrate	   surfaces	   from	  
the	   environment	   by	   coating.	   Many	   different	   coating	   techniques	   have	   been	  
developed	   and	   addressed	   in	   literature,	   e.g.	   anodizing,	   electrochemical	   plating	  
and	  conversion	  coatings	  [36].	  As	  an	  example	  for	  conversion	  coatings,	  phosphate	  
conversion	   coatings	   have	   been	   successfully	   established	   for	   magnesium	   and	  
other	  metals.	   By	   using	   plasma	   electrolytic	   oxidation	   (PEO)	   specimen	  made	   of	  
WE43	   (containing	  magnesium,  ≈  4%  Y,  ≈  3%  rare   earths   and  <  0.5%  Zr)	   and	  
AZ91D	  (containing	  magnesium,	  ≈  9%  Al,  <  1%  Zn  and  each  <  0.5%  Si,  Fe,  Cu,  
Ni)	   were	   phosphate	   conversion	   coated	   electrochemically	   in	   water	   [37].	  
Phosphate	  conversion	  coating	  was	  also	  achieved	  by	  heat	  treatment	  (300	  °C)	  of	  
an	  ionic	  liquid	  (tetraoctylammonium	  di(2-­‐ethylhexyl)phosphate)	  applied	  to	  the	  
surface	  of	  an	  AZ31B	  (containing	  magnesium,  ≈  3%  Al,  <  1%  Zn  and  <  0.5%  Mn)	  	  
specimen	  [38].	  
Furthermore,	   coating	   of	   magnesium	   with	   oxidized	   magnesium	   compounds	  
could	   succeed	   in	   protecting	   the	  material.	   Plasma	   spray	   coating	   of	  magnesium	  
with	   magnesium	   fluoride	   (MgF2)	   nanoparticles	   was	   reported	   [39].	   Exploiting	  
the	   above	   mentioned	   protective	   properties	   of	   aluminium	   oxides,	   cold	   spray	  
coating	  with	  pure	  aluminium	  and	  Al2O3	  particles,	  respectively,	  was	  reported	  to	  
enhance	   the	   surface	  properties	  of	   an	  AZ91E	   (containing	  magnesium,	  ≈  9%  Al,  
<  1%  Zn  and  each  <  0.5%  Si,  Fe,  Cu,  Ni,  with  slightly  altered  contributions  of  the  
latter  four  elements)	  magnesium	  alloy	  [40].	  
Another	   noteworthy	   class	   of	   materials	   that	   has	   been	   employed	   for	   corrosion	  
protection	  of	  metallic	  magnesium	  is	  that	  of	   layered	  double	  hydroxides	  (LDHs).	  
As	   explicated	   in	   subsection	  2.2.2,	   magnesium-­‐containing	   LDHs	   are	   widely	  
tunable	  in	  terms	  of	  their	  compositions	  and	  by	  this	  in	  their	  properties,	  while	  the	  
close	  relation	  to	  Mg(OH)2	  is	  maintained.	  In	  brief,	  LDH	  films	  comprising	  from	  the	  
Mg2+-­‐Fe3+	   system	   or	   the	   Mg2+-­‐Al3+	   system,	   respectively,	   were	   synthesized	  
directly	   on	   the	   magnesium	   surface	   and	   increased	   the	   substrates	   corrosion	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resistance	  [41,42].	  In	  another	  case,	  an	  LDH	  containing	  Mg2+,	  Al3+	  and	  WO42−,	  was	  
supplemented	   to	   a	   resin-­‐based	   coating	   which	   also	   showed	   anticorrosive	  
properties.	   The	   anticorrosive	   properties	   were	   attributed	   to	   the	   exchange	   of	  
WO42−	  with	  corrosive	  Cl−	  from	  the	  corrosion	  medium	  [43].	  	  
Due	   to	   magnesium’s	   distinct	   susceptibility	   to	   corrosion,	   anticorrosion	  
techniques	  and	  anticorrosive	  substances	  are	  of	  particular	   interest	  with	  regard	  
to	   technical	   applications	   of	   magnesium.	   In	   particular,	   the	   differentiated	  
avoidance	   or	   employment	   of	   impurities	   and	   alloying	   elements,	   respectively,	  
plays	   a	   key	   role	   to	   this	   manner.	   In	   addition,	   oxidized	   species,	   such	   as	  
phosphates,	  fluorides	  and	  layered	  double	  hydroxides,	  were	  applied	  as	  coatings	  
on	   magnesium	   surfaces	   in	   order	   to	   prevent	   corrosion.	   A	   thorough	  
understanding	  of	  magnesium	  and	  its	  corrosion	  might	  promote	  development	  and	  
enhancement	  of	  anticorrosion	  strategies.	  	  
	  
Degradability	  as	  an	  opportunity	  for	  biomedical	  applications	  
Magnesium	  and	  its	  alloys	  have	  a	  long	  standing	  history	  in	  the	  field	  of	  biomedical	  
application	  and	  have	  recently	  gained	  an	   increasing	   interest	   for	   the	  application	  
as	  biodegradable,	  temporary	  implant	  materials,	  avoiding	  secondary	  surgery	  for	  
removal	  [1,8].	  In	  the	  following,	  an	  overview	  on	  selected	  applications	  and	  on	  the	  
osteoconductive	  properties	  of	  magnesium	  and	  its	  alloys	  with	  regard	  to	  medical	  
applications	  is	  given.	  
In	  1878	  Edward	  C.	  Huse	  successfully	  treated	  bleeding	  vessels	  with	  a	  magnesium	  
wire	   ligature	  [1].	  At	  present,	  magnesium	  wires	  are	  of	  relevance	  for	  orthopedic	  
fixation	   and	   their	   corrosion	   resistance	   is	   in	   the	   focus	   of	   recent	   research	   [44].	  
Another	   promising	   application	   of	   magnesium	   wires	   is	   based	   on	   the	  
supplementation	  of	  magnesium	  alloy	  wires	  to	  calcium	  phosphate	  cements	  that	  
are	  used	  for	  the	  treatment	  of	  bone	  defects.	  Wires	  made	  of	  ZEK	  100	  were	  shown	  
to	  reinforce	  the	  cement	  towards	  a	  potential	  use	  for	  load-­‐bearing	  purposes	  [45].	  	  
Magnesium	   and	   its	   alloys	   have	   also	   attracted	   interest	   in	   the	   field	   of	  
cardiovascular	   diseases.	   Coronary	   stents	   made	   of	   magnesium	   alloys	   were	  
considered	  of	   high	   interest	   due	   to	   their	   biodegradable	  nature	   and	  mechanical	  
properties	   (Fig.	  1)	   [46]	   	  and	  were	   tested	   in	   the	  course	  of	  clinical	   trials	   for	   the	  
treatment	   of	   coronary	   artery	   disease	   patients	   [47].	   Furthermore,	   absorbable	  
magnesium	   stents	   are	   promising	   for	   the	   treatment	   of	   coronary	   diseases	   in	  
pediatrics,	  considering	  the	  vessel	  growth	  and	  remodeling	  in	  the	  course	  of	  ageing	  
and	  growth	  of	  the	  patient	  [48].	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Fig.	  1:	  Absorbable	  magnesium	  stent	  (from	  ref.	  [46]).	  
	  
Degradable	  magnesium	  stents	  are	  also	  of	   interest	   for	   the	   treatment	  of	  chronic	  
rhinosinusitis	   in	  order	   to	  maintain	  ventilation	  of	   the	  paranasal	   sinuses	  and	   to	  
avoid	  the	  formation	  of	  scar	  tissue	  [49].	  
Exploiting	   the	   favorable	   properties	   for	   stent	   applications,	   magnesium	   alloy	  
scaffolds	   are	   expected	   to	   stabilize	   lesioned	   ventricular	   myocardium	   in	  
combination	   with	   biological	   graft	   material.	   The	   design	   of	   the	   magnesium	  
scaffolds	  is	  intended	  to	  provide	  proper	  mechanical	  stability	  until	  the	  biological	  
material	  has	  reached	  sufficient	  strength	  [50].	  
Various	  magnesium	  and	  magnesium	  alloy	  based	  implants	  have	  been	  in	  the	  focus	  
of	   recent	   developments	   and	   examinations	   in	   orthopedics	   and	   trauma	   surgery	  
[1,27].	  A	  selection	  of	  degradable	  implants	  for	  orthopedic	  application	  is	  shown	  in	  
Fig.	   2.	   For	   this	   purpose,	   mechanical	   and	   corrosion	   properties	   of	   magnesium	  
alloys	   are	   in	   the	   focus	   of	   recent	   examinations	   [51].	   In	   particular,	   magnesium	  
plates	   (Fig.	   2,	   middle)	   have	   been	   employed	   to	   stabilize	   fractured	   bones	   in	  
comparison	  to	  frequently	  used	  surgical	  steel	  [1,27]	  and	  are	  also	  in	  the	  focus	  of	  
the	  results	  described	  in	  section	  3.3.	  
	  
	  
Fig.	   2:	  Orthopedic	   implants.	   From	   top	   to	   bottom:	  A	  MgCa0.8	   screw,	   a	   ZEK100	  
plate	  and	  an	  intramedullary	  LAE442	  nail	  (modified	  from	  ref.	  [27]).	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Biodegradable	   screws	   for	   application	   in	   orthopedics	  were	  manufactured	   from	  
MgYREZr	   alloy	   and	   inserted	   into	   the	  marrow	   cavity	   of	   rabbit	   femora	   (Fig.	   3).	  
Good	   biocompatibility	   and	   osteoconductivity	   were	   found	   and	   no	   toxic	   effects	  
were	   observed	   [52].	   Recently,	   the	   absorbable	   bone	   compression	   screw	  
MAGNEZIX®	  CS	  3.2,	  produced	  by	  the	  medical	  technology	  company	  Syntellix	  AG,	  
has	   reached	   marketability.	   However,	   due	   to	   the	   fading	   of	   the	   implants,	   the	  
applicability	  of	  magnesium	  for	  load-­‐bearing,	  large-­‐scale	  prostheses	  is	  limited.	  	  
	  
	  
Fig.	   3:	   	   A	   biodegradable	   orthopedic	   MgYREZr	   screw,	   length	   is	   6	  mm	   (from	  
ref.	  [52]).	  
	  
Biocompatility	  is	  a	  major	  precondition	  for	  biomedical	  applicability	  and	  has	  been	  
reported	   for	   magnesium	   and	   many	   of	   its	   alloys	   [9,10,31].	   Biocompatibility	  
problems	   are	   reported	   scarcely.	   Exemplarily,	   local	   pathological	   effects	   were	  
reported	  in	  a	  long-­‐term	  study	  (12	  months)	  of	  ZEK100	  tibia	  implants	  in	  rabbits,	  
although	  general	  negative	  effects	  on	  the	  animals	  were	  not	  found	  [53].	  	  
In	  summary,	  application	  of	  magnesium	  and	  its	  alloys	  as	  biodegradable	  implant	  
materials	  have	  been	  reported	  since	  the	  19th	  century	  and	  have	  recently	  attained	  
high	   interest	  again.	  The	  promise	  of	  magnesium-­‐based	   implants	  with	  regard	   to	  
cardiovascular	  disease	  treatment	  was	  shown	  within	  clinical	  trials.	  Furthermore,	  
magnesium-­‐based	   implants	  are	  of	  high	   interest	   for	  orthopedic	  application,	  e.g.	  
in	   osteosynthesis	   systems,	   amongst	   other	   advantages	   due	   to	   their	  mechanical	  
properties.	  	  
	  
Osteoinductive	  properties	  of	  magnesium	  and	  magnesium	  hydroxide	  
In	  various	  studies,	  including	  different	  compositions,	  magnesium	  and	  some	  of	  its	  
alloys	   were	   shown	   to	   have	   osteoinductive	   properties	   [9,10].	   Implants	   made	  
from	   these	   materials	   induced	   bone	   growth	   adjacent	   to	   the	   fading	   implant,	  
promoting	   bone	   healing.	   The	   mechanism	   of	   the	   osteoinductive	   effects	   of	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magnesium	  have	  not	  been	  explained	  yet,	  however,	  many	  different	  theories	  exist	  
and	   many	   factors	   have	   to	   be	   considered.	   Electrical	   stimulation	   of	   osteoblast	  
(bone	   synthesizing	   cells)	   in	   the	   course	   of	   magnesium/alloy	   corrosion	   was	  
presumed	   to	   be	   crucial	   for	   the	   osteoinduction	   [13,54].	   Furthermore,	   the	  
presence	  of	  alloying	  elements	  or	  elements	   released	   from	   implant	   coatings	  has	  
been	  suspected	  	  to	  be	  responsible	  for	  enhanced	  bone	  growth	  [7,13].	  In	  addition,	  
implant	   surface	   properties	   such	   as	   roughness	   and	   shape	   were	   found	   to	   be	  
decisive	  for	  bone-­‐implant	  interactions	  [13,55].	  	  
In	  2010,	  a	  prominent	  corrosion	  product	  of	  magnesium	  came	   into	   focus	  of	   this	  
topic.	   Janning	  et	  al.	   implanted	   cylinders	  made	  of	  pure	  Mg(OH)2	   into	   the	   femur	  
condyles	  of	   rabbits	   (Fig.	   4).	   In	   the	   following	  weeks	   an	   increased	  bone	  growth	  
was	  observed	  adjacent	  to	  the	  Mg(OH)2	  cylinders	  lacking	  metal	  characteristics,	  in	  
particular	  their	  electrochemical	  properties,	  and	  alloying	  elements.	  	  
	  
	  
Fig.	   4:	   Schematic	   depiction	   of	   implantation	   site	   of	   the	   magnesium	   hydroxide	  
cylinder	  in	  the	  femur	  condyle	  of	  a	  rabbit	  (modified	  from	  ref.	  [13]).	  
	  
Enhanced	   bone	   growth	   around	   the	   Mg(OH)2	   cylinders	   was	   attributed	   to	   an	  
increased	  osteoblast	  activity	  due	   to	   the	  Mg2+	   rich	  environment	   [13].	  This	   is	   in	  
accordance	   with	   the	   observation	   that	   osteoblast	   numbers	   were	   shown	   to	   be	  
reduced	  in	  a	  magnesium	  deficiency	  diet,	  which	  in	  turn	  led	  to	  a	  decrease	  in	  bone	  
density	   [56].	   Furthermore,	   enhanced	   osteoblast	   activity	   was	   observed	   in	  
alkaline	   environments	   as	   well	   [57],	   which	   are	   to	   be	   expected	   adjacent	   to	   a	  
degrading	   metal	   hydroxide.	   Hence,	   magnesium	   hydroxide	   and	   related	  
compounds	  are	   interesting	  as	   a	   coating	  material	   for	   sustainable	   implants	   (see	  
sections	  4.2	  and	  4.3).	  
Amongst	   other	   advantages,	   osteoinductive	  properties	   of	  magnesium,	   a	   variety	  
of	  its	  alloys	  and	  magnesium	  hydroxide	  contribute	  to	  the	  potential	  of	  magnesium	  
based	   implant	   materials.	   Magnesium	   hydroxide	   might	   be	   of	   interest	   for	  
osteoinductive	  coatings,	  but	  is	  fixed	  in	  its	  properties,	  whereas	  application	  fields	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differ	   in	   their	   respective	   demand.	   This	   emphasizes	   the	   need	   for	   magnesium-­‐
containing	   and	   –releasing	   compounds	   which	   can	   be	   adapted	   to	   the	   desired	  
application.	   The	   properties	   of	   a	   group	   of	   such	   compounds,	   magnesium-­‐
containing	  layered	  double	  hydroxides,	  are	  described	  in	  section	  2.2.	  
	  
2.1.2	  	   Corrosion	  examination	  
The	   general	   applicability	   of	   magnesium	   and	   alloys	   for	   automotive	   and	  
biomedical	   applications	   was	   shown.	   By	   a	   thorough	   understanding	   of	   the	  
corrosion	   process,	   the	   spectrum	   of	   further	   applications	   could	   be	   widened.	  
Corrosion	  of	  magnesium	  is	  a	  complex	  process,	   the	  exact	  mechanisms	  of	  which	  
have	  not	  been	   fully	  understood	  yet.	  Different	   efforts	  have	  been	  made	   to	   track	  
the	   course	   of	   corrosion	   and	   to	   examine	   the	   effects	   of	   the	   medium	   on	   the	  
corrosion.	  Furthermore,	  identification	  of	  the	  compounds	  formed	  under	  different	  
conditions	   is	   of	   interest	   in	   order	   to	   increase	   the	   predictive	   power	   of	   in	  vitro	  
studies.	  	  
	  
Tracking	  of	  the	  corrosion	  
Over	   the	   years,	   various	  methods	   and	   testing	   setups	   have	   been	   established	   in	  
order	  to	  track	  the	  course	  of	  magnesium	  corrosion	  and	  to	  examine	  the	  influence	  
of	   the	   different	   parameters.	   In	   the	   following,	   a	   selection	   of	   methods	   applied,	  
focusing	  on	  the	  tracking	  of	  the	  respective	  corrosion	  rates,	  is	  discussed.	  
The	  examination	  of	   the	  magnesium	  specimens	   themselves	  gives	   a	   first	   insight	  
into	  the	  corrosion	  mechanisms	  in	  their	  ex	  vivo	  state	  or	  in	  an	  in	  vivo	  assay.	  With	  
regard	   to	   load-­‐bearing	   applications,	   appropriate	   mechanical	   integrity	  
throughout	   the	   corrosion	   process	   is	   desired	   [58].	   Hence,	   methods	   for	   the	  
estimation	  of	  mechanical	  properties	  were	  applied	  as	  described	  in	  section	  3.3.	  	  
A	  simple	  method	  for	  tracking	  the	  course	  of	  degradation	  is	  to	  estimate	  the	  mass	  
loss	  of	  magnesium	  samples	  over	  time.	  In	  typical	  setups,	  samples	  were	  exposed	  
to	   chromium	   acid,	   dissolving	   the	   corrosion	   products	   while	   leaving	   the	  
magnesium	  sample	  intact	  [59,60].	  	  
Since	   magnesium	   corrosion	   is	   accompanied	   by	   the	   chemical	   formation	   of	  
various	  compounds,	  monitoring	  the	  amount	  and	  concentration	  of	  these	  is	  also	  a	  
possibility	  to	  track	  the	  course	  of	  corrosion.	  Ultimately,	  Mg0	  dissolves	  under	  the	  
formation	  of	  MgII,	  which	   can	  be	  bound	   in	  a	   corrosion	   layer	   in	   form	  of	  various	  
amorphous	  and	  crystalline	  compounds,	  e.g.	  in	  form	  of	  magnesium	  hydroxides	  or	  
magnesium	  carbonate	  derivates.	  The	  corrosion	  layers	  and	  the	  Mg2+	  compounds	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present	   therein	   have	   been	   investigated	   by	   physicochemical	   analysis	   methods	  
such	  as	  spectroscopic	  methods,	  microscopy	  or	  X-­‐ray	  diffraction	  [6,61].	  	  
In	   the	   course	  of	   corrosion,	  Mg2+	   ions	  also	  occur	   in	   the	   solution	  and	  are	  hence	  
principally	  detectable	  in	  the	  environment.	  Mg2+	  determination	  in	  the	  medium	  of	  
in	  vitro	   setups	   can	   be	   performed	   by	   collecting	   the	   medium	   and	   performing	  
elemental	   analysis,	   e.g.	   ICP-­‐OES	   [5].	   The	   in	  vivo	   determination	   of	   ions	   such	   as	  
Mg2+	  or	  Ca2+	  directly	  in	  the	  tissue	  surrounding	  the	  implants	  is	  a	  major	  challenge	  
of	   in	  vivo	   studies.	  A	   possibility	   to	   determine	   ion	   concentrations	   semi-­‐online	   is	  
given	   by	   microdialysis.	   Adjacent	   to	   the	   implants,	   ion	   conductive	   probes	   are	  
inserted	  into	  the	  tissue.	  Dialysates	  taken	  were	  analyzed	  with	  means	  suitable	  for	  
the	  determination	  of	  ion	  concentrations,	  e.g.	  ICP-­‐OES,	  AAS	  [62].	  	  
With	   regard	   to	   biological	   environments	   as	   in	   cell	   culture	   assays	   or	   in	  vivo	  
studies,	  osmotic	  pressure	  variations	  of	  the	  solutions	  caused	  by	  Mg2+	  and	  other	  
species	   are	   of	   interest.	   Hence,	   estimation	   of	   osmolarity	   was	   part	   of	   the	  
examination	  in	  some	  studies	  [5,63].	  
Another	   species	   the	   formation	  of	  which	   is	   commonly	  expected	   to	  occur	   in	   the	  
course	   of	   magnesium	   degradation	   are	   hydroxide	   ions.	   By	   monitoring	   the	  
evolution	  of	  pH	  values,	  Mg2+	  concentrations	  can	  principally	  be	  estimated	  by	  the	  
concentration	  of	  the	  hydroxide	  ions	  derived	  from	  the	  pH	  value.	  However,	   local	  
pH	   values,	   close	   to	   the	   magnesium	   specimen,	   commonly	   differ	   from	   the	   pH	  
values	   in	   solution	   [64],	   amongst	   others	   depending	   on	   turbulence	   in	   the	   setup	  
[65].	   Furthermore	   has	   the	   corrosion	   medium,	   such	   as	   simulated	   body	   fluids	  
(SBFs),	  has	  influence	  on	  the	  pH;	  hence	  the	  reliability	  of	  pH	  monitoring	  in	  order	  
to	  track	  the	  course	  of	  corrosion	  is	  limited	  [66].	  
The	  formation	  of	  hydrogen	  in	  the	  course	  of	  magnesium	  degradation	  is	  expected	  
and	  has	  been	  observed	  in	  several	  studies.	  In	  principle,	  formed	  hydrogen	  gas	  can	  
be	   collected,	   and	   the	   degradation	   rate	   can	   be	   calculated	   according	   to	   the	  
captured	   gas	   volume	   [59,66].	   However,	   depending	   on	   the	   experimental	   setup	  
and	  methodology,	   the	   “negative	  difference	  effect”	   (NDE)	  has	   to	  be	   considered,	  
which	   leads	   to	   a	   non-­‐compliance	   between	   hydrogen	   evolution	   and	  
electrochemically	   estimated	   corrosion	   rates	   [3,67].	   Hydrogen	   evolution	   was	  
also	  reported	  in	  context	  of	   in	  vivo	  studies.	  Degradation	  of	  magnesium	  implants	  
at	   high	   rates	   led	   to	   the	   formation	   of	   subcutaneous	   gas	   bubbles	   [9].	   However,	  
these	  bubbles	  were	  shown	  to	  contain	  other	  gases	  than	  hydrogen	  as	  well	  [9,68],	  
as	  hydrogen	  was	  shown	  to	  be	  highly	  diffusive	  [68].	  	  
With	  regard	  to	  established	  and	  potential	  applications,	  a	  thorough	  understanding	  
of	   corrosion	  properties,	   such	  as	   corrosion	  rates,	   is	  of	  high	   interest	   in	  order	   to	  
either	  prevent	  or	  exploit	  the	  corrosion.	  A	  variety	  of	  testing	  methods	  with	  focus	  
on	  the	  magnesium	  specimen	  and	  on	  the	  substances	  formed	  was	  developed	  and	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various	   studies	   reported.	   Taking	   into	   account	   a	   selection	   of	   the	   approaches	  
explicated,	   i.e.	   estimation	   of	   weight	   loss,	   change	   of	   osmolality	   and	   pH,	   the	  




Magnesium	  and	  most	  of	  its	  alloys	  are	  prone	  to	  corrosion	  under	  conditions	  that	  
can	   be	   met	   with	   regard	   to	   outdoor	   conditions,	   technical	   applications	   and	  
biomedical	   purposes.	   Whereas	   corrosion	   occurs	   only	   slowly	   in	   air	   contact	  
[3,69],	   magnesium	   is	   vastly	   susceptible	   to	   corrosion	   when	   stored	   under	  
aqueous	   conditions	   [3,65].	   For	   a	   better	   understanding	   of	   the	   corrosion,	   test	  
setups	   are	   needed	   that	   allow	   for	   the	   examination	   of	   the	   influence	   of	   liquid	  
phases	  with	  which	  magnesium	   is	   in	   contact.	  For	   this,	  different	  aqueous	  media	  
were	  examined	  with	  regard	  to	  their	  applicability	  in	  these	  setups.	  	  
The	   application	   of	   deionized	   water	   as	   the	   medium	   allows	   for	   a	   simplified	  
tracking	  and	  analysis	  of	  the	  specimen	  in	  in	  vitro	  setups.	  Unfortunately,	  complex	  
technical	   conditions,	  not	   to	  mention	   in	  vivo	   environments,	   are	  not	   reproduced	  
well.	  As	  a	  first	  approach,	  ion	  loadings	  of	  complex	  systems	  can	  often	  be	  matched	  
by	   the	   use	   of	   sodium	   chloride	   solutions,	   e.g.	   0.9%	   (0.154	  mol∙L−1)	   for	   the	  
imitation	   of	   physiological	   conditions.	   Sodium	   chloride	   solution	   with	   varying	  
concentrations,	  e.g.	  0.2	  –	  1	  mol∙L−1,	  have	  been	  used	  in	  salt	  spray	  corrosion	  tests	  
[70].	  	  
For	   approximation	   of	   the	   respective	   setups	   to	   in	  vivo	   conditions,	   different	  
aqueous	   media	   proved	   to	   be	   interesting	   for	   the	   examination	   of	   magnesium	  
under	  physiological	  in	  vitro	  conditions.	  Hank’s	  balanced	  salt	  solution	  (HBSS)	  is	  a	  
comparably	  simple	  saline	  solution	  which	  contains	  a	  selection	  of	  inorganic	  salts	  
and	   is	   characterized	   by	   a	   low	   buffering	   capacity	   [5,6].	   Simulated	   body	   fluids	  
(SBFs)	  also	  comprise	  a	  solution	  of	  inorganic	  salts	  and	  reflect	  the	  inorganic	  part	  
of	  human	  blood	  plasma	  [6,71].	  Dulbecco’s	  modified	  eagle	  medium	  (DMEM)	  is	  a	  
more	  complex	  solution,	  which	  also	  features	  organic	  substances,	  e.g.	  amino	  acids,	  
vitamins	   or	   glucose	   and	   is	   characterized	   by	   a	   comparably	   high	   buffering	  
capacity	  [6,72].	  These	  media	  were	  employed	  in	  the	  course	  of	  the	  examinations	  
discussed	   in	   section	  3.2	   and	   their	   respective	   compositions	   are	   listed	   in	   this	  
section.	  Degradation	   setups	  however	   are	  not	   limited	   to	   aqeous	   solutions,	   also	  
liquid	   fuels	   are	   relevant	   media	   for	   corrosion	   examination.	   Exemplarily,	  
magnesium	   was	   shown	   to	   degrade	   faster	   than	   aluminium	   in	   palm	   biodiesel;	  
however,	   no	   crystalline	   corrosion	   products	   were	   detectable	   after	   60	  days	   at	  
room	  temperature	  [73].	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Not	  only	   the	  choice	  of	   the	  medium	   influences	   the	  corrosion	  behavior,	  but	  also	  
turbulence	   and	   exchange	   of	   the	   medium	   are	   relevant	   parameters.	   Local	  
alkalization	   adjacent	   to	   corroding	   metal	   surfaces	   was	   shown	   to	   decrease	  
corrosion	   rates	   [3,74].	   The	   change	   from	   a	   static	  medium	   to	   a	   stirred	  medium	  
was	   shown	   to	   balance	   the	   local	   pH	   and	   by	   this	   to	   increase	   degradation	   rates	  
[3,65].	   Depending	   on	   the	   application,	   the	   medium	   can	   also	   be	   exchanged	  
continuously	  by	  applying	  a	  constant	  flow	  rate	  as	  described	  in	  section	  3.3.	  	  
Further	   important	   parameters	   for	   degradation	   setups	   are	   composition	   and	  
pressure	  of	  the	  gas	  phase	  in	  contact	  with	  the	  medium.	  By	  introduction	  of	  further	  
species,	  chemical	  equilibria	  are	  shifted	  and	  additional	  reaction	  pathways	  might	  
lead	   to	   the	   formation	  of	  alternative	  compounds.	  Exemplary,	  different	  amounts	  
of	   CO2	   and	   SO2	   led	   to	   the	   formation	   of	   magnesium	   carbonates	   and	   sulfates,	  
respectively	  [6,65,69].	  	  
Despite	   the	  number	  of	   studies	   and	   the	   employment	  of	   sophisticated	  methods,	  
results	   gained	   from	   in	  vitro	   studies	   often	   differ	   considerably	   from	   responding	  
in	  vivo	   studies	   [7,75].	   In	  vivo	   environments,	   such	   as	   blood	   plasma	   and	  
intercellular	   fluid,	   contain	   proteins,	   which	   might	   decrease	   corrosion	   rates	  
presumably	  due	  to	  adsorption	  on	  the	  metal	  surfaces.	  However,	  amino	  acids	  and	  
organic	   chelating	   compounds	   might	   complex	   metal	   ions	   and	   by	   this	   increase	  
corrosion	  rates	  [64].	  In	  order	  to	  examine	  the	  effect	  of	  proteins	  on	  degradation,	  
the	  medium	  in	  the	  respective	  in	  vitro	  setup	  can	  be	  supplemented	  with	  proteins	  
and	  protein	  mixtures,	  such	  as	  fetal	  bovine	  serum	  (FBS)	  [6].	  Hence,	  applicability	  
of	  corrosive	  media	  lacking	  these	  bio-­‐organic	  compounds,	  such	  as	  SBF,	  has	  to	  be	  
examined	  critically	  [76].	  
Corrosion	  behavior	   of	  magnesium	  and	   its	   alloys	  was	   shown	   to	  depend	  on	   the	  
conditions	   of	   the	   respective	   corrosion	   environments,	   in	   particular	   complex	  
in	  vivo	   conditions.	   In	   order	   to	   reproduce	   these	   conditions	   to	   some	   extent,	  
in	  vitro	   corrosion	   test	   setups	   frequently	   include	   differently	   composed	   and	  
differently	  buffered	  media,	  e.g.	  HBSS,	  SBF	  and	  DMEM.	  These	  media	  were	  part	  of	  
the	   examinations	   described	   in	   section	  3.2,	   also	   considering	   the	   influence	   of	  
further	   parameters	   such	   as	   CO2	   gassing	   and	   protein	   supplementation.	  
Furthermore,	   amount	   and	   turbulence	   of	   the	  media	   can	   be	   varied	   in	   order	   to	  
examine	  the	  corrosion	  behavior	  (see	  section	  3.3).	  Results	  collected	  from	  in	  vitro	  
corrosion	   studies	   often	   differ	   from	   results	   gained	   from	   in	  vivo	   studies.	  
Nonetheless,	   sophisticated	   test	   setups	   and	   differentiated	   analysis	   of	   the	   data	  
gained	  might	  increase	  the	  predictive	  power	  of	  in	  vitro	  studies.	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Corrosion	  layer	  compounds	  
In	   order	   to	   better	   understand	   the	   corrosion	   and	   to	   increase	   the	   predictive	  
power	  of	  in	  vitro	  studies,	  it	  is	  crucial	  to	  identify	  the	  corrosion	  products	  that	  form	  
along	  the	  reaction	  pathway.	  In	  the	  following,	  an	  overview	  of	  species	  found	  and	  
reported	  in	  some	  studies	  is	  given.	  	  
A	   magnesium	   oxide	   layer	   is	   the	   natural	   corrosion	   product	   that	   forms	   on	  
magnesium	  surfaces.	   In	   contrast	   to	  aluminium	  oxide	   layers	  on	  aluminium,	   the	  
MgO	   layers	   are	  not	  dense.	  The	   reason	   can	  be	   found	   in	   the	   fact	   that	   the	  molar	  
volume	  of	  MgO	  is	  considerably	  lower	  than	  that	  of	  magnesium	  [77].	  	  
In	  presence	  of	  water,	  commonly	  conversion	   to	  a	  magnesium	  hydroxide	  occurs	  
[32].	  The	  overall	  passivating	  effect	  of	  magnesium	  hydroxide	  layers,	  however,	  is	  
considered	   as	   low	   [3].	   Furthermore,	   solubility	   of	   the	   magnesium	   hydroxide	  
layer	  was	   shown	   to	   be	   enhanced	   in	   the	   presence	   of	   certain	   concentrations	   of	  
chlorides,	  which	  can	  be	  met	  under	  physiological	  [78]	  and	  in	  vivo	  conditions	  [7].	  
Dissolution	  of	  the	  protective	  hydroxide	   layer	  and	  by	  this	  release	  of	   ions	  opens	  
additional	  pathways	  for	  following	  reactions.	  
The	   formation	   of	   phosphate	   containing	   layers	   at	   the	   surface	   of	  magnesium	   is	  
well	   known	   and	   even	   desired	   if	   conversion	   coating	   is	   performed	   [36–38].	  
Phosphorous	   and	  oxygen	   could	  be	   found	  by	  EDX	   in	   some	  degradation	   studies	  
[5,64,78].	   Since	   widely	   used	   physiological	   media	   contain	   phosphate	   sources	  
such	   as	   Na2HPO4	   (HBSS	   and	   SBF)	   and	   NaH2PO4	   (DMEM),	   magnesium	  
phosphates	   are	   likely	   to	   occur	   in	   course	   of	   degradation	   studies.	   Exemplarily,	  
amorphous,	   (Mg,Ca)x(PO4)y(CO3)z(OH)i,	   was	   reported	   on	   the	   surface	   of	   a	  
magnesium	  rare-­‐earth	  alloy	   in	  an	   in	  vitro	   study	  employing	  SBF	  as	   the	  medium	  
[79].	   Structure	   and	   composition	   of	   calcium	   phosphates	   were	   shown	   to	   be	  
dependent	  on	  the	  HCO3−	  content	  in	  SBF	  [80].	  Formation	  of	  crystalline	  phosphate	  
compounds	   was	   reported	   in	   only	   few	   cases.	   Exemplarily,	   the	   formation	   of	  
struvite,	   MgNH4PO4∙6H2O,	   on	   a	   magnesium-­‐sputtered	   titanium	   substrate	   was	  
reported,	   after	   the	   sample	   had	   been	   exposed	   to	   an	   ammonium	   phosphate	  
solution.	  In	  the	  presence	  of	  Ca2+	  ions,	  struvite	  was	  expected	  to	  be	  dissolved	  for	  
the	  formation	  of	  calcium	  phosphates	  [81].	  In	  an	  in	  vivo	  (rats)	  assay,	  magnesium-­‐
containing	  calcium	  phosphates,	  MgxCay(PO4)z,	  were	  found	  on	  a	  Mg-­‐Mn-­‐Zn	  alloy.	  
The	   fast	   deposition	   of	   biological	   calcium	   phosphate	   was	   attributed	   to	   the	  
presence	  of	  a	  corrosion	  layer,	  however,	  its	  crystallinity	  was	  not	  discussed	  [54].	  
In	  the	  presence	  of	  dissolved	  CO2	  from	  the	  gas	  phase	  or	  supplementation	  of	  the	  
medium	   with	   soluble	   CO32−/HCO3−	   salts,	   respectively,	   corrosion	   layers	   were	  
shown	   to	   contain	   CO32−/HCO3−	   ions	   [82].	   Hence,	   a	   variety	   of	   magnesium	  
carbonate	   and	   hydrogen	   carbonate	   compounds	   were	   found	   as	   corrosion	  
products	  in	  some	  degradation	  studies.	  Nesquehonite,	  Mg(HCO3)(OH)∙2H2O,	  was	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found	   as	   a	   corrosion	   product	   on	  magnesium	   that	  was	   immersed	   in	  HBSS	   and	  
DMEM,	   respectively,	   under	   cell	   culture	   conditions	   [5].	   It	   was	   also	   found	   on	  
AZ91D	   alloys	   samples	   exposed	   to	   atmospheric	   conditions	   after	   preliminary	  
treatment	   with	   NaCl.	   Furthermore,	   it	   was	   stated	   that	   nesquehonite	   could	   be	  
formed	   either	   by	   hydration	   of	   magnesite,	   MgCO3,	   or	   by	   transformation	   of	  
hydromagnesite,	   Mg5(CO3)4(OH)2∙4H2O,	   depending	   on	   the	   CO2	   pressure	   [83].	  
Nesquehonite	   was	   also	   found	   in	   course	   of	   the	   examinations	   described	   in	  
section	  3.2.	  	  
Interestingly,	   nesquehonite	   found	   in	   mines	   (Sounion,	   Lavrion	  mining	   district,	  
Greece)	   was	   reported	   to	   be	   associated	   amongst	   others	   with	   hydromagnesite	  
and	  hydrotalcite	  [84].	  The	  latter	  can	  be	  described	  as	  the	  prototype	  compound	  of	  
Mg-­‐Al-­‐CO3-­‐LDHs	  (subsection	  2.2.1).	  	  
Whereas	   the	   respective	   formulae	   of	   magnesium	   carbonates	   and	   hydrogen	  
carbonates	  are	  often	  similar	  or	  even	   the	  same	  (Mg5(CO3)4(OH)2∙5H2O	   for	  both	  
dypingite	  and	  giorgiosite),	  their	  crystalline	  structures	  can	  differ	  fundamentally.	  
Hence,	  elemental	  analysis	  methods,	  e.g.	  EDX,	  are	  often	  not	  suited	  to	  distinguish	  
between	  different	  magnesium	  carbonates.	  X-­‐ray	  diffraction	  is	  a	  method	  capable	  
to	   distinguish	   between	   different	   crystalline	   products	   and	   the	   structures	   of	  
various	   magnesium	   carbonates,	   which	   are	   well	   investigated.	   Fig.	   5	   gives	   an	  
overview	   of	   a	   selection	   of	   XRD	   patterns	   (reflection	   positions)	   of	   magnesium	  
carbonates,	  hydrates,	  hydroxides	  and	  hydrogen	  carbonates,	  respectively.	  
	  
	  
Fig.	   5:	   Overview	   of	   XRD	   patterns	   (reflection	   patterns)	   of	   a	   selection	   of	  
magnesium	  carbonates	  (WinXPow	  database,	  Stoe).	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Formation	   of	   magnesium	   sulfates	   and	   sulfites	   such	   as	   MgSO4∙6H2O	   and	  
MgSO3∙6H2O	   were	   attributed	   to	   increased	   SO2	   contents	   in	   the	   atmosphere	   of	  
industrial	  environments	  [65,69].	  	  
Various	  magnesium	  compounds	  were	  found	  in	  corrosion	  layers	  on	  magnesium	  
specimen.	   Furthermore,	   conversion	   of	   certain	   magnesium	   carbonate	  
compounds	   was	   reported	   also.	   Inherent	   to	   the	   different	   compounds	   are	  
different	   reactivities	   and	   solubilities,	   respectively,	   also	   depending	   on	   the	  
medium.	  Identification	  of	  the	  species	  can	  be	  performed	  by	  various	  methods,	  e.g.	  
X-­‐ray	  diffraction	  for	  the	  identification	  of	  crystalline	  compounds.	  Knowledge	  on	  
the	  corrosion	  products	   formed	  is	  crucial	   in	  order	  to	  get	  a	  better	  picture	  of	   the	  
corrosion	  processes.	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2.2	  	   Layered	  double	  hydroxides	  as	  a	  versatile	  class	  of	  biomaterials	  
In	   the	   following	   subsections	   layered	   double	   hydroxides	   are	   introduced	   as	   a	  
promising	   class	   of	  material	  with	   special	   regard	   to	   their	   applicability	   as	   novel	  
biomaterials.	  Versatility	  of	  these	  materials	  is	  emphasized	  by	  a	  discussion	  of	  the	  
numerous	   possibilities	   to	   vary	   the	   composition	   and	   the	   synthetic	  methods	   by	  
which	   LDHs	   can	   be	   obtained	   and	   their	   properties	   be	   tuned.	   Furthermore,	  
processing	  of	  LDH	  materials	  towards	  their	  application	  in	  technical	  and	  medical	  
fields	  is	  discussed.	  	  
	  
2.2.1	  	   Structural	  aspects	  
Layered	   double	   hydroxides	   (LDHs)	   with	   the	   formula	   [MII1–xMIIIx(OH)2x+][An–
]x/n∙yH2O	  LDHs	  are	  also	  known	  as	  anionic	  clays	  or	  hydrotalcite-­‐like	  compounds.	  
Hydrotalcite,	   [Mg6Al2(OH)16][CO3]∙4H2O,	   which	   can	   be	   considered	   as	   the	  
prototype	   compound	   for	   this	   class	   of	   clay-­‐type	   materials,	   was	   discovered	   in	  
1842	   by	   Carl	   Hochstetter.	   Over	   the	   years,	   various	   LDHs	   have	   been	   obtained	  
synthetically.	   Besides	   their	   potential	   for	   various	   applications,	   also	   structural	  
features	  were	  in	  the	  focus	  of	  the	  examination	  of	  LDHs.	  
The	   respective	   LDHs	   can	   be	   derived	   from	   their	   according	  MII	   hydroxides	   (e.g.	  
Mg(OH)2,	  CdI2	  type)	  by	  substituting	  a	  certain	  amount	  of	  the	  bivalent	  cations	  MII	  
with	  trivalent	  cations	  MIII	  (e.g.	  Al3+),	  which	  generates	  surplus	  positive	  charges	  in	  
the	   MII/MIII-­‐hydroxide	   layers.	   Commonly	   these	   positively	   charged	   metal	  
hydroxide	   layers	   are	   referred	   to	   as	   main	   layers.	   These	   main	   layers	   are	   built	  
from	  compressed,	  edge-­‐sharing	  metal	  hydroxide	  octahedra	  with	  hydroxide	  ions	  
occupying	  positions	  of	  densely	  packed	  layers	  and	  oriented	  perpendicular	  to	  the	  
plane	  of	  the	  layers.	  The	  surplus	  positive	  charges	  in	  the	  main	  layers	  are	  balanced	  
by	  anions	  An–,	  which	  are	  placed	  together	  with	  water	  molecules	  in	  the	  interlayer	  
regions	  or	  galleries.	  Whereas	  ionic	  bonding	  is	  prevalent	  within	  the	  main	  layers,	  
the	  layer	  stacking	  is	  stabilized	  by	  hydrogen	  bonding	  and	  dispersion	  forces	  [14].	  
A	   schematic	   depiction	   of	   the	   structures	   of	   magnesium	   hydroxide	   and	  
magnesium-­‐containing	   layered	   double	   hydroxides	   is	   shown	   in	   Fig.	   6.	   The	  
presence	  of	  anions	  in	  the	  interlayers	  of	  the	  LDH	  increases	  the	  distance	  between	  
the	  main	  layers	  compared	  to	  magnesium	  hydroxide	  layers,	  as	  it	  is	  implied	  in	  Fig.	  
6.	   Basal	   spacings	   depend	   on	   size,	   arrangement	   and	   orientation	   of	   the	   anions	  
(explicated	  in	  subsection	  2.2.2).	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Fig.	  6:	  Schematic	  depiction	  of	  the	  structures	  of	  magnesium	  hydroxide	  (left)	  and	  
magnesium-­‐containing	  layered	  double	  hydroxides	  (right).	  	  
	  
The	  brucite-­‐like	   layers	   in	  LDHs	  may	  be	   stacked	   in	  manifold	  ways,	   resulting	   in	  
different	  polytypes.	  In	  principle,	  when	  hydroxyl	  groups	  of	  one	  sheet	  are	  located	  
vertically	   above	   the	   hydroxyl	   groups	   of	   the	   adjacent	   sheet	   (AA	   stacking),	   this	  
results	   in	   the	   formation	   of	   trigonal-­‐prismatic	   sites	   between	   them;	   an	   offset	  
arrangement	   of	   the	   hydroxyl	   groups	   (AB)	   of	   adjacent	   sheets	   creates	  
octahedralsites.	   The	   polytypes	   may	   comprise	   a	   variety	   of	   stacking	   sequences	  
(like	   ABAB	   or	   ABCABC),	   but	   disorder	   is	   also	   common;	   especially	   early	   X-­‐ray	  
diffraction	  analyses	  did	  not	  always	  take	  into	  account	  signs	  of	  stacking	  disorder	  
(broadened	  reflections,	  higher	  background	  diffraction)	  and	  therefore,	  the	  often	  
complicated	  stacking	  sequences	  derived	  in	  early	  X-­‐ray	  diffraction	  work	  on	  LDHs	  
have	  to	  be	  viewed	  with	  care.	  The	  different	  stacking	  sequences	  or	  polytypes	  are	  
denoted	   according	   to	   the	   number	   of	   the	   sheets	   stacked	   along	   the	   c	   axis	   and	  
according	  to	  the	  symmetry	  resulting	  from	  the	  stacking.	  A	  hexagonal	  symmetry	  
is	   denoted	   by	   “H”	   and	   a	   rhombohedral	   symmetry	   is	   denoted	   by	   “R”.	   Hence,	  
brucite,	   Mg(OH)2,	   is	   denoted	   by	   “1H”.	   Stacking	   sequences	   for	   multi-­‐layer	  
polytypes	   and	   according	   denotations	   were	   systematically	   derived	   by	   Bookin	  
and	  Drits.	  It	  was	  shown	  that	  there	  are	  three	  two-­‐layer	  polytypes	  with	  hexagonal	  
stacking	   (2H1	   to	   2H3),	   whilst	   there	   are	   nine	   possible	   three-­‐layer	   polytypes	  
including	   two	   with	   rhombohedral	   symmetry	   (3R1	   and	   3R2)	   and	   seven	   with	  
hexagonal	  symmetry	  (3H1	  to	  3H7)	  [14].	  	  
X-­‐ray	  diffraction	   (XRD)	   is	   routinely	   employed	   to	   gain	   information	  on	   the	  LDH	  
crystal	   structure.	   A	   typical	   XRD	   pattern	   of	   LDHs	   is	   shown	   in	   Fig.	   7	   (from	  
ref.	  [85]).	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Fig.	  7:	  Typical	  XRD	  pattern	  of	  LDHs	  (from	  ref.	  [85]).	  
	  
In	  principle,	  there	  are	  three	  groups	  of	  reflections	  in	  XRD	  patterns	  of	  LDHs.	  (A)	  
At	  low	  diffraction	  angles	  a	  series	  of	  (00l)	  reflections	  is	  characteristic,	  by	  which	  
basal	  spacings	  along	  the	  c	  axis	  can	  be	  calculated.	  Basal	  spacings	  are	  of	  particular	  
interest	  for	  the	  characterization	  of	  LDHs	  with	  different	  anions	  in	  the	  interlayers.	  
A	  selection	  of	  XRD	  patterns	  of	  Mg-­‐Al-­‐LDHs	  with	  different	  anions	  is	  given	  in	  Fig.	  
8	  (from	  ref.	  [86]).	  (B)	  At	  higher	  angles	  the	  (110)	  reflection	  (and	  possibly	  other	  
hk0	   reflections)	   can	   be	   detected,	  which	   allow	   the	   determination	   of	   the	   lattice	  
constant	  a	  within	   the	  main	   layers	   and	   thus	   of	   the	   cation-­‐cation	   distances.	   (C)	  
Information	   on	   the	   stacking	   patterns	   of	   the	   layers	   can	   be	   gained	   from	   (hkl)	  
reflections,	  e.g.	  from	  the	  (10l)	  reflections	  at	  intermediate	  diffraction	  angles.	  	  
	  
	  
Fig.	  8:	  XRD	  patterns	  of	  Mg-­‐Al-­‐LDHs	  with	  (a)	  CO32−,	   (b)	  NO3−,	   (c)	  ClO4−	  and	  (d)	  
SO42−	  in	  the	  LDH	  interlayers.	  XRD	  pattern	  (c)	  shows	  a	  second	  phase	  with	  a	  (003)	  
reflection	   similar	   to	   that	   of	   the	   carbonate-­‐bearing	   material	   (from	   ref.	  [86]).	  
Broadening	  of	  reflections	  can	  clearly	  be	  recognized	  around	  55°	  2Θ.	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However,	   deduction	   of	   information	   may	   be	   affected	   by	   certain	   structural	  
features	   of	   LDHs,	   which	   lead	   to	   shifts	   and	   increased	   broadening	   of	   XRD	  
reflections.	   Two	   frequently	   found	   features	   are	   interstratification	   and	  
turbostratic	   disorder.	   Interstratification	   occurs	   in	   LDHs	   that	   comprise	  
interlayers	   with	   varying	   interlayer	   anions	   and/or	   varying	  water	   content,	   and	  
mainly	   affects	   the	   relationship	   between	   (00l)	   reflections	   of	   different	   order.	   In	  
case	   of	   turbostratic	   disorder,	   LDH	  main	   layers	   are	   shifted	   as	   well	   as	   twisted	  
against	  each	  other,	  leading	  to	  a	  broadening	  of	  (hkl)	  reflections	  [14].	  	  
	  
2.2.2	  	   Tunable	  composition	  
In	   accordance	  with	   the	   general	   formula,	   various	   combinations	   of	   bivalent	  MII,	  
trivalent	   MIII	   cations	   and	   anions	   An–	   have	   been	   reported	   to	   form	   LDHs.	   Also,	  
LDHs	  with	   varying	  MII/MIII	   ratios	   were	   found.	   In	   the	   following,	   the	   LDHs	   are	  
named	  according	   to	  MII-­‐MIII-­‐A-­‐LDH;	  e.g.	   a	  LDH	  containing	  Mg2+,	  Al3+	   and	  CO32–	  
ions	  is	  named	  Mg-­‐Al-­‐CO3-­‐LDH.	  	  
As	   explicated	   above	   (subsection	  2.1.1),	   magnesium	   hydroxide	   is	   one	   of	   the	  
dominant	   corrosion	   products	   of	   metallic	   magnesium	   and	   its	   alloys	   under	  
various	  aqueous	  conditions.	  It	  shows	  promising	  properties	  like	  osteoinductivity,	  
but	   due	   to	   its	   single-­‐compound	   nature	   its	   composition	   is	   fixed	   and	   its	  
properties,	   like	   the	   solubility	   and	   dissolution	   rate,	   can	   only	   be	   varied	   in	   a	  
narrow	   window,	   for	   example	   by	   changing	   the	   size	   of	   (small)	   particles.	  
Magnesium-­‐containing	   layered	   double	   hydroxides	   can	   be	   derived	   from	  
magnesium	  hydroxide	  as	  explained	  above,	  and	  are	  tunable	  in	  their	  composition	  
and	   by	   this,	   properties.	  With	   regard	   to	   the	   close	   relation	   to	  Mg(OH)2	   and	   the	  
publications	  (in	  particular	  chapters	  4	  and	  5)	  in	  this	  thesis,	  Mg-­‐LDHs	  are	  in	  the	  
focus	  of	  the	  discussion.	  	  
	  
Cation	  combinations	  and	  cation	  ratios	  
Various	  LDH	  systems	  which	  comprise	  a	  wide	  repertoire	  of	  bivalent	  and	  trivalent	  
cations	  were	  found,	  making	  this	  class	  of	  material	  favorable	  for	  many	  purposes.	  
Depending	  on	  the	  demands	  of	  the	  respective	  application,	  different	  elements	  can	  
be	   incorporated	   in	   the	   material	   whilst	   avoiding	   the	   creation	   of	   a	   multiphase	  
system.	   With	   regard	   to	   the	   publications	   in	   chapters	   4	   and	   5,	   a	   selection	   of	  
elements	   that	   have	   been	   reported	   to	   form	   Mg-­‐LDHs,	   Al-­‐LDHs	   and	   Fe-­‐LDHs,	  
respectively,	  is	  listed	  in	  	  Table	  1	  [87].	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Table	  1:	  Selection	  of	  cation	  combinations	  that	   form	  Mg-­‐LDHs,	  Al-­‐LDHs	  and	  Fe-­‐
LDHs	  (according	  to	  information	  from	  ref.	  [87]).	  
MII	   MIII	  
Mg	   Al,	  Cr,	  Fe,	  V	  
Ca,	  Cd,	  Co,	  Cu,	  Li,	  Mg,	  Mn,	  Ni,	  Zn	   Al	  
Mg,	  Ni	   Fe	  
	  
Stability	  of	  LDHs	  was	  shown	  to	  depend	  on	  the	  choice	  of	  cations.	  For	  LDHs	  with	  
MIII	  =	  Al3+	  or	  Fe3+	   an	   increasing	   stability	   sequence	  was	   reported	  depending	  on	  
the	  choice	  of	  MII:	  Mg2+	  <	  Mn2+	  <	  Co2+	  ≈	  Ni2+	  <	  Zn2+	  [88],	  which	  was	  confirmed	  for	  
MIII	  =	  Cr3+	  [89].	  Furthermore,	  Al-­‐LDHs	  were	  found	  to	  be	  more	  stable	  than	  FeIII-­‐
LDHs	  [88].	  	  
LDHs	   with	   more	   than	   two	   sorts	   of	   cations	   were	   reported	   also.	   Partial	  
substitution	  of	  Mg2+	  ions	  with	  noble	  metal	  ions	  led	  to	  the	  formation	  of	  Mg-­‐PdII-­‐
Al-­‐LDH	   and	  Mg-­‐PtII-­‐Al-­‐LDH	   [90].	   Mg-­‐LDHs	  with	   two	   sorts	   of	   trivalent	   cations	  
such	  as	  Mg-­‐Al-­‐Fe-­‐LDH	  [91]	  and	  also	  with	  noble	  metal	  cations	  as	   in	  Mg-­‐Al-­‐MIII-­‐
LDH	  (with	  MIII	  =	  Rh3+,	  Ir3+	  and	  Ru3+)	  were	  found	  [90].	  Furthermore,	  LDHs	  with	  
four	  cations:	  Cu-­‐Co-­‐Zn-­‐Al-­‐LDH	  [92]	  and	  five	  cations	  Cu-­‐Zn-­‐Mn-­‐Fe-­‐Al-­‐LDH	  were	  
described.	  The	  latter	  was	  active	  towards	  hydrogen	  peroxide	  oxidation	  of	  phenol	  
[21].	  	  
Not	  only	  could	  the	  choice	  of	   the	  cations	  be	  altered,	  also	  the	  cation	  ratios	  were	  
varied	  for	  some	  LDH	  systems,	  allowing	  for	  a	  further	  tuning	  of	  the	  properties	  of	  
the	  materials	  [93].	  In	  the	  case	  of	  the	  Mg-­‐Al-­‐LDHs,	  MII:MIII	  ratios	  between	  2:1	  and	  
4:1	  were	  reported	  [94].	  In	  this	  LDH	  system,	  attempts	  for	  higher	  ratios	  led	  to	  the	  
formation	  of	  Mg(OH)2,	  whereas	  higher	  contributions	  of	  Al3+	  led	  to	  the	  formation	  
of	  Al(OH)3.	  Similar	  results	  were	  observed	  for	  Ni-­‐Al-­‐LDHs	  [95].	  Variation	  of	   the	  
cation	   ratio	   can	   be	   detected	   by	   elemental	   analysis	   and	   indirectly	   by	   X-­‐ray	  
diffraction.	   In	  case	  of	  Mg-­‐Al-­‐	  and	  Mg-­‐Fe-­‐LDHs,	   the	  respective	  (003)	  reflections	  
were	  as	  expected	  reported	  to	  shift	  to	  smaller	  reflection	  angles	  when	  the	  amount	  
of	  larger	  cations	  was	  increased	  [94,96].	  	  
In	  the	  context	  of	   the	  adsorption	  of	  norfloxacin	  (a	  broad-­‐spectrum	  antibiotic)	  a	  
Mg-­‐Al-­‐LDH	   system	  with	   varying	  Mg:Al	   ratios	   and	   supplementations	  with	   Sn4+	  
ions	  was	  investigated.	  It	  was	  found	  that	  the	  increase	  of	  Al3+	  ion	  contribution	  led	  
to	   enhanced	   sorption	   properties,	   whereas	   incorporation	   of	   Sn4+	   led	   to	   an	  
attenuation	  [97].	  	  
Besides	   the	  mentioned	  MII-­‐MIII	   systems,	  also	  Li-­‐Al-­‐LDHs	  can	   form	  according	  to	  
the	   more	   general	   LDH	   formula	   [Mz+1–xMIIIx(OH)2]ζ+[An–]ζ/n∙yH2O	   with	   z=1	   and	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ζ	  =	  2x−1	  (adapted	  from	  [87]).	  This	  formula	  also	  describes	  the	  MII-­‐MIII-­‐LDHs	  for	  
which	   z=2	   and	   ζ	  =	  x.	   In	   accordance	  with	   their	  MII-­‐MIII	   counterparts,	   inorganic	  
and	   organic	   anions	   were	   intercalated	   into	   Li-­‐Al-­‐LDHs.	   Exemplarily,	   fenbufen	  
was	  intercalated	  into	  Li-­‐Al-­‐	  as	  well	  as	   into	  Mg-­‐Al-­‐,	  Zn-­‐Al-­‐	  and	  Fe-­‐Al-­‐LDHs	  [98].	  
Whereas	  Mg-­‐LDHs	   can	   be	   derived	   from	  brucite	   (Mg(OH)2),	   Li-­‐Al-­‐LDHs	   can	   be	  
derived	   from	   Al(OH)3.	   Exemplarily,	   a	   Li-­‐Al-­‐Cl-­‐LDH	   was	   obtained	   by	   the	  
intercalation	  of	  LiCl	  in	  Al(OH)3	  (gibbsite),	  with	  Li+	  ions	  filling	  vacant	  octahedral	  
voids	   in	   the	  hexagonal	  Al(OH)3	   lattice	   [99].	   Intriguingly,	   a	  Li-­‐Al-­‐Cl-­‐LDH	  with	  a	  
rhombohedral	   stacking	   sequence	   was	   synthesized	   by	   intercalation	   of	   LiCl	   in	  
bayerite.	   This	   LDH	   system	   showed	   anion	   exchange	   capability	   towards	  
dicarboxylate	  anions,	  e.g.	  malonate	  and	  fumarate	  [100].	  However,	  a	  variation	  of	  
the	   cation	   ratio	   could	  not	   be	   found	   in	   literature,	   hence	   the	   formulae	   reported	  
comprised	  [Li0.33Al0.66(OH)2]	  and	  [LiAl2(OH)6],	  respectively	  [87].	  	  
Various	   cations	   and	   cation	   combinations	   were	   reported	   to	   form	   LDHs.	   In	  
contrast	  to	  single	  compounds,	  such	  as	  the	  corresponding	  MII-­‐	  or	  MIII	  hydroxides,	  
properties	  of	  the	  LDHs	  can	  be	  altered	  by	  the	  variation	  of	  the	  ion	  species,	  cation	  
ratios	   and	   by	   incorporation	   of	   further	   elements.	   Mg-­‐LDHs	   with	   different	  
trivalent	  cations	  and	  Mg-­‐Al-­‐LDHs	  with	  different	  cation	  ratios	  were	  employed	  in	  
course	  of	  the	  examinations	  described	  in	  sections	  5.2	  and	  5.3.	  
	  
Inorganic	  anions	  
Besides	   the	  variation	  of	   cations,	   the	   targeted	   intercalation	  of	   inorganic	   anions	  
into	   the	   interlayers	   is	   another	   possibility	   to	   tune	   the	   composition	   and	  by	   this	  
properties	  of	  the	  respective	  LDH	  system.	  Furthermore,	  the	  uptake	  of	  potentially	  
hazardous	   anions	   by	   LDH	   materials	   is	   of	   interest	   with	   regard	   to	   safety	  
applications.	  
As	   in	   hydrotalcite,	   simple	   anions	   such	   as	   Cl−,	   HPO42−,	   I−,	   NO3−,	   OH−	   and	   SO42−	  
were	   found	   in	   the	   interlayers	  of	  different	  LDHs	   [87].	   In	   general,	   the	   following	  
schematic	  stability	  sequence	  of	  monovalent	  mineral	  acid	  anions	  was	  found:	  OH−	  
>	   F−	   >	   Cl−	   >	   Br−	   >	   NO3−	   >	   I−,	   whereas	   for	   bivalent	   anions	   CO32−	   >	   SO42−	   was	  
reported	   [15].	  This	   sequence	  was	   complemented	  with	   further	   species	   and	   the	  
comparison	  between	  monovalent	   and	  bivalent	   anions,	   leading	   to:	   SO42−	  >	  F−	  >	  
HPO42−	   >	   Cl−	   >	   B(OH)4−	   >	   NO3−	   [101].	   These	   sequences	   imply	   the	   particular	  
challenge	  of	  the	  exclusion	  of	  carbon	  dioxide	  and	  carbonate	  ions	  in	  the	  syntheses	  
of	  LDHs	  of	  other	  anions,	  which	  are	  less	  stable.	  Exemplarily,	  the	  extensive	  affinity	  
of	  carbonate	   ions	   in	   the	  Mg-­‐Al-­‐LDH	  system	  and,	  by	   this,	   the	  decrease	   in	  anion	  
adsorption	   and	   exchange	   properties	   (for	   2,4,6-­‐trinitrophenol	   and	  
dodecylbenzylsulfonate,	  respectively)	  of	  the	  CO3-­‐LDH	  in	  comparison	  to	  a	  Cl-­‐LDH	  
were	  shown	  [102].	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The	  capability	   to	   incorporate	  various	   inorganic	  anions	  opens	  the	  possibility	   to	  
use	  LDHs	  for	  the	  uptake	  of	  anions	  that	  have	  to	  be	  removed	  from	  the	  respective	  
environments.	   For	   example,	   the	   uptake	   of	   boron	   species	   [103]	   and	   oxyanions	  
such	   as	   arsenate	   or	   chromate	   [85]	   in	   the	   context	   of	   water	   purification	   were	  
evaluated.	  Oxyanions	  of	  heavy	  metals	  such	  as	  V10O286−	  and	  Mo7O246−	  [104]	  and	  
Keggin	  ions	  (H2W12O406−)	  [105]	  were	  intercalated	  into	  Mg-­‐Al-­‐LDHs,	  whereas	  the	  
stability	   sequence	   SeO42−	   >	   CrO42−	   >	   MoO42−	   was	   found	   for	   a	   Ca-­‐Al-­‐SO4-­‐LDH	  
system	   [106].	   Furthermore,	   Ni-­‐Al-­‐LDHs	   with	   intercalated	   coordination	  
compounds	  such	  as	  hexacyanoferrate(II)	  [107]	  and	  hexacyanoferrate(III)	  [108]	  
were	  synthesized.	  	  
Various	  inorganic	  anions,	  including	  simple	  anions	  derived	  from	  mineral	  acids	  as	  
well	   as	   more	   complex	   polyoxometalates	   were	   incorporated	   into	   LDH	  
interlayers.	   Stability	   sequences	   depending	   on	   the	   intercalant	   were	   found,	  
allowing	  for	  targeted	  variation	  of	  LDHs	  and	  LDHs	  based	  materials.	  	  	  	  
	  
Organic	  anions	  
Besides	   the	   inorganic	   anions	   mentioned,	   a	   variety	   of	   organic	   anions	   were	  
reported	   to	   be	   suitable	   intercalants	   for	   different	   LDH	   systems	   allowing	   for	  
further	   variation	   of	   this	   class	   of	   materials.	   Intercalation	   of	   functional	   and	  
bioactive	  anions,	   respectively,	   gives	  possibilities	   for	  potential	   bio	  applications.	  
Also,	  the	  potential	  for	  a	  controlled	  release	  from	  LDH	  based	  materials	  was	  in	  the	  
focus	  of	  many	  studies.	  In	  the	  following,	  a	  brief	  overview	  on	  organic	  intercalants	  
and	  potential	  application	  fields	  is	  given.	  
Comparison	  of	  inorganic	  LDHs	  with	  organically	  modified	  LDHs	  emphasizes	  the	  
influence	  of	  the	  interlayer	  anion.	  Particle	  charge,	  surface	  polarity,	  exchange	  and	  
adsorption	   properties	   were	   shown	   to	   be	   affected	   strongly	   by	   the	   interlayer	  
anion,	  as	  it	  was	  exemplarily	  assessed	  for	  a	  Mg-­‐Al-­‐Cl-­‐LDH	  and	  a	  dodecylsulfate-­‐
LDH	  [109].	  	  
Intercalation	   and	   combination,	   respectively,	   with	   functional	   organic	   anions	  
might	   widen	   the	   spectrum	   of	   applications	   of	   LDH-­‐based	   materials.	   In	   some	  
cases,	  enhanced	  acid	  resistance	  [110]	  and	  thermal	  stability	  [111]	  were	  reported	  
for	   intercalated	   organic	  molecules.	   LDHs	  with	   thermally	   stabilized	   dyes	  were	  
considered	  for	  the	  potential	  application	  in	  paints	  [112]	  and	  for	  the	  use	  in	  solid-­‐
state	   dye	   lasers	   and	   chemical	   sensors	   [113].	   Labeling	   of	   LDH	   particles	   with	  
fluorescent	  dyes	  for	  particle	  tracking	  in	  biological	  environments	  was	  evaluated	  
[114],	   and	   the	   uptake	   of	   non-­‐biodegradables	   and	   dyes	   is	   also	   of	   interest	   for	  
wastewater	  cleaning	  [115].	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Combination	  with	  bioactive	  agents	  opens	  pathways	   for	  various	  applications	   in	  
the	   field	   of	   biomaterials	   and	   biomedicine.	   Hence,	   this	   topic	   has	   found	  
consideration	  in	  numerous	  journal	  articles	  and	  reviews	  and	  merely	  an	  overview	  
and	   comparably	   few	   examples	   can	   be	   considered	   for	   this	   discussion.	   With	  
regard	   to	  medical	   application	   (subsections	  2.2.4	   and	  2.2.5)	  different	   substance	  
classes	  were	  reported	  to	  be	  suitable	   for	   intercalation	  and	  release	  systems:	  e.g.	  
antibiotics,	   anticancer	   agents,	   vitamins,	   amino	   acids	   and	   peptides,	  
anticardiovascular	   agents,	   agents	   for	   diabetes	   or	   osteoporosis	   treatment,	  
antifibrinolytic	   agents,	   antihypertensives,	   liposomes,	   antimycotic,	  
anticoagulants,	   antioxidants	   immunosuppressant	   corticosteroids	   and	  
nucleosides	   [24].	   Numerous	   non-­‐steroidal	   antiinflammatory	   drugs	   (NSAIDs)	  
were	  found	  to	  be	  suitable	  for	  the	  intercalation	  in	  LDH	  interlayers	  [23].	  In	  some	  
cases,	  multiple	  organic	  modifications	  were	  performed	  with	  LDHs,	  exemplarily,	  
the	   enzyme	   penicillin	   G	   acylase	   was	   immobilized	   on	   a	   glutamate-­‐Mg-­‐Al-­‐LDH	  
[110].	  	  
With	  regard	  to	  the	  use	  for	  pharmaceutical	  and	  nutraceutical	  applications,	  Zn-­‐Al-­‐
LDHs	   with	   vitamins	   (vitamin	  A:	   retinoic	   acid,	   vitamin	  C:	   ascorbic	   acid	   and	  
vitamin	  E:	  tocopherol)	  as	  intercalants	  were	  synthesized	  and	  examined	  [116].	  	  
A	   LDH	   system	   that	   can	   be	   found	   remarkable	   frequently	   is	   the	   Mg-­‐Al-­‐LDH	  
system.	   Many	   examples	   of	   organically	   modified	   Mg-­‐Al-­‐LDH	   were	   reported,	  
comprising	  substances	  from	  the	  classes	  mentioned	  above	  [24].	  Amongst	  various	  
others,	   vitamin	  derivates	   (thiamine	  pyrophosphate)	   [117],	  NSAIDs	   (diclofenac	  
and	   ibuprofen)	  [118,119],	  antibiotics	  (chloramphenicol)	   [120,121],	  amino	  acid	  
anions	  (derived	  from	  L-­‐proline,	  aspartic	  acid	  and	  glutamic	  acid)	  [122,123]	  and	  
nucleoside	  monophosphates	  (CMP,	  AMP	  and	  GMP)	  were	  intercalated.	  Even	  the	  
intercalation	  of	  DNA	  was	  reported	  [124,125],	  but	  doubts	  remain	  with	  regard	  to	  
the	   actual	   nature	   of	   the	   material,	   i.e.	   whether	   it	   is	   a	   true	   intercalation	  
compound.	  A	  selection	  of	  intercalants	  is	  shown	  in	  Fig.	  9.	  
	  
	  
Fig.	   9:	   From	   left	   to	   right:	   dodecylsulfate	   (anionic	   surfactant),	   ascorbic	   acid	  
(vitamer,	  vitamin	  C),	  diclofenac	  (NSAID)	  and	  L-­‐proline	  (amino	  acid).	  
	  
Numerous	   intercalation	   compounds	   comprising	   different	   organic	   anions	   with	  
various	  LDHs	  were	  reported,	   indicating	  a	  vast	  tunability	  of	  LDHs.	   In	  particular	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the	   organic	   modification	   with	   bioactive	   compounds	   might	   vastly	   widen	   the	  
spectrum	  of	  possible	  application.	  Also,	  enhanced	  stability	  of	  intercalated	  species	  
in	   comparison	   to	   pristine	   substances	   was	   reported	   in	   some	   cases.	   However,	  
stability	   and	   exchange	  properties	   of	   the	   intercalants	   under	   in	  vivo	   or	   complex	  
in	  vitro	  conditions	  have	  been	  barely	  in	  the	  focus	  of	  investigations.	  	  
	  
Orientation	  of	  anions	  
Not	   only	   can	   the	   choice	   of	   the	   respective	   anions,	   but	   also	   their	   orientation	  
within	   the	   interlayers	   influence	   the	   properties	   of	   the	   respective	   LDH.	  
Furthermore,	   stability	   and	   properties	   of	   the	   anions	   were	   also	   affected	   by	  
intercalation	  as	   reported	   in	   some	  cases.	   	  Variations	  of	   the	  orientation	  and	   the	  
alignment	  of	  the	  interlayer	  anions	  result	  in	  a	  shift	  of	  interlayer	  distances,	  which	  
can	  be	  easily	  detected	  by	  X-­‐ray	  diffraction	  [126].	  
Orientation	  and	  alignment	  of	  the	  respective	  anions	  was	  shown	  to	  depend	  on	  the	  
choice	  of	  intercalant.	  Exemplarily,	  ascorbate	  and	  citrate	  anions	  were	  found	  as	  a	  
monolayer	  stacking	   in	  Zn-­‐Al-­‐LDHs,	  whereas	   retinoate	  and	   indole	  acetate	  were	  
found	  as	  a	  bilayer	  stacking	  in	  similarly	  prepared	  Zn-­‐Al-­‐LDHs	  (Fig.	  10)	  [116].	  	  
	  
	  
Fig.	  10:	  Anion	  stacking	  in	  the	  interlayers	  of	  LDHs	  (modified	  from	  ref.	  [116]).	  
	  
The	  orientation	  and	  in	  particular	  the	  alignment	  of	  methyl	  orange	  intercalated	  in	  
Mg-­‐Al-­‐LDH	  were	  considered	  to	  be	  responsible	  for	  the	  photostability	  of	  the	  dye	  
molecules.	   The	   rigid	   LDH	   layers	   stabilized	   certain	   configurations	   and	   by	   this	  
hindered	  photoisomerization	  [113].	  Tilt	  angle	  (74°),	  arrangement	  and	  enhanced	  
stability	   of	   the	   methyl	   orange	   ions	   were	   confirmed	   by	   molecular	   simulation	  
[127].	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Also,	   orientation	   can	   be	   influenced	   by	   the	   synthesis	   conditions.	   Sterically	  
demanding	  dodecyl	   sulfate	   ions	  were	   reported	   to	  be	   intercalated	  via	  different	  
methods.	  Depending	  on	   the	  synthesis	  protocols,	  varying	  degrees	  of	   interlacing	  
of	  the	  dodecyl	  chains	  were	  found,	  leading	  to	  LDHs	  with	  different	  basal	  spacings:	  
≈	  26	  Å,  ≈	  36	  Å	  and	  ≈	  47	  Å	  (Mg-­‐Al-­‐	  and	  Ni-­‐Al-­‐LDH	  systems).	  Two	  different	  cases	  
of	  interlacing	  are	  schematically	  shown	  in	  Fig.	  11	  (according	  to	  information	  from	  
ref.	  [128]).	   However,	   basal	   spacings	   in	   these	   systems	   were	   reported	   to	   be	  
independent	  of	   the	  amount	  of	  dodecyl	  sulfate	   in	   the	   interlayers	  [128].	  Besides	  
orientation,	   swelling	   behavior	   of	   Mg-­‐Al-­‐,	   Ni-­‐Al-­‐	   and	   Co-­‐Al-­‐LDHs	   intercalated	  
with	  2-­‐hydroxyethanesulfonate	  was	  examined.	  Basal	  spacing	  were	  found	  to	  be	  
increased,	  depending	  on	  relative	  humidity	  [129].	  	  
	  
	  
Fig.	  11:	  Two	  different	  forms	  of	  anion	  interlacing	  in	  LDH	  interlayers	  (according	  
to	  information	  from	  ref.	  [128]).	  
	  
Orientation	  and	  alignment	  of	  the	  interlayer	  anion	  were	  shown	  to	  influence	  the	  
properties	  of	  both	  the	  intercalated	  species	  and	  the	  resulting	  LDH.	  In	  particular	  
the	  interlayer	  distance	  is	  affected	  by	  orientation	  and	  alignment,	  and	  hence	  was	  
in	  the	  focus	  of	  material	  characterization.	  Thus,	  besides	  composition,	  orientation	  
and	  alignment	  are	  variable	  attributes	  that	  have	  to	  be	  considered	  in	  the	  course	  of	  
LDH	  material	  evaluation.	  
	  
Morphology	  
Variation	  of	  particle	  morphology	  offers	  further	  possibilites	  for	  the	  modification	  
of	   LDHs.	   Commonly,	   LDH	   particles	   found	   were	   reported	   as	   hexagonal	   plates	  
[130].	   SEM	   images	   of	   hexagonally	   shaped	   Mg-­‐Al-­‐CO3-­‐LDH	   nanoparticles	   are	  
shown	  in	  Fig.	  12.	  The	  SEM	  images	  were	  collected	   in	  the	  course	  of	   the	  diploma	  
thesis	   of	   the	   author	   of	   this	   thesis:	   “Doppelhydroxide	   mit	   Schichtstruktur:	   ihr	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Auflöseverhalten	   und	   ihre	   Eignung	   als	   Implantatbeschichtung”	   (“Layered	  
double	  hydroxides:	  their	  degradation	  behavior	  and	  their	  applicability	  as	  implant	  
coatings”,	  2010,	  Leibniz	  Universität	  Hannover).	  	  
Employing	  sophisticated	  synthesis	  protocols	   that	   included	  the	  addition	  of,	  e.g.,	  
organic	   solvents	   and	   surfactants,	   and	   various	   types	   of	   heat	   treatment,	  
respectively,	   a	   variety	   of	   morphologies	   were	   generated.	   However,	   novel	  
morphologies	   predominantly	   resulted	   from	   stacking	   and	   intergrowth	   of	   the	  
hexagonal	  particles	  mentioned.	  	  
	  
	  	   	  
Fig.	   12:	   SEM	   images	   of	   hexagonally	   shaped	  Mg-­‐Al-­‐CO3-­‐LDH	  nanoparticles	   as	   a	  
coating	  on	  a	  TiAl6V4	  substrate.	  
	  
Assembly	  of	  sheet-­‐shaped	  LDH	  particles	  led	  to	  the	  formation	  of	  flower-­‐like	  and	  
octahedron-­‐shaped	   Co-­‐Fe-­‐LDH	   particles,	   respectively.	   Synthesis	   protocols	  
comprised	  an	  ethylene	  glycol	  based	  reaction	  solution	   in	  the	  presence	  of	   lysine	  
[131].	   Rod-­‐like	   LDH	   particles	   with	   stacked	   platelets	   were	   obtained	   from	   an	  
isooctane	  based	  solution	  with	  dodecylsulfate,	  1-­‐butanol,	  and	  a	  nonionic	  triblock	  
copolymer	  P1940	  as	  surfactants	  [132].	   	   Interestingly,	  the	  morphology	  changed	  
to	  belt-­‐like	  structures	  in	  which	  the	  LDH	  particles	  exhibited	  an	  oriented	  growth,	  
corresponding	  to	  a	  varied	  aspect	  ratio,	  when	  P1940	  was	  added	  during	  an	  earlier	  
step	   in	   the	   synthesis	   [132].	   Another	   approach	   that	   resulted	   in	   LDH	   particles	  
with	  varied	  aspect	  ratio	  employed	  high	  concentrations	  of	  H2O2.	  LDH	  sheets	  with	  
reduced	   thickness	   were	   obtained	   via	   the	   separation	   of	   Zn-­‐Al-­‐LDH	   layers,	  
presumably	  triggered	  by	  the	  decomposition	  of	  the	  H2O2	  [133].	  
Also	   hollow	   particles	   at	   the	   low	  micrometer	   scale	   were	   obtained.	   Ni-­‐Co-­‐LDH	  
nanocages	  were	  obtained	  by	  exposing	  a	  metal-­‐organic	  framework	  precursor,	  in	  
particular	   zeolithic	   imidazolate	   framework-­‐67	   (ZIF-­‐67),	   to	   a	   solution	  of	  nickel	  
nitrate	   in	   ethanol.	   After	   reflux,	   hollow	   LDH	   nanocages	   formed	   from	   thin	   LDH	  
platelets	  (Fig.	  13)	  [134].	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Fig.	   13:	   SEM	   and	   TEM	   images	   of	   Co-­‐LDH	   (a-­‐c:	   Mg-­‐Co-­‐LDHs,	   d-­‐f:	   Ni-­‐Co-­‐LDHs)	  
cages.	  The	  selected	  selected	  area	  electron	  diffraction	  (SAED)	  pattern	  of	  a	  single	  
Mg-­‐Co-­‐LDH	  cage	  is	  shown	  in	  the	  inset	  of	  c)	  (modified	  from	  ref.	  [134]).	  
	  
Mg-­‐Fe-­‐LDH	   microspheres	   were	   synthesized	   by	   an	   autoclave	   treatment	   of	   a	  
metal	  salt	  solution	  in	  ethylene	  glycol.	  The	  microspheres	  were	  also	  composed	  of	  
LDH	  platelets	   [135].	   Solid	  Mg-­‐Al-­‐LDH	  microspheres,	   also	   consisting	  of	   smaller	  
flake-­‐shaped	  LDH	  particles,	  were	   obtained	  by	   spray	  drying	   of	   an	  LDH	  aerosol	  
dispersion	  [136].	  
A	  centimeter	  scale	  monolithic	  xerogel	   from	  a	  Mg-­‐Al-­‐LDH	  system	  was	  obtained	  
by	  a	  LDH	  precursor	  which	  was	  synthesized	  by	  sol-­‐gel	  reaction	  in	  water/ethanol	  
with	  poly(ethylene	  oxide)	  and	  propylene	  oxide.	  Subsequently	  to	  calcination,	  the	  
precursor	   was	   exposed	   to	   a	   sodium	   carbonate	   solution,	   and	   exhibited	  
hierarchical	   channels	   and	   enhanced	   sorption	   affinity	   for	   pyranine	   [137].	  
Neglecting	   the	  exposure	   to	  an	  aqueous	  solution	  subsequent	   to	   calcination,	   the	  
thermally	  caused	  decomposition	  of	  a	  Mg-­‐Al-­‐LDH	  was	  further	  employed	  for	  the	  
targeted	   synthesis	   of	   a	   hierarchical,	   porous	   mixed	   Mg-­‐Al	   oxide	   [138].	   Both	  
hierarchical	   materials,	   LDHs	   and	   mixed	   metal	   oxides,	   were	   considered	  
interesting	  for	  applications	  in,	  e.g.,	  catalysis	  and	  adsorption	  [137,138].	  	  	  
LDH	   particles	   at	   nanometer	   and	   micrometer	   scale	   with	   novel	   morphologies	  
such	   as	   hollow	   and	   solid	   spheres,	   respectively,	   were	   obtained	   via	   different	  
synthesis	  routes.	  Commonly,	  novel	  morphologies	  were	  deducible	  from	  smaller,	  
platelet-­‐like	  LDH	  particles.	  By	  employing	  sophisticated	  reaction	  protocols,	  also	  
particles	   with	   varied	   aspect	   ratios	   and	   substances	   with	   enhanced	   surface	  
properties	  were	  obtained.	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2.2.3	  	   Synthetic	  methods	  
An	  overview	  on	  various	  possibilities	  to	  obtain	  and	  modify	  LDHs	  is	  given	  in	  the	  
following	   subsection.	   In	   accordance	   with	   the	   variability	   described	   above,	  
composition	   and	  morphology	   and	   thus	   the	   properties	   of	   the	   products	   can	   be	  
influenced	  at	  various	  steps	  of	  the	  synthesis	  protocols.	  Precipitation	  is	  commonly	  
the	  method	  of	  choice	  in	  order	  to	  obtain	  LDHs.	  Depending	  on	  the	  affinity	  of	  the	  
interlayer	   anion,	   anion	   exchange	   reactions	   can	   be	   employed	   to	   obtain	   novel	  
materials	   such	   as	   organically	   modified	   LDHs.	   Calcined	   LDHs	   also	   feature	   a	  
structure	  memory	  effect,	  which	  allows	  the	  LDHs	  to	  be	  reformed	  from	  the	  mixed	  
metal	  oxides	  when	  exposed	  to	  aqueous	  conditions	  [16].	  For	  many	  LDH	  systems,	  
protocols	  for	  the	  synthesis	  of	  colloidal	  suspension	  were	  reported.	  Furthermore,	  
novel	  and	  rare	  syntheses	  are	  discussed.	  	  
	  
Precipitation	  
Coprecipitation	   is	   a	   common	   approach	  which	  was	   successfully	   applied	   in	   the	  
synthesis	  of	  various	  LDHs.	  This	  method	  was	  also	  chosen	  for	  the	  synthesis	  of	  the	  
LDH	   materials	   applied	   in	   our	   work	   as	   described	   in	   chapters	  4	   and	   5.	   In	  
principle,	  precursor	  solutions	  of	  metal	  salts	  and	  base	  are	  either	  combined	  in	  a	  
reaction	   vessel	   or	   one	   solution	   is	   added	   to	   the	   other.	   Different	   anions	   can	   be	  
added	   in	   form	   of	   soluble	   salts	   to	   the	   base	   solution,	   if	   the	   respective	   anion	   is	  
stable	   under	   these	   alkaline	   conditions.	   Coprecipitation	   can	   be	   performed	  
including	   pH	   control,	   where	   the	   range	   is	   determined	   by	   the	   solubility	   of	   the	  
separated	  metal	  hydroxides.	  As	  expected,	   the	  pH	  required	   to	   form	  the	  desired	  
LDH	   system	   is	   increased	  with	   increased	   solubility	   of	   the	  MII	   hydroxide.	   For	   a	  
sufficiently	  soluble	  MIII	  hydroxide	  (e.g.	  Cr3+)	  the	  precipitation	  occurs	  in	  one	  step,	  
whereas	   for	   lowly	   soluble	   MIII	   hydroxides	   (e.g.	   Al3+	   and	   Fe3+)	   the	   metal	  
hydroxides	  were	   found	  as	   intermediates.	  Due	  to	  their	  role	  as	  reactants	   for	   the	  
LDH	   formation,	   the	   pH	   is	   increased	   with	   decreased	   MIII	   hydroxide	   solubility.	  
[88,89].	   If	   applicable,	   amphoteric	   properties	   of	   the	   respective	  MIII	   hydroxides	  
have	   to	   be	   considered	   in	   the	   course	   of	   precipitation	   and	   further	   treatment	  
including	  strong	  bases	  in	  order	  to	  avoid	  dissolution	  of	  the	  products	  formed.	  	  
Coprecipitation	   can	   be	   performed	   with	   various	   simple	   anions;	   however,	   the	  
exclusion	  of	  carbonate	  is	  a	  key	  challenge.	  Whereas	  according	  to	  many	  synthesis	  
protocols	   NaOH	   is	   used	   as	   the	   base,	   ammonium	   hydroxide	   was	   used	   for	   the	  
synthesis	  of	  nitrate	  LDHs	  (Mg-­‐Al)	  which	  are	  of	  high	  interest	  for	  anion	  exchange	  
reactions	  due	   to	   the	   facile	   exchange	  of	  nitrate	   ions.	  Despite	   the	   absence	  of	   an	  
inert	  gas	  blanket,	  nitrate	  ions	  were	  intercalated	  preferentially,	  presumably	  due	  
to	  a	  complexation	  of	  carbonate	  ions	  by	  ammonium	  ions	  [139].	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Following	  an	  alternative	  pathway,	  the	  homogeneous	  precipitation	  is	  triggered	  at	  
elevated	   temperatures	   by	   the	   decomposition	   of	   urea,	   which	   is	   added	   to	   the	  
metal	  salt	  solution	  prior	  to	  heating.	  The	  homogeneous	  precipitation	  occurs	  due	  
to	   the	   formation	  of	   ammonium	  carbonate	   in	   this	  one-­‐pot	   approach.	   Following	  
this	  method,	  aluminium-­‐LDHs	  with	  Mg2+,	  Ni2+	  and	  Zn2+	  as	  bivalent	  cations	  were	  
successfully	   synthesized	   first	   [140].	   A	   similar	   approach	   was	   used	   for	   the	  
precipitation	   of	   hydrotalcite	   [141]	  which	   can	   be	   designated	   the	   prototype	   for	  
Mg-­‐Al-­‐LDHs.	   However,	   this	   method	   is	   accompanied	   by	   the	   presence	   of	   large	  
amounts	   of	   carbonate	   ions,	   which	   renders	   this	   method	   unpractical	   for	   the	  
synthesis	  of	  reactive	  precursor	  LDHs	  such	  as	  nitrate	  LDHs.	  	  
	  
Anion	  exchange	  	  
The	   inherent	  capability	  of	  LDHs	   to	  perform	  anion	  exchange	  reactions	   is	  based	  
on	   different	   affinities	   of	   anions	   to	   the	   respective	   interlayers	   and	   entropical	  
reasons.	   This	   method	   was	   used	   and	   investigated	   for	   various	   LDH,	   including	  
inorganic	  LDHs	  [15,142]	  as	  well	  as	  organically	  modified	  LDHs	  [143].	  Despite	  the	  
large	   and	   increasing	   number	   of	   LDH	   compounds	   obtained	   via	   the	   anion	  
exchange	  route,	  the	  exact	  mechanism	  has	  not	  been	  described	  yet.	  	  
Commonly,	   anion	   exchange	   reactions	   are	   performed	   by	   adding	   a	   solution	  
containing	   the	   dissolved	   anion	   to	   a	   dispersion	   of	   the	   precursor-­‐LDH.	   The	  
mixture	   is	   subsequently	   stirred	   for	   a	   period	   of	   days	   at	   room	   temperature	   or	  
slightly	  elevated	  temperatures.	  
Availability	  of	  a	  reactive	  precursor	  LDH	  with	  a	  weakly	  bonded	  anion	  is	  crucial	  
for	   the	  anion	  exchange.	  Since	  anions	  such	  as	  nitrate	  or	  chloride	  anions	  can	  be	  
relatively	   easily	   replaced	   by	   various	   other	   anions,	  NO3-­‐LDHs	   and	  Cl-­‐LDHs	   are	  
interesting	   precursors	   for	   the	   synthesis	   of	   various	   other	   LDHs.	   Exemplarily,	  
ciprofloxacin	   (a	  broad-­‐spectrum	  antibiotic)	  was	   intercalated	   into	  a	  Zn-­‐Al-­‐NO3-­‐
LDH	  system	  [111],	  and	  diclofenac	  (an	  NSAID)	  was	  intercalated	  into	  a	  Mg-­‐Al-­‐Cl-­‐
LDH	  [119].	  	  
Intercalation	  of	  hydrophobic	  drugs	   into	   the	  LDH	   interlayers	   is	  of	  high	   interest	  
for	  biomedical	  application;	  however,	  the	  hydrophobic	  nature	  presents	  the	  need	  
for	   sophisticated	   reaction	   protocols,	   comprising	   auxiliary	   substances.	  
Hydrophobic	   agents,	   i.e.	   gramicidin	   and	   amphotericin	  B,	   were	   successfully	  
intercalated	  into	  a	  NO3-­‐LDH	  system	  using	  cholate	  and	  6-­‐O-­‐(N-­‐heptylcarbamoyl)-­‐
methyl-­‐α-­‐D-­‐glucopyranoside	   (Hecameg),	   respectively,	   as	  detergents	   [144].	  The	  
structures	  of	  ciprofloxacin	  and	  amphotericin	  B	  are	  shown	  in	  Fig.	  14.	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Fig.	   14:	   Intercalated	   anions,	   left:	   ciprofloxacin	   (antibiotic)	   and	   right:	  
amphotericin	  B	  (pharmaceutical	  fungicide).	  	  
	  
Recrystallization	  	  
Another	   possibility	   for	   the	   variation	   of	   LDHs	  with	   regard	   to	   the	   anion	   in	   the	  
interlayer	   exploits	   the	   structural	   memory	   effect	   of	   LDHs.	   After	   calcination	   at	  
moderate	   temperatures	   (typically	   between	   573	  K	   and	   773	  K)	   the	   calcination	  
products,	  mixed	  metal	  oxides,	  were	  shown	  to	  reform	  the	  layered	  structure	  when	  
exposed	  to	  aqueous	  solutions.	  In	  the	  course	  of	  the	  recrystallization	  of	  the	  mixed	  
metal	   oxides,	   anions	   from	   the	   respective	   solutions	   are	   incorporated	   in	   the	  
structure	  of	  the	  re-­‐formed	  LDH	  [16].	  	  
This	  method	  was	  shown	  to	  be	  suitable	  for	  the	  targeted	  intercalation	  of	  inorganic	  
and	  organic	  anions	  such	  as	  polyoxometallates	  and	  dodecyl	  sulfates,	  respectively.	  
For	   this,	   calcined	   Mg-­‐Al-­‐LDHs	   (723	  K)	   were	   added	   to	   decarbonated,	   water-­‐
based	   solutions	   of	   the	   respective	   anions	   [145].	   Over	   the	   years,	   various	  
sophisticated	   LDHs	   were	   obtained	   following	   and	   adjusting	   this	   approach.	  
Comparison	  of	  Mg-­‐Al-­‐Cl-­‐	  with	  Mg-­‐Al-­‐CO3-­‐LDH	  indicated	  that	  reconstruction	  and	  
anion	  adsorption	  properties	  of	  the	  calcined	  material	  depend	  on	  interlayer	  anion	  
and	  crystallinity	  of	  the	  pre-­‐calcined	  LDH	  [102].	  
	  
Colloidal	  suspensions	  
Research	   on	   LDH	   particles	   with	   small	   size	   gained	   an	   increasing	   interest,	   and	  
availability	   of	   long-­‐term	   stable	   nanosuspensions	   is	   of	   high	   interest	   for	   many	  
applications	   [146].	   In	   the	   following,	   an	   overview	   on	   synthesis,	   particle	   size	  
control	   and	   potential	   with	   regard	   to	   biomedical	   applications	   of	   LDH	  
nanosuspensions	  is	  given.	  
The	   successful	   synthesis	   of	   Mg-­‐Al-­‐LDH	   nanosuspensions	   was	   reported	   for	  
different	  anions	  and	  also	  for	  varying	  Mg:Al	  ratios.	  Fabrication	  of	  sols	  from	  bulk	  
material	   comprised	   energy	   intake	   from	   ultrasonication	   or	   hydrothermal	  
conditions.	   Average	   particle	   sizes	   were	   reported	   to	   be	   increased	   by	  
hydrothermal	   treatment	   time.	   It	   is	   noted	   that	  both	   a	   too	   short	   and	  a	   too	   long	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hydrothermal	  treatment	  resulted	  in	  unstable	  suspensions	  [17,18].	  Particle	  size	  
distribution	  curves	  of	  Mg-­‐Al-­‐Cl-­‐LDHs	   in	   the	  course	  of	  hydrothermal	   treatment	  
are	  shown	  in	  Fig.	  15	  (from	  ref.	  [17]).	  	  
	  
	  
Fig.	   15:	   Particle	   size	   distribution	   of	   Mg-­‐Al-­‐Cl-­‐LDHs	   in	   the	   course	   of	  
hydrothermal	   treatment	   at	   100	  °C.	   Distribution	   curves	   were	   obtained	   via	  
photon	  correlation	  spectroscopy	  (from	  ref.	  [17]).	  
	  
Employing	   an	   alternative	   source	   of	   energy	   intake,	   a	   colloidal	   Mg-­‐Al-­‐OH-­‐LDH	  
suspension	  was	  obtained	  by	  using	  laser	  ablation	  of	  magnesium	  and	  aluminium	  
targets	   in	   water.	   Cation	   ratio	   and	   phase	   purity	   depended	   on	   the	   synthesis	  
parameters,	  in	  particular	  ablation	  duration	  [147].	  
The	   particle	   size	   distribution	   was	   reported	   to	   be	   narrowed	   by	   separation	   of	  
nucleation	  and	  aging	  steps	  in	  course	  of	  the	  precipitation.	  Thus,	  coprecipitation	  
of	  a	  metal	  salt	  precursor	  solution	  and	  an	  alkaline	  solution	  in	  a	  colloid	  mill	  with	  a	  
following	   aging	   phase	   resulted	   in	   a	   narrow	   size	   distribution	   for	   Mg-­‐Al-­‐LDHs	  
[148].	  Following	  a	  different	  approach,	  a	  narrow	  size	  distribution	  of	  Ca-­‐Al-­‐LDH	  
nanoparticles	   was	   reported	   to	   be	   achieved	   by	   using	   the	   aqueous	   phase	   of	  
reverse	   micelles	   (dodecylsulfate	   in	   isooctane	   and	   butan-­‐1-­‐ol)	   as	   nanoscale	  
reactors	   for	   precipitation.	   Furthermore,	   particles	   size	   was	   varied	   by	   the	  
water:dodecylsulfate	  ratio	  [149].	  	  
With	   regard	   to	   biomedical	   applications,	   LDH	   particles	   with	   small	   size	   are	  
interesting	   as	   delivery	   vehicles	   with	   regard	   to	   protection	   of	   the	   intercalated	  
drug	  and	  cellular	  uptake	  capacity.	  Exemplarily,	  Mg-­‐Al-­‐LDH	  nanoparticles	  were	  
shown	  to	  be	  an	   interesting	  delivery	  system	  for	   intercalated	  Green	  Fluorescent	  
Protein	   (GFP)	   [150]	   and	   intercalated,	   small	   interfering	   RNAs	   (siRNAs).	   In	   the	  
latter	   study,	   intercalation	   and	   delivery	   were	   investigated	   depending	   on	   the	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average	  size	  of	  the	  LDH	  nanoparticles,	  whereas	  smaller	  particles	  were	  found	  to	  
be	  of	  more	  promise	  [151].	  	  
Synthesis	   of	   nanosuspensions	   and	   control	   of	   particle	   size	   were	   achieved	   by	  
energy	   intake,	   i.e.	   ultrasonication	   and	   hydrothermal	   treatment,	   for	   different	  
LDH	   systems.	   Organically	  modified	   LDH	   nanoparticles	   are	   also	   of	   interest	   for	  
biomedical	  applications,	  due	  to	  their	  promise	  as	  delivery	  vehicles.	  Furthermore,	  
LDH	   nanosuspensions	   are	   expected	   to	   feature	   a	   homogeneous	   distribution	   of	  
the	  particles,	  which	   are	  orders	   of	   size	   smaller	   than	   the	   components	  of	   typical	  
processing	   systems	   such	   as	   nozzles	   of	   spray-­‐coating	   devices	   (see	  
subsection	  2.2.4	  and	  sections	  4.2	  and	  5.2).	  	  
	  
Further	  approaches	  
The	  synthesis	  methods	  presented	  above	  each	  present	  their	  own	  advantages	  and	  
disadvantages.	  Development	  of	  new	  synthesis	  routes	  or	  the	  transfer	  of	  synthesis	  
routes	  known	  from	  other	  chemical	  systems	  might	  contribute	  to	  the	  versatility	  of	  
layered	   double	   hydroxides.	   Some	   sophisticated,	   yet	   rarely	   used,	   synthesis	  
protocols	  are	  discussed	  here.	  	  
As	  mentioned	  above,	  in	  the	  context	  of	  corrosion	  protection,	  the	  formation	  of	  Mg-­‐
LDHs	   on	   the	   surface	   of	   metallic	   magnesium	   was	   used	   as	   a	   synthesis	   route	  
(subsection	  2.1.1.).	   Pure	   magnesium	   was	   exposed	   to	   a	   moderately	   acidic,	  
aqueous	  solution	  of	  Fe3+	  and	  a	  hydrogen	  carbonate	  /	  carbonate	  system	  in	  order	  
to	  generate	  Mg2+	  ions.	  In	  principle,	  an	  increase	  of	  pH	  and	  temperature	  resulted	  
in	   the	   growth	   of	   an	   oriented	   Mg-­‐Fe-­‐LDH	   film	   that	   increased	   the	   substrates	  
corrosion	   resistance	   [41].	   A	   similar	   approach	  utilizing	   a	  Mg-­‐Al-­‐Zn	   alloy	   led	   to	  
the	   formation	   of	   a	   LDH	   film	   comprising	   Mg2+	   and	   Al3+	   [42].	   In	   a	   different	  
approach,	   a	   Mg-­‐Al-­‐LDH	   was	   synthesized	   by	   hydrolysis	   of	   metal	   hexanolate	  
precursors,	  which	   in	   turn	  were	   obtained	   by	   reaction	   of	   the	   respective	  metals	  
with	  the	  alcohol	  [152].	  
An	  approach	   in	   the	  solid	  state	   that	  excluded	  the	  employment	  of	  a	  solvent	  was	  
carried	  out	  for	  the	  synthesis	  of	  a	  Li-­‐Al-­‐LDH	  by	  grinding	  precursors,	  i.e.	  LiOH∙H2O	  
and	  polycrystalline	  Al(OH)3,	  in	  a	  mortar,	  and	  subsequently	  exposing	  the	  mixture	  
to	  water	  vapor	  [153].	  Also	  a	  Mg-­‐Al-­‐LDH	  with	  hydrogen	  carbonate	  and	  carbonate	  
as	   anions	   was	   obtained	   by	   grinding	   Mg(OH)2,	   Al(OH)3	   and	   NaHCO3	   in	   a	  
planetary	   mill.	   The	   product	   was	   obtained	   after	   washing	   with	   water	   and	  	  
subsequent	  drying	  [154].	  As	  mentioned	  above,	  successful	  exclusion	  of	  carbonate	  
ions	   in	   the	   preparation	   of	   NO3-­‐LDHs	   is	   of	   interest	   for	   subsequent	   use	   of	   the	  
LDHs	   as	   reactive	   precursors	   for	   organically	   modified	   LDHs.	   Employing	   the	  
mechanochemical	   approach,	   grinding	  of	  NaOH	  pellets	  with	  magnesium	  nitrate	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and	  aluminium	  nitrate	  led	  to	  the	  formation	  of	  a	  carbonate-­‐free	  Mg-­‐Al-­‐NO3-­‐LDH.	  	  
Further	  treatment	  and	  purification	  included	  washing	  with	  deionized	  water	  and	  
drying	  under	  vacuum	  [155].	  
Another	   approach	   for	   the	   intercalation	   of	   organic	   substances	   into	   LDHs,	  
avoiding	  the	  employment	  of	  water	  as	  solvent,	  comprised	  the	  thermal	  reaction	  of	  
molten	   sebacic	   acid	   with	   Mg-­‐Al-­‐CO3-­‐NO3-­‐LDH.	   The	   substances	   were	   mixed	  
thoroughly	   and	   heated	   to	   150	  °C.	   Intercalation	   occurred	   to	   a	   certain	   degree,	  
however	  a	  polyphasic	  product	  was	  obtained	   [156].	  A	  precursor	  approach	  was	  
used	   for	   the	   intercalation	   of	   cobalt	   phthalocyanine	   into	   the	   layered	   antimony	  
hydrogen	   phosphate	   (HSb(PO4)2).	   For	   this,	   cobalt	   exchanged	   (8%)	  
phosphatoantimonic	  acid	  was	  refluxed	  with	  molten	  1,2-­‐dicyanobenzene,	  hence,	  
the	  guest	  molecule	  was	  synthesized	  in	  situ	  [157].	  	  
	  
2.2.4	   Development	  of	  layered	  double	  hydroxides	  directed	  towards	  
application	  	  
Layered	  double	  hydroxides	  are	  a	  versatile	  class	  of	  materials,	  providing	  a	  variety	  
of	   possibilities	   in	   order	   to	   meet	   the	   demands	   of	   respective	   applications.	   In	  
particular,	   the	   inherent	   possibility	   to	   vary	   the	   composition	   of	   the	   respective	  
LDH	   system	   within	   wide	   ranges	   while	   maintaining	   the	   general	   formula	   is	  
interesting	   for	   numerous	   potential	   applications.	   Over	   the	   years,	   LDHs	   were	  
shown	  to	  be	  of	  interest	  as	  antacids	  and	  as	  components	  in	  various	  systems	  such	  
as	   in	   catalysts	   and	   polymers.	   LDH	   particles	   were	   shown	   to	   enhance	   key	  
properties	   when	   supplemented,	   and	   appear	   to	   be	   promising	   components	   in	  
sophisticated	   drug	   delivery	   systems.	   For	   both	   technical	   and	   biomedical	  
applications,	   various	   methods	   were	   developed	   and	   applied	   in	   order	   to	   coat	  
substrates	   with	   LDHs.	   In	   the	   following,	   a	   selection	   of	   promising	   LDH	   based	  
systems	  and	  their	  development	  for	  application	  are	  presented.	  
	  
Antacids	  
An	  established	  application	  of	  the	  Mg-­‐Al-­‐CO3-­‐LDH	  system	  is	  its	  administration	  in	  
case	   of	   acid	   indigestion.	   Hydrotalcite,	   [Mg6Al2(OH)16][CO3]∙4H2O,	   has	   emerged	  
as	  a	  commercially	  available	  antacid	  (e.g.	  Talcid®,	  Bayer	  AG),	  which	  is	  promising	  
with	   regard	   to	   potential	   clinical	   applications	   of	  Mg-­‐Al-­‐CO3-­‐LDHs	  derived	   from	  
the	   studies	   presented	   in	   chapters	   4	   and	   5.	   Synthesis	   protocols	   and	   antacid	  
activity	   of	   the	   Mg-­‐Al-­‐CO3-­‐LDH	   system	   have	   also	   been	   in	   the	   focus	   of	   recent	  
investigations	  [22].	  
The	  proton	  scavenging	  properties	  of	  LDHs	  are	  also	  of	  interest	  with	  regard	  to	  the	  
supplementation	   of	   LDH	   particles	   to	   poly(vinyl	   chloride),	   PVC.	   Thermal	  
2	  General	  Principles	   37	  
	  
decomposition	  of	  PVC	  proceeds	  with	  the	  formation	  of	  hydrochloric	  acid,	  which	  
entails	   certain	   danger	   potential	   and	   furthermore	   autocatalyses	  
dehydrochlorination	   of	   PVC.	   Mg-­‐Al-­‐CO3-­‐LDH	   particles	   were	   shown	   to	  
compensate	   the	   protons	   of	   the	   acid	   and	   stabilize	   the	   PVC	   by	   electrostatic	  
attraction	  of	  the	  chloride	  ions	  [158].	  
Polyglycolic	  acid	  (PGA),	  polylactic	  acid	  (PLA)	  and	  their	  copolymers	  (PLGA),	  are	  
known	   as	   established	   biomaterials.	   However,	   in	   the	   course	   of	   the	  
biodegradation	  of	  these	  polyesters	  acidification,	  caused	  by	  acidic	  monomers,	  is	  
expected.	  Supplementation	  with	  alkaline	  inorganic,	  filler	  materials	  was	  reported	  
to	   successfully	   compensate	   this	   acidification	   [159].	   Hence,	   the	  mildly	   alkaline	  
properties	  of	  CO3-­‐LDHs	  could	  also	  contribute	  to	  combined	  materials	  comprising	  
biodegradable	  polyesters	  and	  LDHs.	  	  
	  
Catalysts	  
A	  traditional	   field	  of	  application	  is	  catalysis,	  exploiting	  the	  reactivity	  of	  certain	  
LDH	   systems	   in	   organic	   reactions	   as	   reported	   in	   some	   studies.	   Exemplarily,	   a	  
Cu-­‐Zn-­‐Mn-­‐Fe-­‐Al-­‐LDH	   showed	   reactive	   behavior	   towards	   hydrogen	   peroxide	  
oxidation	   of	   phenol	   [21]	   and	   Mg-­‐Fe-­‐LDH	   microspheres	   towards	   the	  
electrooxidation	   of	   ethanol	   [135].	  Hybridization	   of	   LDHs	  with	   semiconducting	  
nanoparticles	   was	   found	   to	   be	   of	   promise	   for	   photocatalysis,	   due	   to	   lifetime	  
increase	  of	   transient	   electrons	   and	  holes	   [19].	   Exemplarily,	   ZnO	  nanoparticles	  
deposited	  on	  a	  Mg-­‐Al-­‐LDH	  showed	  enhanced	  photocatalytic	  activity	  towards	  the	  
decolorization	  of	  Acid	  red	  G	  in	  comparison	  to	  pristine	  ZnO	  particles	  [160].	  
	  
Polymer	  fillers	  
Application	  of	  LDHs	  as	  components	  in	  nanocomposites	  and	  nanohybrids	  gained	  
interest	   due	   to	   processability	   and	   variability	   of	   LDHs.	   The	   latter	   includes	   the	  
possibility	  of	  LDHs	  to	  be	  organically	  modified	  [19,20].	  For	  large-­‐	  and	  small-­‐scale	  
applications,	   LDHs	   were	   supplemented	   to	   rubber	   composites,	   such	   as	   nitrile	  
rubber	   composites,	   butadiene	   rubber	   composites	   and	   silicone	   rubber	  
composites	   in	   order	   to	   improve	   optical,	   mechanical	   and	   thermal	   properties	  
[126].	  	  
With	   regard	   to	   thermal	   resistance	   of	   the	   composite	  material,	   LDHs	  were	   also	  
combined	  with	   carbon	  modifications.	   The	   joint	   heat	   protection	   effect	   of	   LDHs	  
(Li-­‐Al,	   Mg-­‐Al	   and	   Co-­‐Al)	   and	   carbon	   nanotubes	   (MWCNTs)	   in	   silicones	  
demonstrated	   the	   applicability	   of	   LDHs	   as	   flame-­‐retardants	   [161].	   A	   Ni-­‐Fe-­‐
LDH/graphene	   combination	   showed	  activity	   for	   reducing	   fire	  hazard	   in	   epoxy	  
composites	  [162].	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The	   enhancement	   of	   thermal	   resistance	   by	   the	   supplementation	   with	   LDH	  
particles	   is	   attributed	   to	   the	   release	   of	   water	   vapor	   and	   a	   barrier	   effect,	  
separating	   the	   substrate	   from	   the	   oxygen	   [126].	   Depending	   on	   the	  
polymer/LDH	   combination,	   the	   formation	   of	   an	   oxidative	   resistant	   char	   layer,	  
potentially	   promoted	   by	   the	   LDH,	   contributes	   to	   the	   thermal	   resistance	  
[126,162].	  
	  
Drug	  delivery	  vehicles	  
LDHs	  as	  key	  components	  in	  sophisticated	  drug	  delivery	  systems	  have	  gained	  an	  
increasing	  interest	  in	  the	  field	  of	  degradable	  biomaterials.	  Over	  the	  years,	  a	  vast	  
selection	   of	   drug/LDH	   compounds	   and	   combinations,	   respectively,	   were	  
synthesized	  and	  evaluated	  for	  their	  potential	  as	  release	  systems	  [23,24].	  In	  the	  
following,	   an	   overview	   on	   approaches	   in	   order	   to	   control	   release	   rates	   and	  
methods	   for	   the	   examination	   of	   drug-­‐LDH	   compounds	   is	   given.	   Furthermore,	  
the	  necessity	  of	  the	  application	  of	  intercalation	  compounds	  in	  contrast	  to	  more	  
simple	  systems	  is	  discussed.	  	  
A	  central	  issue	  of	  drug	  release	  systems	  is	  the	  control	  of	  the	  release	  rates.	  Since	  
depending	  on	  the	  application,	  a	  burst	  release	  of	  the	  agent	  can	  be	  advantageous	  
or	  detrimental	  [163],	  release	  systems	  have	  to	  be	  adjustable.	  A	  schematic	  release	  
profile	  of	  with	  burst	  release	  characteristics	  in	  comparison	  with	  a	  release	  profile	  




Fig.	   16:	   Schematic	   comparison	   of	   release	   profiles	   with	   burst	   release	   profile	  
(solid	   line)	   and	   with	   controlled	   release	   behavior	   (dashed	   line),	   according	   to	  
information	  from	  ref.	  [163].	  
	  
Release	   from	   LDHs	   was	   shown	   to	   be	   basically	   controlled	   by	   the	   pH	   of	   the	  
environment	  and	  the	  properties	  intrinsic	  to	  the	  drug/LDH	  system.	  In	  particular,	  
2	  General	  Principles	   39	  
	  
cation	  binding	  strength	  and	  nature	  of	  the	  intercalant	  were	  shown	  to	  determine	  
the	  dissolution	  kinetics.	  Dissolution	  was	  shown	  to	  be	  influenced	  by	  surface	  acid-­‐
base	  equilibria	  and	  detachment	  of	  metal	  cations	   from	  protonated	  LDH	  surface	  
sites	   [164].	   Hence,	   variation	   of	   the	   LDH	   system	   in	   a	   particular	   drug/LDH	  
combination	   might	   be	   sufficient	   in	   order	   to	   influence	   the	   release	   properties	  
[165].	  	  
As	   stated	   above,	   intercalation	   of	   drugs	   into	   LDH	   interlayers	   is	   not	   limited	   to	  
hydrophilic	   agents.	   Intercalation	   of	   hydrophobic	   agents	   gramicidin	   and	  
amphotericin	  B	  into	  Mg-­‐Al-­‐LDH	  was	  performed	  by	  the	  use	  of	  detergents	  [144].	  
Additionally,	  an	  LDH-­‐based	  release	  system	  for	  neutral	  and	  lipophilic	  substances	  
was	   obtained	   by	   intercalation	   of	   a	   phospholipid	   bilayer	   into	  Mg-­‐Al-­‐LDH.	   As	   a	  
model	   for	   a	   release	   system	   for	   lipophilic	   drugs,	   release	   of	   1,6-­‐diphenyl-­‐1,3,5-­‐
hexatriene	  was	  analyzed	  and	  found	  to	  be	  attenuated	  for	  a	  period	  of	  weeks	  [166].	  
The	   various	   studies	   on	   intercalation	   and	   release	   of	   various	   drugs	   performed	  
[23,24]	  mainly	   focused	  on	   the	  physicochemical	   in	  vitro	  properties	  of	   the	  drug-­‐
LDH	  compounds.	  For	  some	  drug-­‐LDH	  systems,	  subsequent	  and	  complementary	  
cell	   culture	   studies	   comprising	   different	   approaches	   were	   reported.	  
Exemplarily,	   a	  Mg-­‐Al-­‐heparin-­‐LDH	  was	  obtained,	   and	   found	   to	  be	  a	  promising	  
nanocarrier	   system	  due	   to	   its	   in	  vitro	   release	  behavior	  and	   the	   stability	  of	   the	  
heparin	  in	  the	  interlayers	  [167].	  Stability	  was	  confirmed	  by	  molecular	  dynamics	  
simulations	  with	  regard	  to	  the	  use	  of	  heparin-­‐LDH	  systems	  for	  cellular	  delivery	  
[168].	  In	  subsequent	  assays	  with	  smooth	  muscle	  cells,	  the	  potential	  of	  heparin-­‐
LDHs	  for	  anti-­‐restenotic	  therapy	  was	  examined	  [169],	  focusing	  amongst	  others	  
on	  the	  uptake	  of	  the	  drug	  by	  the	  cells	  and	  the	  influence	  of	  the	  LDH	  on	  cellular	  
delivery	  [170].	  	  
Despite	  the	  vast	  number	  of	  drug-­‐LDH	  systems	  investigated,	   few	   in	  vivo	  studies	  
were	   performed.	   As	   for	   synthesis	   and	   in	  vitro	   studies,	   NSAID-­‐LDHs	   were	   of	  
central	   interest.	   Mice	   were	   fed	   with	   indomethacin-­‐LDH	   and	   ketoprofen-­‐LDH,	  
respectively,	  and	  showed	  enhanced	  gastrointestinal	  compatibility	  for	  the	  drug-­‐
LDH	  system	  in	  comparison	  to	  the	  pure	  drugs	  [171,172].	  Furthermore,	  a	  Zn-­‐Al-­‐
diclofenac-­‐LDH	   containing	   dispersion	   was	   administered	   as	   eye-­‐drops	   to	   New	  
Zealand	   rabbits.	   No	   eye	   irritation	   was	   found	   and	   LDH	   was	   considered	   as	   a	  
promising	  ocular	  drug	  delivery	   system	   [173].	   In	   another	  mice	   study,	   a	  Mg-­‐Al-­‐
LDH	  was	   evaluated	   as	   a	  DNA	  vaccine	  delivery	   vector	  with	   regards	   to	   restrain	  
tumor	   formation	   and	   melanoma	   growth	   [174].	   When	   intercalated	   with	  
podophyllotoxin,	  Mg-­‐Al-­‐LDH	  was	  found	  effective	  against	  tumor	  cells	  in	  vitro	  and	  
in	  vivo	  (mice)	  [175].	  
Most	   studies	   concentrated	   on	   the	   intercalation	   of	   the	   drugs	   and	   on	   the	  
properties	  of	  the	  drug-­‐LDH	  intercalation	  compounds.	  However,	  intercalation	  of	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drugs	   into	  LDH	   interlayers	   is	  a	  demanding	  process	   that	  has	   to	  be	  adjusted	   for	  
every	  drug/LDH	  system.	  Drug	  delivery	   systems	   that	   comprise	  mixtures	  of	   the	  
respective	   drugs	   with	   LDH	   can	   be	   obtained	   more	   simply.	   Exemplary,	   drug-­‐
loaded	   LDH	   films	   (e.g.	   with	   tetracycline	   or	   vancomycin)	   were	   in	   principle	  
synthesized	  by	  solvent	  evaporation	  of	  a	  Mg-­‐Al-­‐CO3-­‐LDH	  suspension	  which	  was	  
supplemented	   with	   the	   respective	   drug	   solutions	   [176].	   Besides	   simplicity	   in	  
production	  and	  processing	  of	  the	  mixtures,	  synthesis	  protocols	  seem	  to	  be	  more	  
easily	  transferable.	  Drug	  delivery	  performances	  of	  ciprofloxacin/LDH	  mixtures	  
as	  coatings	  are	  discussed	  in	  chapter	  5.	  
Adsorption	   is	   a	   further	   method	   of	   interest	   to	   immobilize	   drugs	   on	   LDHs.	  
Interactions	  between	  drugs	  and	  LDHs	  are	  expected	  to	  depend	  on	  the	  charge	  of	  
the	   respective	   drugs	   [176].	   The	   expectation	   would	   be	   that	   the	   positively	  
charged	   LDH	   layers	   would	   preferable	   adsorb	   species	   with	   negative	   charges	  
[177].	  Nonetheless,	  ibuprofen	  could	  be	  adsorbed	  both	  as	  an	  anion	  as	  well	  as	  in	  
form	  of	  a	  neutral	  copper	  complex	  on	  a	  Mg-­‐Al-­‐LDH.	  However,	  in	  comparison	  to	  a	  
Mg-­‐Al-­‐ibuprofen-­‐LDH	  intercalation	  compound,	  the	  amount	  of	  immobilized	  drug	  
was	   decreased	   [178].	   Furthermore,	   zwitterionic	   tetracycline	   and	   positively	  
charged	   vancomycin	   were	   found	   to	   bind	   to	   Mg-­‐Al-­‐CO3-­‐LDHs	   [176].	   As	  
mentioned	  above,	  adsorption	  ability	  of	   the	  clay-­‐type	  material	  was	   found	   to	  be	  
tunable	   by	   the	   cation	   ratio	   MII:MIII	   [97]	   (subsection	  2.2.2).	   Also,	   adsorption	  
properties	   depended	   on	   the	   choice	   of	   anion	   in	   the	   interlayers,	   e.g.	   Cl-­‐LDHs	  
showed	  enhanced	  performances	  in	  comparison	  to	  CO3-­‐LDHs	  [97,102].	  
An	   LDH	   based	   nanohybrid	   system	   that	   allows	   for	   an	   external	   control	   was	  
obtained	   and	   examined	   for	   the	  magnetic	   field	   controlled	   release	   of	   diclofenac	  
and	   ibuprofen.	  Drug	  release	  from	  the	  magnesium	  ferrite/Mg-­‐Al-­‐LDH	  core-­‐shell	  
nanoparticles	   depended	   on	   particle	   size,	   core	   content	   of	   the	   particles	   and	  
strength	  of	  the	  external	  magnetic	  field.	  Intriguingly,	  the	  on-­‐off	  operation	  of	  the	  
magnetic	  field	  yielded	  in	  a	  pulsatile	  drug	  release	  profile.	  The	  nanohybrids	  were	  
assessed	   suitable	   for	   the	   administration	   by	   injection	   and	   for	   drug	   targeting	  
[179,180].	  	  
LDHs	   served	   as	   drug	   delivery	   vehicles	   and	   key	   components	   in	   drug	   delivery	  
systems,	   respectively,	   applied	   in	   the	   course	   of	   in	  vitro	   and	   in	  vivo	   studies.	  
Whereas	   most	   studies	   concentrated	   on	   intercalation	   compounds,	   studies	   on	  
drug/LDH	   mixtures	   and	   adsorption	   compounds	   were	   reported,	   as	   well.	   The	  
latter	   two	   would	   allow	   for	   a	   simplified	   preparation,	   still	   exploiting	   the	  
variability	  of	  the	  LDH	  material	  class.	  Coating	  of	  implants	  with	  drug-­‐loaded	  LDHs	  
might	   allow	   for	   a	   local	   drug	   delivery,	   avoiding	   a	   systemic	   dosage	   with	   the	  
respective	  drug.	  This	  is	  of	  high	  relevance	  for	  antibiotics,	  since	  bacterial	  infection	  
2	  General	  Principles	   41	  
	  
during	   and	   after	   surgery	   is	   a	  major	   concern,	   as	   is	   the	   formation	   of	   antibiotic	  
resistances.	  
	  
Feasibility	  of	  LDH	  coatings	  for	  technical	  and	  medical	  applications	  
Functional	   coatings	  on	   substrates	   can	  provide	   a	  wide	   spectrum	  of	   advantages	  
besides	   aesthetic	   demands.	   Coatings	   made	   of	   LDHs	   and	   derived	   of	   LDHs,	  
respectively,	   can	   be	   prepared	   by	   various	   approaches	   and	   are	   of	   interest	   for	  
technical	  and	  biomedical	  applications	  [181].	  	  
LDH	  coatings	  can	  either	  be	  grown	   in	  situ	  on	  the	  surface	  of	  metal	  substrates	  or	  
can	   be	   obtained	   by	   the	   processing	   of	   precursor	   suspensions.	   As	   mentioned	  
above,	  magnesium	  and	  magnesium	  alloys	  were	  endowed	  with	  in	  situ	  grown	  LDH	  
layers	   in	   order	   to	   enhance	   the	   corrosion	   resistance	   of	   the	   metal	   substrates	  
[41,42].	  An	   in	  situ	   grown	  Zn-­‐Al-­‐LDH	  on	  aluminium	  substrates	  was	   reported	   to	  
feature	   intrinsic	   self-­‐healing	   properties	   by	   dissolution/recrystallization	  
processes	  in	  NaCl	  solution	  [182].	  In	  order	  to	  coat	  substrates	  with	  LDHs	  storable	  
and	   processable	   LDH	   suspensions	   are	   of	   importance.	   In	   general,	   LDH	   coating	  
techniques	   comprise	   the	   targeted	   separation	   of	   LDH	   particles	   from	   a	  
solvent/dispersion	  medium.	  
Employing	   LDH	   suspensions	   as	   precursors,	   layer-­‐by-­‐layer	   coating	   techniques	  
were	  proven	  to	  be	  practicable	  for	  many	  LDH	  coatings.	  Based	  on	  the	  positive	  zeta	  
potential	  of	  LDH	  particles	  [177],	  LDH	  coatings	  are	  expected	  to	  attract	  negatively	  
charged	   species.	   By	   applying	   alternating	   sequences	   of	   LDH	   suspensions	   and	  
solutions/suspensions	  of	  the	  second	  species,	  the	  coating	  is	  expected	  to	  form	  due	  
to	  the	  electrostatic	   interaction.	  By	  this	  means,	  a	  Mg-­‐Al-­‐LDH	  based	  coating	  was	  
fabricated	   on	   quartz	   substrates	   for	   antireflection	   and	   antifogging	   purposes	  
[183]	   and	   a	   Ni-­‐Al-­‐LDH/bi-­‐protein	   film	   on	   an	   ITO-­‐coated	   glass	   substrate.	   The	  
latter	  system	  exhibited	  electrocatalytic	  properties	  towards	  catechol	  [184].	  Also	  
exploiting	  the	  surface	  charge	  of	  LDHs,	  electrophoretic	  deposition	  was	  applied	  in	  
order	   to	   create	   LDH	   coatings.	   By	   applying	   electric	   fields,	   Mg-­‐Al-­‐LDHs	   were	  
successfully	  attached	  to	  aluminium	  and	  ITO	  substrates.	   In	  both	  cases,	   the	  LDH	  
coatings	   exhibited	   a	   high	   degree	   of	   orientation	   [185,186].	   Furthermore,	   a	  
magnetic	   field	  assisted	   layer-­‐by-­‐layer	  deposition	  of	  a	  Co-­‐Fe-­‐LDH	  was	  reported	  
[187].	  
Another	  approved	  method	  for	  the	  fabrication	  of	  LDH	  coatings	  is	  spin	  coating.	  In	  
course	   of	   this	  method,	   the	   glass	   substrate	   is	  wetted	  with	   the	   LDH	   suspension	  
and	  subsequently	  rotated	  in	  order	  to	  remove	  the	  liquid	  [181].	  This	  method	  was	  
successfully	   performed	   with	   LDH	   suspensions	   comprising	   different	   cation	  
combinations	  (Mg-­‐Al-­‐,	  Zn-­‐Al-­‐	  and	  Co-­‐Al-­‐)	  and	  ratios.	  For	  the	  same	  group	  of	  LDH	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systems	  investigated,	  thinner,	  yet	  more	  stable	  coatings	  were	  obtained	  following	  
the	  layer-­‐by-­‐layer	  approach	  [188].	  	  
It	  has	  to	  be	  noted	  that	  some	  coating	  techniques,	  such	  doctor	  blading,	  are	  limited	  
to	   simple	   substrate	   geometries	   and	   hence	   inappropriate	   for	   geometrically	  
demanding	   substrates	   such	   as	  medical	   implants	   (see	   subsection	  2.2.5).	  Hence,	  
the	   shapes	   of	   prostheses	   have	   to	   be	   taken	   into	   account	   for	   development	   and	  
employment	   of	   LDH	   coating	   techniques.	   Following	   a	   simple	   approach,	   coating	  
could	   in	   principle	   performed	   by	   wetting	   a	   substrate	   with	   an	   LDH	   containing	  
suspension	   and	   subsequently	   applying	   elevated	   temperatures.	  Removal	   of	   the	  
solvent/dispersion	   phase	   should	   result	   in	   a	   crust	   of	   the	   formerly	   mobile	  
particles.	   Temperature	   has	   to	   be	   chosen	   carefully	   with	   regard	   to	   thermal	  
stability	  of	  substrates	  and	  coating	  materials.	  This	  approach	  has	  been	  followed	  in	  
order	   to	   fabricate	   the	   substrates	   for	   the	   studies	   presented	   in	   sections	  5.3	   and	  
5.4.	   Implants	   employed	   in	   the	   examinations	   described	   in	   sections	  4.2	   and	   5.2	  
were	   coated	   by	   spray	   coating.	   This	   technique	   comprises	   the	   application	   of	   a	  
nebulized	  LDH	  suspension	  to	  a	  previously	  heated	  substrate	  surface.	  Also	  when	  
following	   this	   approach,	   temperatures	   have	   to	   be	   chosen	   with	   regard	   to	   the	  
substances	  applied.	  
Various	  approaches	  in	  order	  to	  coat	  substrates	  with	  LDHs	  were	  developed	  and	  
reported.	  Whereas	  coating	  of	  metallic	  magnesium	  with	  Mg-­‐LDHs	  was	  performed	  
following	   a	   conversion	   coating	   protocol,	   coating	   of	   alternative	   substrates	  
included	  application	  of	  LDH	  particles	  from	  precursor	  suspensions.	  Derived	  from	  
the	   vast	   variety	   of	   LDHs	   synthesized,	   various	   precursor	   suspensions	   and	  
nanosuspensions	  are	   available	   and	  LDH	  particles	  proved	   stable	  under	  various	  
conditions	   that	  can	  be	  met	   in	  course	  of	  processing.	  Hence,	  LDHs	  are	  a	   tunable	  
class	  of	  material,	  suitable	  for	  various	  coating	  techniques	  with	  regard	  to	  various	  
applications.	  
	  
2.2.5	   Potential	  application	  of	  Mg-­‐LDHs	  in	  orthopedics	  and	  otolaryngology	  
In	   order	   to	   increase	   the	   longevity	   of	  medical	   implants,	   functionalization	  with	  
sustainable	   biomaterials	   is	   of	   high	   interest.	   In	   this	   context,	   the	   favourable	  
general	   tunability	   and	   processability	   of	   LDHs	   and	   LDH-­‐based	   materials	   have	  
been	   described	   above.	   In	   particular,	   magnesium-­‐containing	   LDHs	   were	  
evaluated	  as	  a	  promising	  class	  of	  materials.	  In	  the	  following,	  the	  applicability	  of	  
Mg-­‐LDHs	   with	   regard	   to	   orthopedics	   and	   otolaryngology	   is	   briefly	   discussed,	  
and	   a	   short	   overview	   on	   the	   respective	   medical	   situations	   of	   the	   application	  
fields	  is	  given.	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Hip	  joint	  replacement	  
Occurring	  with	  more	  than	  800,000	  annual	  cases,	  total	  hip	  arthroplasty	  (THA)	  is	  
one	   of	   the	   most	   common	   surgeries	   worldwide	   [11,189].	   THA	   comprises	   the	  
restoration	   of	   damaged	   or	   degenerated	   structures,	   mainly	   caused	   by	  
osteoarthritis,	   and	   furthermore	   by	   femoral	   neck	   fracture	   and	   tumours	   [190].	  
Various	  prostheses	  were	  developed	  to	  replace	  damaged	  areas	  of	  bone	  from	  the	  
hip	   joint.	   A	   selection	   of	   hip	   prostheses	   made	   of	   titanium	   alloy	   and	   Co-­‐Cr-­‐Mo	  
alloy	   is	   shown	   in	   Fig.	   17	   (from	   ref.	  [12]).	   In	   principle,	   the	   stems	   of	   the	  
prostheses	   are	   designed	   to	   be	   placed	   into	   the	   thighbone,	   and	   the	   cups	   are	  
designed	  to	  fit	  to	  the	  socket	  of	  the	  pelvis	  bone.	  	  
	  
	  
Fig.	  17:	  Photographs	  of	  different	  hip	  prostheses	  made	  of	  titanium	  alloy	  (nr.	  1,	  3	  
and	   4)	   and	   Co-­‐Cr-­‐Mo	   alloy	   (nr.	   2).	   The	   prostheses	   are	   equipped	   with	   heads	  
made	   of	   stainless	   steel	   (nr.	   2	   and	   3)	   and	   of	   ceramic	   material	   (nr.	   4)	   (from	  
ref.	  [12]).	  
	  
Limited	   longevity	   and	  early	   loosening	  of	   the	  prostheses	  are	  key	   challenges,	   in	  
particular	  with	   regard	   to	  young	  patients	   and	  prosthesis	   revision.	  Longevity	  of	  
artificial	   joint	   replacements	   is	   limited,	   amongst	   other	   causes,	   by	   aseptic	  
loosening	  [190,191].	  Therefore,	  improving	  the	  implant	  fixation	  by	  enhancement	  
of	  the	  bone	  ongrowth	  to	  the	  implant	  is	  of	  high	  interest.	  A	  central	  approach	  is	  the	  
development	  of	  bioactive	  coating	  systems	  for	  metal	  and	  metal	  alloy	  implants.	  A	  
widely	   used	   substance	   class	   are	   calcium	   phosphates,	   e.g.	   hydroxyapatite,	  
Ca10(PO4)6(OH)2	   [192].	   They	   can	   be	   viewed	   as	   a	   current	   industrial	   gold	  
standard,	  and	  attempts	  to	  improve	  the	  osseointegration	  of	  hip	  implants	  have	  to	  
take	  their	  performance	  as	  a	  benchmark.	  These	  coating	  systems	  are	  supposed	  to	  
enhance	  the	  bioactivity	  of	  the	  implant	  surfaces	  towards	  the	  stimulation	  of	  bone	  
growth	  and	  by	  this,	   to	  minimize	  the	   formation	  of	  gaps	  between	  the	  bones	  and	  
the	  implants.	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The	   promise	   of	   magnesium-­‐containing	   implant	   coatings	   with	   regard	   to	  
prospective	  osteoconductive	  and	  osteoinductive	  properties	  has	  been	  explicated	  
in	   subsection	  2.1.1.	   As	   described	   in	   subsection	  2.2.2,	   magnesium-­‐containing	  
LDHs	  can	  be	  derived	  from	  magnesium	  hydroxide,	  resulting	  in	  a	  tunable	  class	  of	  
magnesium	  compounds.	  Furthermore,	  the	  processability	  of	  LDHs	  allows	  for	  the	  
coating	   of	   various	   substrates,	   as	   described	   in	   subsection	  2.2.4.	   Hence,	  
magnesium-­‐containing	   LDH	   systems	   have	   come	   into	   focus	   of	   biomaterial	  
research	  with	  regard	  to	  the	  coating	  of	  joint	  replacement	  prosthesis.	  The	  in	  vitro	  
and	  in	  vivo	  evaluation	  of	  Mg-­‐Al-­‐	  and	  Mg-­‐Fe-­‐LDHs	  as	  orthopedic	  implant	  coating	  
materials	  is	  discussed	  in	  chapter	  4.	  	  
	  
Middle	  ear	  ossicular	  chain	  replacement	  
Middle	  ear	  diseases,	  such	  as	  chronic	  otitis	  media	  or	  cholesteatoma,	  might	   lead	  
to	   the	   loss	   of	   the	   malleus,	   incus	   and	   stapes.	   These	   bones	   are	   part	   of	   the	  
mechanical	   sound	   transduction	   system,	   the	   loss	   of	   which	   results	   in	   sound	  
conduction	  impairment.	  In	  the	  course	  of	  the	  medical	  treatment,	  these	  bones	  can	  
be	  replaced	  by	  a	   total	  ossicular	  replacement	  prosthesis	  (TORP)	   in	  order	  to	  re-­‐
construct	  the	  sound	  transduction	  system	  from	  the	  outer	  to	  the	  inner	  ear	  [193].	  
A	  depiction	  of	   the	  healthy	  middle	   ear,	   implanted	  middle	   ear	   and	  prosthesis	   is	  
shown	  in	  Fig.	  18a	  to	  Fig.	  18c	  (from	  ref.	  [193]).	  
Depending	   on	   the	   indications,	   functionalization	   with	   growth	   factors	   and	  
equipment	   of	   the	   prostheses	   with	   collagen	   pads	   are	   of	   interest.	   The	  
functionalization	  with	   growth	   factors	   is	   supposed	   to	   enhance	   implant	   fixation	  
by	   improving	   the	   connection	   to	   the	   residual	   stapes	   at	   the	   intersection	   to	   the	  
inner	  ear	  (Fig.	  18b,	  from	  ref.	  [193]).	  For	  this,	  protein-­‐based	  growth	  factors,	  such	  
as	   the	   Bone	   Morphogenetic	   Protein	   (BMP2),	   were	   attached	   to	   a	   mesoporous	  
silica	  film	  at	  the	  tip	  of	  the	  prosthesis	  (in	  direction	  to	  the	  inner	  ear).	  The	  collagen	  
pad	  (Fig.	  18b,	  from	  ref.	  [193]),	  commonly	  made	  of	  the	  patient’s	  own	  collagen,	  is	  
inserted	  in	  order	  to	  enable	  mechanical	  mediation	  of	  pressure	  variations	  and	  to	  
protect	   the	   tympanic	   drum	  membrance	   from	   contact	  with	   sharp	   edges	   of	   the	  
prosthesis.	  Sound	  transmission	  shall	  be	  improved	  by	  synthetic	  composite	  pads	  
featuring	  adaptable	  viscoelastic	  properties	  [193].	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Fig.	  18:	  From	  left	  to	  right:	  Schematic	  cross	  section	  views	  of	  a	  healthy	  middle	  ear	  
(a)	  and	  of	  an	  implanted	  middle	  ear	  prosthesis	  (b),	  as	  well	  as	  a	  photography	  of	  a	  
middle	  ear	  prosthesis	  made	  of	  Bioverit®	  II	  (from	  ref.	  [193]).	  
	  
Besides	   sound	   transmission,	   also	   the	   combating	   of	   bacterial	   infections	   and	  
formation	   of	   bacterial	   biofilms	   are	   major	   challenges	   for	   middle	   ear	   surgery.	  
Infections	   can	   occur	   due	   to	   persistence	   or	   recidivism	  of	   the	   chronic	   infection,	  
which	  initially	  had	  caused	  the	  destruction	  of	  the	  middle	  ear	  bones,	  but	  can	  also	  
be	   introduced	   during	   the	   operation.	   Hence,	   antibiotic	   functionalization	   of	   the	  
prostheses	  with	  drug	  delivery	  systems	  is	  of	  high	  interest	  [194,195].	  	  
In	  order	  to	  allow	  for	  the	  equipment	  of	  the	  implants	  with	  drug	  delivery	  systems,	  
biocompatible	  materials	  that	  can	  be	  attached	  to	  implant	  surfaces	  are	  of	  interest.	  
A	   promising	   class	   of	   novel	   biomaterials	   with	   regard	   to	   application	   in	  
otolaryngology	   are	   magnesium-­‐containing	   LDHs.	   Their	   processability	   to	  
coatings	  and	  their	  applicability	  in	  drug	  delivery	  systems	  have	  been	  discussed	  in	  
subsection	  2.2.4.	   Furthermore,	   their	   tunability	   and	   hence	   adaptability	   makes	  
them	   favorable	   for	   many	   application	   sites,	   as	   discussed	   in	   subsection	  2.2.2.	  
Examination	   of	   drug-­‐loaded	  Mg-­‐Al-­‐LDH	   coatings	   on	  middle	   ear	   prostheses	   in	  
rabbits	  as	  well	  as	   the	   in	  vivo	  degradation	  behavior	  and	   the	  biocompatibility	  of	  
pristine	   Mg-­‐Al-­‐LDH	   coatings	   in	   this	   unique	   operation	   site	   are	   discussed	   in	  
chapter	  5.	   Furthermore,	   the	   in	  vitro	   activity	   and	   in	  vitro	   cell	   compatibility	   of	  
ciprofloxacin/LDH	  mixtures	  are	  discussed.	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3	   Magnesium	  Degradation	  under	  Physiological	  Conditions	  
3.1	  	   Preface	  
This	   chapter	   deals	   in	   two	   articles	   with	   the	   corrosion	   examination	   of	   pure	  
magnesium	   discs	   (section	  3.2)	   and	   magnesium	   alloy	   ZEK100	   plates	   under	  
physiological	   conditions	   (section	  3.3).	   Comprehensive	   examination,	   including	  
appropriate	   testing	   devices,	   application	   of	   physiological	   media	   and	  
identification	  of	  corrosion	  products	  could	  contribute	  to	  a	  better	  understanding	  
of	  corrosion	  processes,	  which	  exact	  mechanism	  has	  not	  been	  entirely	  revealed	  
yet.	  	  
Experimental	   setups	   for	   the	   corrosion	   examination	   of	   pure	   magnesium	   as	  
described	   in	   section	  3.2	   comprised	   the	   application	   of	   physiological	   media	  
(HBSS,	  DMEM	  and	  SBF)	  and	  cell	  culture	  conditions,	  in	  particular	  CO2	  gassing.	  In	  
order	  to	  examine	  the	  influence	  of	  proteins	  on	  the	  corrosion,	  foetal	  bovine	  serum	  
(FBS)	  was	  supplemented	  in	  varying	  amounts	  to	  the	  respective	  media.	  Tracking	  
of	   the	   corrosion	   process	  was	   performed	   by	   the	   estimation	   of	   the	  weight	   loss	  
over	   time,	   osmolality,	   pH	   and	   by	   optical	   evaluation.	   Crystalline	   corrosion	  
products	   formed	   were	   identified	   by	   XRD	   measurements.	   Nesquehonite,	  
Mg(HCO3)(OH)∙2H2O,	  was	   found	   as	   the	   dominant	   product	   on	   all	   samples	   that	  
were	  immersed	  at	  least	  for	  one	  day.	  Brucite,	  Mg(OH)2,	  was	  among	  the	  corrosion	  
products	   on	   samples	   that	   were	   immersed	   in	   lowly	   buffered	   HBSS	   setups.	  
Calcium	   phosphates	   were	   found	   on	   a	   sample	   that	   was	   immersed	   in	   SBF	   for	  
seven	   days;	   these	   were	   presumably	   formed	   due	   to	   the	   high	   calcium	   and	  
phosphate	   content	   of	   the	   SBF.	   The	   formation	   of	   the	   magnesium	   carbonate	  
compound	   instead	  of	  magnesium	  hydroxide	  was	  attributed	   to	   the	  presence	  of	  
CO2	  gassing,	  acting	  as	  carbonate	  source.	  	  
As	   described	   in	   section	  3.3,	  magnesium	   alloy	   ZEK100	   plates	  were	   exposed	   to	  
physiological	  conditions	  that	  included	  HBSS	  as	  the	  medium	  in	  flow	  mode.	  After	  
the	  respective	  examination	  periods,	  the	  plates	  were	  characterized	  via	  four	  point	  
bending	  tests	  with	  regard	  to	  their	  mechanical	  properties	  and	  via	  SEM,	  EDX	  and	  
XRD	  with	  regard	  to	  surface	  alterations	  and	  the	  formation	  of	  corrosion	  products.	  
Mechanical	   tests	   indicated	   varying	   bending	   strengths	   in	   the	   course	   of	   the	  
immersion,	  whereas	  the	  bending	  strength	  after	  the	  longest	  incubation	  time	  was	  
increased	   in	   comparison	   to	   the	   samples	   of	   the	   shorter	   periods.	   Surface	  
examination	   revealed	   considerable	   contributions	   of	   Ca,	   P	   and	  O	   according	   to	  
EDX	  data,	  indicating	  the	  presence	  of	  calcium	  phosphates.	  However,	  according	  to	  
XRD	   measurements,	   brucite,	   Mg(OH)2,	   was	   found	   as	   the	   solely	   crystalline	  
corrosion	   product,	   whereas	   neither	   magnesium	   carbonates	   nor	   crystalline	  
phosphates	  were	   found.	  However,	   the	   presence	   of	  magnesium	  hydroxide	   as	   a	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corrosion	   product	   of	   magnesium	   exposed	   to	   lowly	   buffered	   HBSS	   is	   in	  
accordance	  with	  the	  study	  presented	  in	  section	  3.2.	  
In	  the	  studies	  presented	  in	  sections	  3.2	  and	  3.3,	  it	  was	  shown	  that	  the	  formation	  
of	   different	   corrosion	   products	   depends	   strongly	   on	   the	   corrosion	   conditions.	  
Magnesium	  hydroxide	  was	  predominantly	  found	  when	  magnesium	  and	  its	  alloy	  
ZEK100	  were	   immersed	  under	   lowly	  buffered,	  physiological	  conditions	  as	  met	  
in	  HBSS.	   The	   formation	   of	   nesquehonite,	  Mg(HCO3)(OH)∙2H2O,	  was	   favored	   in	  
carbonate	  enriched	  conditions	   in	  DMEM	  and	  SBF	  with	  CO2	  gassing.	  Hence,	   the	  
formation	   of	   magnesium	   carbonates	   should	   be	   considered	   for	   further	  
investigations	  of	  the	  corrosion	  behavior	  and	  the	  applications	  of	  magnesium	  as	  a	  
degradable	  implant	  material.	  
By	   using	   soluble	   magnesium	   salts	   as	   precursors,	   the	   formation	   of	   different	  
magnesium	   carbonate	   compounds	   under	   different	   synthesis	   conditions	   has	  
further	   been	   examined	   in	   the	   B.	  Sc.	   thesis	   of	   Dennes	   Nettelroth:	   “Darstellung	  
von	  Magnesiumhydroxycarbonaten	  mit	  definierter	  Morphologie”	  (“Preparation	  
of	   Magnesium	   Hydroxy	   Carbonates	   with	   Defined	   Morphology”,	   2012,	   Leibniz	  
Universität	   Hannover),	   supervised	   by	   the	   author.	   It	   was	   shown	   that	   the	  
formation	   and	   the	   morphologies	   of	   the	   magnesium	   compounds,	   in	   particular	  
nesquehonite,	   Mg(HCO3)(OH)∙2H2O),	   and	   hydromagnesite,	  
Mg5(CO3)4(OH)2∙4H2O,	  strongly	  depend	  on	  the	  synthesis	  parameters.	  	  
Despite	   the	   progress	   achieved	   by	   the	   employment	   of	   studies	   comprising	  
combined	   methods	   and	   sophisticated	   test	   devices	   and	   analytical	   methods,	  
results	  of	   in	  vitro	   and	  corresponding	   in	  vivo	   studies	  still	  differ	  considerably.	   In	  
order	   to	   further	   increase	   the	   predictive	   power	   of	   in	  vitro	   studies,	   the	  
identification	  of	  the	  corrosion	  products	  that	  form	  along	  the	  reaction	  pathways	  is	  
crucial.	  Also,	  the	  use	  of	  corrosion	  media	  which	  most	  closely	  resemble	  the	  in	  vivo	  
conditions	  is	  advised.	  With	  regard	  to	  medical	  applications	  of	  magnesium-­‐based	  
implants,	  biocompatibility	  and	  the	  corrosion	  behavior	  could	  be	   investigated	   in	  
the	   course	   of	   in	  vivo	   studies	  with	   regard	   to	   the	   respective	   human	   application.	  
Furthermore,	  the	  influence	  of	  alloying	  elements	  and	  the	  efficacy	  of	  anticorrosion	  
strategies	  could	  be	  interesting	  for	  future	  examinations.	  
For	   the	   article	   presented	   in	   section	  3.2,	   the	   author	   of	   this	   thesis	   and	   Frank	  
Feyerabend	   are	   the	   first	   authors,	   who	   contributed	   equally	   to	   this	   study.	   The	  
manuscript	  was	   for	   the	  most	  part	  drafted	  by	  the	  author	  of	   this	   thesis.	  All	  XRD	  
measurements	   and	   according	   data	   interpretation	   were	   performed	   and	  
contributed	   accordingly	   to	   the	   publications	   by	   him.	   The	   immersion	  
experiments,	  SEM	  imaging	  and	  the	  examination	  with	  regard	  to	  corrosion	  rates,	  
osmolality	  and	  pH	  values	  were	  performed	  and	  contributed	  to	  the	  manuscript	  by	  
Frank	  Feyerabend.	  Regine	  Willumeit	  and	  Peter	  Behrens	  supervised	  the	  studies	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and	   revised	   the	   manuscript.	   This	   study	   was	   primarily	   initiated	   by	   Frank	  
Feyerabend	  and	  Peter	  Behrens.	  	  
For	  the	  article	  presented	  in	  section	  3.3,	  Hazibullah	  Waizy	  is	  the	  first	  author,	  and	  
the	   author	   of	   this	   thesis	   is	   a	   co-­‐author.	   All	   XRD	  measurements	   and	   according	  
data	   interpretation	  were	  performed	  and	  contributed	   to	   the	  publication	  by	   the	  
author	   of	   this	   thesis.	   The	  manuscript	  was	   prepared	   by	  Hazibullah	  Waizy,	   and	  
written	   by	   Andreas	  Weizbauer	   and	   Christian	  Modrejewski.	   Data	   analysis	  was	  
performed	  by	  Hazibullah	  Waizy	  and	  Andreas	  Weizbauer.	  The	  in	  vitro	  corrosion	  
examinations	  were	  performed	  by	  Christian	  Modrejewski	  under	  the	  supervision	  
of	  Hazibullah	  Waizy.	  The	  ZEK100	  plates	  were	  manufactured	  and	  analyzed	  (SEM	  
and	   EDX)	   by	   Arne	   Lucas.	   Berend	   Denkena,	   Peter	   Behrens,	   Andrea	   Meyer-­‐
Lindenberg	  and	  Friedrich-­‐Wilhelm	  Bach	  revised	  the	  manuscript	  primarily.	  The	  
study	   was	   initiated	   by	   Fritz	   Thorey,	   who	   participated	   in	   its	   design	   and	  
coordination.	   Further	   coordination	   was	   contributed	   by	   Frank	   Witte	   and	  
Henning	  Windhagen,	  who	  also	  helped	  to	  draft	  the	  manuscript.	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3.2	  	   Degradation	  Rates	  and	  Corrosion	  Products	  of	  Magnesium	  Exposed	  
to	  Different	  Aqueous	  Media	  under	  Physiological	  Conditions	  
Marc	  Kieke*,	  Frank	  Feyerabend*,	  Regine	  Willumeit,	  Peter	  Behrens	  
	  
*These	  authors	  contributed	  equally	  to	  this	  study.	  
	  
This	  section	  will	  be	  submitted	  as	  an	  original	  research	  article.	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Degradation Rates and Corrosion Products of Magnesium Exposed to Different 
Aqueous Media under Physiological Conditions 
Marc Kieke ▪ Peter Behrens ▪ Frank Feyerabend ▪ Regine Willumeit 
 
Abstract 
Since magnesium and many of its alloys are a promising class of degradable implant materials, a thorough 
understanding of their degradation under physiological conditions is a key challenge in the field of biomaterial 
science. In order to increase the predictive power of in vitro studies, it is necessary to imitate the in vivo 
conditions, track the decomposition process and identify the corrosion products that form during the degradation 
pathway. In this in vitro study, slices of pure magnesium were exposed to Hank’s balanced salt solution (HBSS), 
Dulbecco’s modified eagle medium (DMEM) and Simulated body fluid (SBF), respectively, under cell culture 
conditions, which included CO2 gassing. The series were repeated with supplements of FBS, added to the 
respective media. Degradation rates, osmolality and pH were found to vary with the choice of medium and 
supplementation with proteins. In order to identify the crystalline degradation products, the crusts formed on the 
specimens were investigated via XRD measurements. Brucite (Mg(OH)2) was found among the corrosion 
product as anticipated; interestingly, nesquehonite (MgCO3·3H2O / Mg(HCO3)(OH)·2H2O) could be found to be 
the dominant corrosion product in this study.  
Keywords: magnesium, degradation, corrosion, brucite, nesquehonite 
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1 Introduction 
Since many decades magnesium has gained an increasing interest in the field of implant materials 
[1].Biodegradable cardiovascular magnesium stents were successfully tested for clinical applications [2,3]. Due 
to its mechanical properties, which are comparable to those of bone, magnesium is also of high interest for 
orthopedic research [4]. In addition, metallic magnesium and its corrosion product magnesium hydroxide also 
show osteoconductive properties [5,6]. 
Since magnesium is highly susceptible to degradation in aqueous environments, efforts have been made both to 
decelerate as well as to exploit this process. For the application as a part of large, load-bearing prosthesis, an 
uncontrolled, i.e. too rapid, degradation is obviously a major disadvantage. On the other hand, the 
osteoconductive properties mentioned can support the incorporation of an implant made of or coated with 
magnesium or magnesium compounds [7,8]. 
Thus, the degradation of metallic magnesium is an obstacle as well as a chance in the field of degradable 
biomaterials. A thorough understanding of the kinetics and mechanisms of this process is therefore crucial in 
order to better understand the corrosion behavior and in this way increase the predictive power of in vitro 
studies, the results of which have so far often differed considerably from those of in vivo studies[4,9]. In vitro 
degradation setups provide many opportunities to follow the course of decomposition online, such as pH and 
conductivity monitoring [10,11], but the identity of the corrosion products formed from magnesium and the 
supplements of the media cannot be derived from these parameters alone. Electron-dispersive X-ray 
spectroscopy (EDS) analysis can be performed discontinuously on the corrosion products to gain information on 
their composition, but without differentiating between different products with the same elemental formula. 
Moreover, most instruments only give semi-quantitative data, because they are not calibrated to the respective 
elements. X-ray diffraction is suitable for the identification of crystalline phases that may have formed and have 
been deposited during the degradation process either directly or by follow-up reactions. 
Magnesium hydroxide is the dominant crystalline corrosion product of magnesium and its alloys upon exposure 
to aqueous media, as has been shown before by various studies [12]. Since the solubility of the hardly soluble 
Mg(OH)2 can be increased, for example by the presence of chloride ions [13,14] and by buffering of pH, 
magnesium hydroxide is not the only product which can be expected. Alternative products such as phosphates 
and carbonates, respectively, were found in various studies. In an in vivo approach, a magnesium containing 
calcium phosphate (MgxCay(PO4)z) was found after the degradation on the surface of a Mg-Mn-Zn alloy [7], 
while the degradation of a magnesium rare-earth alloy led to the in vitro formation of complex products with the 
general formula (Mg,Ca)x(PO4)y(CO3)z(OH)i [15]. The formation of magnesium carbonates (MgCO3) was 
reported by various authors, when pure magnesium was exposed to different aqueous media [16,17]. However, 
many studies did not distinguish between different modifications of the carbonates and phosphates, respectively.  
With regard to the issues mentioned, it is of central interest to estimate the degradation rates of magnesium 
exposed to aqueous media under conditions similar and relevant to in vivo conditions. For this purpose, we have 
studied the degradation of pure magnesium under cell culture conditions in cell free media. As the respective 
media Hank’s Buffered Salt Solution (HBSS), Simulated Body Fluid (SBF) and Dulbecco’s Modified Eagle 
Medium (DMEM) were applied. The cell culture conditions included a CO2 (5 %) and O2 (21 %) gassing, as 
well as a temperature of 37 °C and 95% relative humidity over the entire experiment. In an additional set of 
experiments, fetal bovine serum (FBS) was added to all the respective media. Degradation rates were determined 
by measuring the weight loss of the samples. In order to identify the corrosion products, the surfaces of 
specimens were investigated via SEM and X-ray diffraction (XRD).  
 
2 Materials and Methods 
2.1 Magnesium casting 
Magnesium ingot (purity 99.95 wt.%) was prepared by permanent mould casting. The material was molten under 
protective atmosphere (Ar + 2% SF6) at a temperature of 750 °C. The melt was stirred for 30 min with 200 rpm 
prior to casting the material into preheated moulds (550 °C) made out of mild steel. To assure cleanliness of the 
cast ingots, a filter (Foseco SIVEX FC, Foseco GmbH, Borken, Germany) was used. Cylindrical specimens with 
a diameter of 10 mm and a height of 1.5 mm were cut from the cast blocks via electrical discharge machining. 
The samples were used without further surface treatment.  
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2.2 Degradation media 
Three different media were used for the degradation tests: (I) Hank’s balanced salt solution (HBSS) without Ca 
and Mg ions (Life Technologies, Darmstadt, Germany) as a low-buffered solution; (II) Dulbecco’s modified 
eagle medium Glutamax-I (Life Technologies, Darmstadt, Germany) as a more complex, highly buffered 
solution, and (III) simulated body fluid (SBF-JL2, according to [18]). The compositions of these solutions are 
given in Table 1. For the preparation of the SBF two solutions were prepared. All chemicals were obtained from 
Merck (Darmstadt, Germany). (I) Solution A: 6.129 g NaCl, 5.89 g NaHCO3 and 0.498 g Na2HPO4∙2H2O were 
dissolved in 1 L of double-distilled water. After dissolution, 0.934 mL of 1 M HCl was added. (II) Solution B: 
6.129 g NaCl and 0.54 g CaCl2 were dissolved in 1 L double- distilled water and 0.934 mL HCl was added. Both 
solutions were kept separately in the fridge and mixed (1:1) directly before the experiment. The pH value of the 
resulting solution was 7.4. In a second set of experiments , 10% or 20% FBS (FBS, PAA Laboratories, Linz, 
Austria) were added to these media. 
 
Table 1 Composition of the used corrosion media 
 
ingredient 
HBSS DMEM SBF 
mg/L mM mg/L mM mg/L mM 
amino acids   1852 10.29   
vitamins   31.6 0.15   
inorganic salts       
calcium chloride (CaCl2∙2H2O)   264 1.80 270 1.84 
ferric nitrate (Fe(NO3)3∙9H2O)   0.1 0.000248   
hydrochloric acid (HCl)     934 0.934 
magnesium sulfate (MgSO4∙7H2O)   200 0.813   
potassium chloride (KCl) 400 5.33 400 5.33   
potassium phosphate monobasic (KH2PO4) 60 0.441     
sodium bicarbonate (NaHCO3) 350 4.17 3700 44.05 2945 35.05 
sodium chloride (NaCl) 8000 137.93 6400 110.34 6129 104.88 
sodium phosphate monobasic (NaH2PO4∙2H2O)   141 0.916   
sodium phosphate dibasic (Na2HPO4) anhydrous 48 0.338   249 1.45 
other components       
D-glucose (dextrose) 1000 5.56 4500 25.00   
phenol red   15 0.0399   
sodium pyruvate   110 1.000   
 
 
2.3 Determination of degradation rate, pH and osmolality 
The degradation rate was determined by weight loss. Each sample was weighed (Scaltec SBA52, Scaltec 
Instruments GmbH, Göttingen, Germany) and sterilized (20 minutes in ultrasonic bath with 70% ethanol) prior 
to the immersion (n = 3 per solution). After three days of incubation under cell culture conditions the samples 
were taken from the different corrosion media and dried at 37°C under vacuum overnight. Corrosion residues 
from the samples were removed by immersion in chromic acid (180 g/L in distilled water, VWR International, 
Darmstadt, Germany). The immersion was carried out for 2 times 10 minutes, with the samples being turned 
over in between. Afterwards the samples were rinsed in distilled water and 100% ethanol. After drying, the 
weight of the samples was measured again and the degradation rate (DR) was calculated according to equation 1 
[19]. 
Eq. 1      
            
     
         
A = surface area [cm2], t = time [h], ρ= density (Mg = 1.74) [g/cm3]), ∆W = mass loss [g]. 
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After the immersion of the specimens the different corrosion media were removed from the wells and used for 
analysis of the pH value and osmolality. Solutions without samples were incubated in parallel as controls. The 
pH value was measured by a standard laboratory pH-meter (Sentron SI600, Sentron Europe BV, Roden, 
Netherlands) with an ISFET electrode. The osmolality of the supernatants was analyzed by a cryoscopic 
osmometer (Osmomat Auto, Gonotec GmbH, Berlin, Germany). 50 µL of the supernatant were used for the 
measurement. The device is a freezing point osmometer which determines the osmolality by measuring the 
freezing point. This decreases by 1.86° C when 1 mole of a nonionic solute is added to one kilogram of solvent 
[20]. 
 
2.4 Identification of corrosion products 
2.4.1 Immersion procedure 
Magnesium samples were sonificated for 20 min in dry isopropanol, dried and gamma-sterilized at the In core 
irradiation (ICI) facility of the Geesthacht neutron facility with a total dosage of 29 kGy. All specimens were 
immersed under sterile conditions in 1 mL of the respective media in agarose-coated 12-well plates (Greiner 
Bio-One, Frickenhausen, Germany). Then the samples were incubated under cell culture conditions (37°C, 5% 
CO2, 21% O2 and 95% relative humidity) in an incubator (Heraeus BBD 6620, Fisher Scientific, Schwerte, 
Germany). The immersion time was one, two, three, four and 7 days, respectively. Neither a pH adjustment nor a 
liquid stream was applied. After the immersion all samples were rinsed with deionized water for 1 min, dried 




The samples were visualized by scanning electron microscope (SEM; Auriga, Zeiss, Oberkochen, Germany) to 
visualize the corrosion layers. Images were taken at an accelerating voltage of 20 keV with the secondary 
electron detector (SE2). In order to identify the crystalline products formed and deposited, X-ray diffraction 
(XRD) measurements were performed on a Stoe Theta/Theta diffractometer (Stoe, Darmstadt, Germany) in 
reflection mode using CuKα radiation (λ = 1.54060 Å). The 2Θ range was scanned applying a step size of 0.01° 
(3.0 s per step). The diffractometer was operated at 40 kV and 30 mA. No further sample preparations were 




Data are displayed as mean ± SD. Statistical analysis was performed by using the SigmaStat Software (Systat 
GmbH, Erkrath, Germany; version 11.0). Comparison of corrosion rates was analyzed by applying the one-way 
analysis of variance (ANOVA) with Holm-Sidak post-hoc test. The significance level was p<0.05. 
 
3 Results 
3.1 Morphological analysis 
All samples showed obvious signs of corrosion on the surface. Exemplary photographs of immersed samples 
(respective media, and FBS supplemented media) are given in Fig. 1 (HBSS and HBSS+10%FBS), Fig. 2 
(DMEM and DMEM+10%FBS) and Fig. 3 (SBF and SBF+10%FBS). In general, the amount of white crust and 
flakes fallen off the samples, respectively, increased with immersion time; however, the exact time points of the 
chipping were not determined. According to the appearances, degradation occurred fastest in HBSS. When FBS 
was supplemented to HBSS and DMEM, degradation seemed to be reduced. In contrast, degradation did 
apparently not decrease when FBS was supplemented to SBF.  
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Fig.1 Pictures of the samples immersed in (a. to e.) HBSS and (f. to j.) HBSS+10%FBS. One, two, three, four 
and 7 days, respectively, from left to right  
 
 
Fig. 2 Pictures of the samples immersed in (a. to e.) DMEM and (f. to j.) DMEM+10%FBS. One, two, three, 
four and 7 days, respectively, from left to right  
 
 
Fig. 3 Pictures of the samples immersed in (a. to e.) SBF and (f. to j.) SBF+10%FBS. One, two, three, four and 7 
days, respectively, from left to right  
 
In general, according to the SEM images, two different morphologies could be observed predominantly (Fig. 4). 
First, intergrown needles, which are a typical morphology for magnesium carbonates such as nesquehonite and 
secondly, flake-like shaped crystals. However, the morphology of the crystals that form the crusts on the samples 
does not allow direct conclusions to the identity of the crystalline phases. Comparison of the samples surfaces 
after immersion in the different media showed differences between the surface morphologies. Samples immersed 
in HBSS exhibited mostly flake-like crystals, whereas on DMEM-immersed samples mainly interconnected 
needles were visible. In all cases the corrosion morphology changed with the addition of proteins.  
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Fig. 4 SEM images of samples immersed for 72 hours in the respective media without (left column) and with 
FBS supplementation (right column). From top to bottom: SEM images of samples immersed in HBSS, 
HBSS+10%FBS, DMEM, DMEM+10%FBS, SBF, SBF+10%FBS. Scale bars represent 25 µm 
 
3.2 Degradation rate, pH and osmolality 
The degradation rate was highest in HBSS and lowest in SBF. According to the statistical analysis, the HBSS 
treatment led to significantly higher degradation rates (compared to all other treatments, Fig. 5). Using HBSS the 
addition of proteins exhibited a significant decrease of degradation rate due to the addition of proteins. This 
effect was much weaker for DMEM, where only the addition of 20 % led to a significant decrease. Presumably, 
due to the low amount of samples no significant differences between DMEM and SBF could be observed. The 
addition of proteins generally resulted in a decrease of the degradation rate, except for SBF, where the higher 
amount of protein increased the degradation rate again (Fig. 6 left). The measurement of osmolality reproduces 
this behavior for DMEM and SBF, but shows a different trend for HBSS (Fig. 6 middle), whereas the increase of 
pH is not correlated to the degradation rate (Fig. 6 right). However, the increase is much lower for DMEM and 
SBF which have a higher buffering capacity than HBSS. 
 
 
Fig. 5 Multiple comparison graph of significant differences between the corrosion rates in the different solutions 
(ANOVA, p<0.05)  
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Fig. 6 Degradation rate, osmolality and pH in the different media after 72 h  
 
3.3 Phase identification via XRD 
Exemplary XRD patterns of samples immersed in HBSS and HBSS+10%FBS are shown in Fig. 7, patterns of 
the DMEM series in Fig. 8, and patterns of the SBF series in Fig. 9 It is to be pointed out that a quantitative 
evaluation of the species is not possible by XRD means in this study. Furthermore, crumbles of different sizes 
fell off most samples at undetermined time points. Next to texture effects, reflections of products formed appear 
in many cases vastly undersized due to high relative intensities of reflections associated with other compounds or 
the magnesium substrates. In particular, reflections that can be assigned to brucite (Mg(OH)2) or to magnesium 
could in some cases hardly be distinguished from noise.  
Magnesium-associated reflections ( , 32.2°, 34.4° and 36.6°) were present in all diffractograms allowing the 
conclusion that the penetration depth of the X-ray beam was sufficient to examine the crusts in their entire 
thickness, allthough the relative intensities were remarkably low in the DMEM series. The reflections are 
marked in the patterns obtained from samples with an immersion time of one day, and selections of reflections of 
the other products are marked, if appropriate, in the respective patterns. According to our evaluation, brucite 
(Mg(OH)2) could be found as one of the corrosion products. Corresponding reflections ( , 18.5° and 38.0°) 
could be found in the HBSS series. Nesquehonite (Mg(HCO3)(OH)·2H2O) characteristic reflections ( , 13.6°, 
23.0°, 29.5° and 34.2°) were dominant in our study, and could be found in all diffractograms in both the HBSS 
series and for all specimens that have been exposed to SBF (+10%FBS) and DMEM (+10%FBS) for longer than 
one day. 
Calcium phosphates were found according to XRD results on a sample immersed in SBF+10%FBS for 7 days 
(Fig. 8). The reflections ( ) can be assigned to a mixture of Ca2P4O12·4H2O and Ca2P2O7·2H2O. However, some 
reflections, e.g. 10.2° and 11.6° remain unassigned.  
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Fig. 7 XRD patterns obtained from samples immersed in (left) HBSS and (right) HBSS+10%FBS. From top to 
bottom: One, two, three, four and 7 days  
 
 
Fig. 8 XRD patterns obtained from samples immersed in (left) DMEM and (right) DMEM+10%FBS. From top 
to bottom: One, two, three, four and 7 days  
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Fig. 9 XRD patterns obtained from samples immersed in (left) SBF and (right) SBF+10%FBS. From top to 
bottom: One, two, three, four and 7 days 
 
4 Discussion 
4.1 Influence of the medium and proteins on the degradation rates and osmolality 
In this study, slices of pure magnesium were exposed to different aqueous media. HBSS has been evaluated to be 
the simplest medium, followed by SBF, while DMEM also includes organic substances [16]. Corrosion rates 
decreased in the order of HBSS, DMEM, SBF. Since proteins are known to retardate magnesium degradation 
under certain conditions [17], a reduction of the decomposition rates was expected in this study. The expectation 
was confirmed for samples immersed in HBSS and DMEM, but not for samples immersed in SBF. As stated 
above, osmolality examinations reproduced this behavior for DMEM and SBF, but not for HBSS. Presumably 
due to the high degradation rates in HBSS, which were highest in this study, and due to the high salt content, 
correlation could not be found.  
 
4.2 Corrosion products  
Two magnesium compounds were found to be the dominant corrosion products in this study: Mg(OH)2 and 
nesquehonite. The latter was found in all media, while Mg(OH)2 was found exclusively in the HBSS studies. 
Measurements revealed the highest pH when HBSS was used as the medium, hence, the presence of Mg(OH)2 in 
the crusts is plausible. Unfortunately, the XRD investigations in this study were not suited to be used for 
quantification.  
The formation of different magnesium carbonate compounds might occur if conditions of future immersion 
setups are altered slightly. Syntheses of different magnesium carbonates described by various authors reveal that 
the formation of different magnesium carbonate species can occur in similar chemical systems. Nesquehonite 
could be synthesized by the addition of a NaCO3 solution to a MgCl2 solution at room temperature [21], while 
the NaCO3–MgCl2 system led to the formation of hydromagnesite (Mg5(CO3)4(OH)2·4H2O) at slightly elevated 
temperatures [22]. Furthermore, the alteration of nesquehonite to hydromagnesite is reported in the context of 
dypingite (Mg5(CO3)4(OH)2·5H2O) [23,24], which was found to be a byproduct in the synthesis of magnesite 
(MgCO3) [25]. Hydromagnesite and magnesite, respectively, were occasionally found to be associated with 
Holocen dolomite (South Australia) [26]. It is noted that some formulae only differ in one equivalent of crystal 
water, a difference that in some cases semi-quantitative methods are probably not able to detect reliably, and the 
formulae of dypingite and giorgiosite are the same (Mg5(CO3)4(OH)2·5H2O).  
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The calcium phosphates found in the SBF series most likely derived from the supplements of the medium, which 
contains a supersaturated calcium phosphate system. Reflections of crystalline magnesium phosphates were not 
detected in this study: either the amount of product was not sufficient to be detected or the magnesium 
phosphates are amorphous, therefore not detectable by XRD means. However, it cannot be excluded by the 
means applied, that certain amounts of Ca2+ were replaced with Mg2+.  
 
4.3 CO2 gassing  
The formation of Mg(OH)2 as the only crystalline corrosion product has been described by various studies that 
did not include CO2 gassing as part of their setup [12]. However, the formation of Mg(OH)2 was not hindered 
entirely in this study. As described above, a variety of magnesium carbonates compounds can be obtained by 
altering the degradation setup. The introduction of CO2 is an additional source of hydrogen carbonates and 
carbonates.  
In this study, the CO2 gassing is likely to be crucial for the formation of nesquehonite. It could be shown that the 
formation of magnesium carbonates is of relevance for CO2 storage using mineral carbonation [27]. Taking also 
the increase of solubility of Mg(OH)2 due to the presence of chlorides [4] into account, a hypothetical scheme for 
the formation of nesquehonite and magnesium/calcium phosphates is shown in Fig. 10. This in vitro scheme is in 
accordance earlier findings [28], including the more direct reaction Mg + CO2 + O2 Æ 2MgCO3 [10]. 
Since the degradation of magnesium is a complex process, the formation of nesquehonite or other carbonates 
might not be describable by a single synthesis route. In future in vitro studies the CO2 pressure of the in vivo 
environment or technical application site should be considered. Since proteins are known to bind CO2 [29], it is 
also likely that certain reaction pathways are more affected by the presence of proteins than others.  
 
 




In this study, the degradation occurred fastest in HBSS, while the supplement with proteins led to a decrease of 
degradation in case of HBSS and DMEM, but not in case of SBF as the respective medium. As expected, brucite 
Mg(OH)2 could be found as one of the corrosion products when HBSS was used. Nesquehonite 
(Mg(HCO3)(OH)·2H2O) was found to be the dominant, crystalline corrosion product, formed within short terms 
in all media.  
Since it is likely that the additional carbonate source promoted the formation of the magnesium carbonate, CO2 
pressure ought to be taken into account for the evaluation of further in vitro studies. Furthermore, it is likely that 
different magnesium carbonates might be found if the experimental setups are altered. While crystalline calcium 
phosphate compounds could be found on one sample of the SBF series, no crystalline magnesium phosphates 
were found in this study.  
 
 
70	  	   3	  Magnesium	  Degradation	  
	  
6 References 
1. Witte F. The history of biodegradable magnesium implants: a review. Acta Biomater. Acta Materialia Inc.; 
2010;6:1680–92.  
2. Waksman R, Erbel R, Di Mario C, Bartunek J, de Bruyne B, Eberli FR, et al. Early- and long-term 
intravascular ultrasound and angiographic findings after bioabsorbable magnesium stent implantation in human 
coronary arteries. JACC. Cardiovasc. Interv. American College of Cardiology Foundation; 2009;2:312–20.  
3. Erne P, Schier M, Resink TJ. The road to bioabsorbable stents: reaching clinical reality? Cardiovasc. 
Intervent. Radiol. 2006;29:11–6.  
4. Witte F, Hort N, Vogt C, Cohen S, Kainer KU, Willumeit R, et al. Degradable biomaterials based on 
magnesium corrosion. Curr. Opin. Solid State Mater. Sci. Elsevier Ltd; 2008;12:63–72.  
5. Janning C, Willbold E, Vogt C, Nellesen J, Meyer-Lindenberg A, Windhagen H, et al. Magnesium hydroxide 
temporarily enhancing osteoblast activity and decreasing the osteoclast number in peri-implant bone 
remodelling. Acta Biomater. 2010;6:1861–8.  
6. Witte F, Kaese V, Haferkamp H, Switzer E, Meyer-Lindenberg A, Wirth CJ, et al. In vivo corrosion of four 
magnesium alloys and the associated bone response. Biomaterials. 2005;26:3557–63.  
7. Xu L, Yu G, Zhang E, Pan F, Yang K. In vivo corrosion behavior of Mg-Mn-Zn alloy for bone implant 
application. J. Biomed. Mater. Res. A. 2007;83:703–11.  
8. Ibasco S, Tamimi F, Meszaros R, Nihouannen D Le, Vengallatore S, Harvey E, et al. Magnesium-sputtered 
titanium for the formation of bioactive coatings. Acta Biomater. Acta Materialia Inc.; 2009;5:2338–47.  
9. Mueller W-D, Lucia Nascimento M, Lorenzo de Mele MF. Critical discussion of the results from different 
corrosion studies of Mg and Mg alloys for biomaterial applications. Acta Biomater. Acta Materialia Inc.; 
2010;6:1749–55.  
10. Feyerabend F, Drücker H, Laipple D, Vogt C, Stekker M, Hort N, et al. Ion release from magnesium 
materials in physiological solutions under different oxygen tensions. J. Mater. Sci. Mater. Med. 2012;23:9–24.  
11. Yang L, Hort N, Willumeit R, Feyerabend F. Effects of corrosion environment and proteins on magnesium 
corrosion. Corros. Eng. Sci. Technol. 2012;47:335–9.  
12. Waizy H, Weizbauer A, Modrejewski C, Witte F, Windhagen H, Lucas A, et al. In vitro corrosion of 
ZEK100 plates in Hank’s Balanced Salt Solution. Biomed. Eng. Online. BioMed Central Ltd; 2012;11:12.  
13. Wang Y, Wei M, Gao J, Hu J, Zhang Y. Corrosion process of pure magnesium in simulated body fluid. 
Mater. Lett. 2008;62:2181–4.  
14. Fournier V, Marcus P, Olefjord I. Oxidation of magnesium. Surf. Interface Anal. 2002;34:494–7.  
15. Rettig R, Virtanen S. Composition of corrosion layers on a magnesium rare-earth alloy in simulated body 
fluids. J. Biomed. Mater. Res. A. 2009;88:359–69.  
16. Tie D, Feyerabend F, Hort N, Willumeit R, Hoeche D. XPS Studies of Magnesium Surfaces after Exposure 
to Dulbecco’s Modified Eagle Medium, Hank's Buffered Salt Solution, and Simulated Body Fluid. Adv. Eng. 
Mater. 2010;12:B699–B704.  
17. Yamamoto A, Hiromoto S. Effect of inorganic salts, amino acids and proteins on the degradation of pure 
magnesium in vitro. Mater. Sci. Eng. C. Elsevier B.V.; 2009;29:1559–68.  
18. Bohner M, Lemaitre J. Can bioactivity be tested in vitro with SBF solution? Biomaterials. 2009;30:2175–9.  




19. ASTM International, Standard Guide for Laboratory Immersion Corrosion Testing of Metals. ASTM Stand. 
NACE / ASTMG31 - 12a. West Conshohocken, PA, USA: ASTM International; 2012.  
20. Abele J. The physical background to freezing point osmometry and its medical-biological applications. Am. 
J. Med. Electron. 1962;2:32–41.  
21. Kloprogge J, Martens W. Low temperature synthesis and characterization of nesquehonite. J. Mater. Sci. 
Lett. 2003;22:825–9.  
22. Cheng W, Li Z. Controlled Supersaturation Precipitation of Hydromagnesite for the MgCl2− Na2CO3 
System at Elevated Temperatures: Chemical Modeling and Experiment. Ind. Eng. Chem. Res. 2010;5:1964–74.  
23. Davies PJ, Bubela B. The Transformation of Nesquehonite into Hydromagnesite. Chem. Geol. 1973;12:289–
300.  
24. Canterford JH, Tsambourakis G, Lambert B. Some observations on the properties of dypingite , Mg5( 
CO3)4(OH)2 x 5H20 , and related minerals. Mineral. Mag. 1984;48:437–42.  
25. Anjos APA, Sifeddine A, Sanders CJ, Patchineelam SR. Synthesis of magnesite at low temperature. 
Carbonates and Evaporites. 2011;26:213–5.  
26. Warren J. Sedimentology and mineralogy of dolomitic Coorong lakes, South Australia. J. Sediment. Res. 
1990;60.  
27. Prigiobbe V, Mazzotti M. Precipitation of Mg-carbonates at elevated temperature and partial pressure of 
CO2. Chem. Eng. J. Elsevier B.V.; 2013;223:755–63.  
28. Willumeit R, Fischer J, Feyerabend F, Hort N, Bismayer U, Heidrich S, et al. Chemical surface alteration of 
biodegradable magnesium exposed to corrosion media. Acta Biomater. Acta Materialia Inc.; 2011;7:2704–15.  
29. Cundari TR, Wilson AK, Drummond ML, Gonzalez HE, Jorgensen KR, Payne S, et al. CO2-formatics: how 
do proteins bind carbon dioxide? J. Chem. Inf. Model. 2009;49:2111–5.  
 
 
72	  	   3	  Magnesium	  Degradation	  
	  
3.3	  	   In	  vitro	  corrosion	  of	  ZEK100	  plates	  in	  Hank’s	  Balanced	  Salt	  Solution	  
Hazibullah	   Waizy,	   Andreas	   Weizbauer,	   Christian	   Modrejeksi,	   Frank	   Witte,	  
Henning	  Windhagen,	  Arne	  Lucas,	  Marc	  Kieke,	  Berend	  Denkena,	  Peter	  Behrens,	  
Andrea	  Meyer-­‐Lindenberg,	  Friedrich-­‐Wilhelm	  Bach,	  Fritz	  Thorey	  
	  
BioMedical	  Engineering	  OnLine	  2012;11:12	  
DOI:	  10.1186/1475-­‐925X-­‐11-­‐12	  
	  
The	  final	  publication	  is	  available	  at	  
http://www.biomedical-­‐engineering-­‐online.com/content/11/1/12	  
	  
Reproduced	  under	  the	  terms	  of	  the	  Creative	  Commons	  Attribution	  Licence.	  	  
	  
	  
3	  Magnesium	  Degradation	   73	  
	  
	  
	   	  
RESEARCH Open Access
In vitro corrosion of ZEK100 plates in Hank’s
Balanced Salt Solution
Hazibullah Waizy1*, Andreas Weizbauer1, Christian Modrejewski1, Frank Witte1, Henning Windhagen1, Arne Lucas2,





Surgery, Hannover Medical School,
Anna-von-Borries-Str.1-7, 30625
Hannover, Germany
Full list of author information is
available at the end of the article
Abstract
Background: In recent years magnesium alloys have been intensively investigated as
potential resorbable materials with appropriate mechanical and corrosion properties.
Particularly in orthopedic research magnesium is interesting because of its
mechanical properties close to those of natural bone, the prevention of both stress
shielding and removal of the implant after surgery.
Methods: ZEK100 plates were examined in this in vitro study with Hank’s Balanced
Salt Solution under physiological conditions with a constant laminar flow rate. After
14, 28 and 42 days of immersion the ZEK100 plates were mechanically tested via
four point bending test. The surfaces of the immersed specimens were characterized
by SEM, EDX and XRD.
Results: The four point bending test displayed an increased bending strength after
6 weeks immersion compared to the 2 week group and 4 week group. The
characterization of the surface revealed the presence of high amounts of O, P and
Ca on the surface and small Mg content. This indicates the precipitation of calcium
phosphates with low solubility on the surface of the ZEK100 plates.
Conclusions: The results of the present in vitro study indicate that ZEK100 is a
potential candidate for degradable orthopedic implants. Further investigations are
needed to examine the degradation behavior.
Keywords: Magnesium alloy, Corrosion, Plates, in vitro study
Background
The first published application of a plate for fracture fixation was 1886 by Carl Hans-
mann [1]. It was not until the beginning of the 20th century when plates as osteosynth-
esis systems was spread due to the works of William Arbuthnot Lane and Albin
Lambotte. In 1907 Lane, a British surgeon, introduced perforated steel plates for use in
internal fixation [2]. Lambotte was one of the first to apply pure magnesium plates in
a clinical case to stabilize a fracture in a young man. After implantation he observed
extensive subcutaneous gas cavities and local swelling caused by rapid degradation [3].
In recent years, new innovative magnesium alloys are being intensively investigated as
potential resorbable materials with appropriate mechanical and corrosion properties.
Particularly in orthopedic research magnesium is interesting because of its mechanical
properties close to those of natural bone, the prevention of both stress shielding and
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removal of the implant after surgery [4]. Orthopedic implants need to provide an initial
fixation and a predictable, gradually degradation adapted to the bone healing process.
ZEK100 is a magnesium alloy which contains 1 wt% zinc, 0.1 wt% zirconium and 0.1 wt
% rare earth metals [5]. Magnesium and its degradation products are non-toxic and it is
an essential co-factor for many enzymes; especially for DNA replication and repair pro-
cesses [6,7]. Furthermore, magnesium acts as a stabilizer of DNA and chromatin structure.
The recommended daily dietary is approximately 300 mg for adults [6]. Zinc as an alloying
ingredient contributes to strength due to solid solution strengthening [7]. In addition, zinc
is one of the essential micro-nutrients in the human body with an estimated daily require-
ment of 15 mg. It is essential to structure and function of over 300 enzymatic reactions
[8]. The zinc finger motif, which is determined by a single zinc ion in the base, is most fre-
quently occurring in transcription factors [8]. Zirconium is usually used as a grain refine-
ment agent in magnesium alloys without aluminum and thereby contributes to
strengthening [7]. In an in vitro study with binary magnesium alloys an addition of Zn or
Zr showed good cytocompatibility, improved strength and a reduced corrosion rate [9].
The rare earth metals comprise seventeen elements which can be classified into two
groups: elements with high and limited solubility in magnesium [10]. Rare earth (RE)
metals improve strength by solid solution strengthening and precipitation strengthening
[7]. The in vitro test with Mg-Y indicate no significant cytotoxicity to osteoblasts; further-
more good cytocompatibility was observed with Mg-Zn-Y alloys [9,11]. Several RE con-
taining alloys such as WE43 or LAE443 have been investigated in former studies and
reported good biocompatibility in vivo [12-16].
The disadvantage of magnesium alloys is the production of hydrogen gas which accu-
mulates in tissue cavities. The amount of gas production is dependent on the corrosion
rate. The accumulation of gas of ZEK100 implants was found in the medullary cavity via
μ-computed tomography (μCT) examinations, though it did not became clinically visible
[17].
In the present study, ZEK100 plates were examined in an in vitro model with Hank’s
Balanced Salt Solution under physiological conditions. A constant laminar flow of the cor-
rosion medium was adjusted. The mechanical properties of the plates after corrosion were
determined via four-point bending test. The surfaces of the immersed specimens were
characterized by SEM, EDX and XRD.
Methods
Material
In this study plates for bone fixation of a biodegradable magnesium alloy were exam-
ined. The magnesium alloy ZEK100 contains 1 wt% zinc, 0.1 wt% zirconium and 0.1
wt% rare earth metals [5]. The analyzed chemical composition of the alloy by ICP-OES
is given in Table 1. The ZEK100-specimens were cut into plates with dimensions of
50 mm × 8 mm × 1 mm by milling processes. In every plate five screw holes were
Table 1 Nominal and analyzed composition of the ZEK100 alloy
Element Mg Zn Zr Rare Earth Elements
Y Nd Ce La
Analyzed composition 98.53 0.961 0.211 0.146 0.02 0.092 0.042
Nominal composition 98.8 1 0.1 0.1
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drilled and counterbored. These screw holes have an inner diameter of 3 mm on the
bone-side and a counterbore diameter of 5 mm (Figure 1).
Microstructural characterization
The corroded plates were analyzed by a scanning electron microscope (SEM) EVO 60
VP by Zeiss. Theses analyses also included an energy dispersive X-ray analysis (EDX)
to detect the distribution of elements on the surface of the corroded specimens and on
the cross-section area of the plates. Therefore the plates were cut in the section of the
middle bore. To achieve an electro conductive surface for the SEM analysis the speci-
mens were also sputtered with gold.
X-ray diffraction (XRD) investigations were performed with a STOE Theta-Theta dif-
fractometer in reflection geometry (wavelength l = 1.54059 Å). The 2θ range from 2 to
65° was scanned with a step size of 0.01° (3.0 s per step) using monochromatized Cu
Ka1 radiation.
Immersion test in a system with a constant flow rate
The immersion test was carried out in Hanks’ Balanced Salt Solution (HBSS) to simu-
late normal ion concentration under physiological tissue conditions. The chemical
composition of HBSS is given in Table 2. The HBSS were produced as dry substance
with phenol red by Biochrom AG, Berlin. The temperature in the test system was mea-
sured by a thermometer (Fisher Scientific, Schwerte, Germany) during corrosion every
day and regulated to 37.4°C +/- 0.5°C. Also the pH was controlled every day during
Figure 1 Picture of a non-corroded plate. The plate consists of ZEK100 and has a dimension of 50 mm
× 8 mm × 1 mm. In every plate five screw holes were drilled and counterbored with an inner diameter of
3 mm on the bone-side and a counterbore diameter of 5 mm.
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corrosion and remained at 7.4. Flow rate was regulated to 2.5 to 3.5 ml/min. After pas-
sing the ZEK100 alloys the solution was discarded (Figure 2).
In this study twelve ZEK100 plate demonstrators, divided into 3 groups with 4
demonstrators, were corroded and tested. The demonstrators were fixed into a test
frame which allows a laminar flow of the HBSS. The first group was corroded over 14
days, the second group over 28 d and the third group over 42 days.
Mechanical testing
In order to specify the mechanical properties of the specimens, they were tested
according to ISO 9585:1990. The four point bending test setup (Figure 3) was designed
for tests with an uniaxial material-testing machine (Mini Bionix 858, MTS Systems in
Mineapolis, USA). The test system consisted of four rollers with a diameter of 8 mm.
The distance between the lower and outer rollers was 32 mm. 10 mm distance was











Figure 2 Picture of the in vitro corrosion testing setup. 1: Glass basin with Hank’s Balanced Salt
Solution. 2: The corrosion medium was warmed in a water bath to 37.4 +/- 0.5°C. 3: HBSS passes the test
system with the specimens with a laminar flow rate of 2.5 to 3.5 ml/min Temperature is checked with a
thermometer. The system is protected against heat loss with styrofoam. 4: The flow rate was maintained
with a pump. The solution was then discarded in a container.
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between the upper and inner rollers. The plates were positioned on the lower rollers
according to the protocol of ISO 9585:1990. The distance between the outer and inner
rollers was 11 mm and contains a screw hole of the demonstrators. The test rig was
produced by the Research Work Shop of the Medical School, Hannover, Germany.
Results
Microstructure and surface composition after immersion
The surface morphology of ZEK100 plates after exposure in Hank’s Balanced Salt Solu-
tion are shown in the SEM images of Figures 4 and 5. On the corrosion surface cracks
were found after all immersion intervals which might be caused by drying. At higher
magnifications, some needle-shaped clusters appeared on the surface of the 2 weeks
group and the 6 weeks group (Figure 4b, g). A more detailed picture of that structure
is given in Figure 4h. In the SEM picture after 4 weeks immersion a peeling of corro-
sion surface can be observed in high magnification view. Small, agglomerated particles
seemed to be formed on the surface (Figure 4e). The pictures of the cross-sections
reveal local pits on the surface (Figure 5). More distinct and deep pits were found after
4 and 6 weeks immersion (Figure 5b, c).
EDX analyses were conducted on a small surface area after every corrosion interval
to determine the elemental composition (Figure 6). The results revealed the presence
of high amounts of the elements O, P and Ca and small amounts of C, Na, Mg, Cl and
K (Table 3).
Figure 3 Picture of the mechanical four-point bending test setup. The test system consisted of four
rollers with a diameter of 8 mm. The distance between the lower and outer rollers was 32 mm. 10 mm
distance was between the upper and inner rollers. The plates were positioned on the lower rollers
according to the protocol of ISO 9585:1990.
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X-ray diffraction (XRD) was applied to identify some of the corrosion products on
the surface. Figure 7 presents the XRD patterns of the ZEK100 plates after all three
different immersion intervals. In all spectra large magnesium and Mg(OH)2 peaks are
clearly visible.
Figure 4 SEM pictures of the surface morphology of ZEK100 plates immersed in Hank’s balanced
salt solution. a)-c) after 2 weeks, d)-e) after 4 weeks, f)-h) after 6 weeks. The black arrow marks needle-
shaped clusters.
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Mechanical characterization of the specimens after immersion
The bending strength was calculated from obtained load-deflection curves. The results
are presented in Figure 8. The results of the bending test displayed a decrease of bend-
ing strength from immersion week 2 to immersion week 4. The tested plates after 6
weeks corrosion showed an increased bending strength.
Discussion
Fracture healing is a complex pathway with determine steps and the healing quality
and speed depends on the size of the fracture gap and the achieved stability. Therefore
an adjusted stability is essential for fracture healing. The discrepancy of the Young’s
Figure 5 SEM pictures of the cross-section area. a) 2 weeks, b) 4 weeks c) 6 weeks. The corrosion pits
are marked by black arrows.
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Figure 6 Example of the EDX analysis. The energy dispersive X-ray analysis (EDX) was applied in order
to detect the distribution of elements on the surface of the corroded specimens.
Table 3 Results of the EDX analysis of the ZEK100 alloy
Element 2 weeks 4 weeks 6 weeks
wt% at% wt% at% wt% at%
C 6.21 10.8 6.66 11.66 6.3 11.01
O 43.07 56.24 43.16 56.76 42.3 55.48
Na 0.63 0.57 0.6 0.55 1.94 1.77
Mg 10.88 9.35 7.7 6.67 10.36 8.94
P 16.94 11.43 15.34 10.42 14.99 10.16
Cl 0.08 0.05 0.16 0.09 0.06 0.04
K 0.28 0.15 0.34 0.19 0.6 0.32
Ca 21.92 11.42 26.03 13.66 23.45 12.28
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modulus of the conventional implants (stainless steel or titan) in regard to bone pro-
motes the occurrence of stress shielding with negative effects to the bone healing.
Degradable implants from magnesium alloys are desirable because of the mentioned
promising characteristics of magnesium. Standard tests with those implants according
to ASTM protocols are rare.
In the present study, ZEK100 plates were examined in an in vitro model with Hank’s
Balanced Salt Solution under physiological conditions. The corrosion medium used in
Figure 7 X-ray diffraction (XRD) patterns of ZEK100 plates. The XRD analysis of the plates after
different immersion times in Hank’s Balanced Salt Solution.
Figure 8 Bending strength of ZEK100 plates. The bending strength of the plates after different time
intervals of exposure to Hank’s Balanced Salt Solution.
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this study is in its ionic content similar to blood plasma with a high chloride concen-
tration. The degradation of magnesium and its alloys are described according to the
following reactions [18]:
Anodic reaction: Mg ® Mg2+ + 2e-
Cathodic reaction: 2 H2O + 2e
- ® H2↑ + 2 OH-
Mg2+ + 2 OH - → Mg(OH)2 (s)
It is reported that the protective Mg(OH)2-film is formed rapidly after 2 h immersion
[19]. The Mg(OH)2-layer on the surface is dissolved by Cl
- into soluble MgCl2:
Mg(OH)2 → MgCl2 + 2 OH−
An illustration of the reactions on the surface of the magnesium alloy is given in
Figure 9. This diagram is in accordance with previous illustrations in Ref. [20,21] and
is intended to demonstrate the corrosion processes on the surface. This dissolution
reaction elevates the local hydroxide concentration near the surface. It is reported that
in stagnant corrosion systems the degradation of magnesium and its alloys lead to an
alkalization of the corrosive medium [22]. As a result of alkalization, a greater tendency
for film formation is reported when the local pH value rise above 10.5 [23]. However,
this effect might be minor in this study due to the NaHCO3 buffer in the corrosion
medium and the flow rate applied in this system. Nevertheless, it is reported that this
buffering agent accelerates the dissolution of magnesium because of the consumption
of the generated OH- [24].
The corrosion in our model is most likely more influenced by the velocity. The
accelerating corrosive effect of the flow rate obtains to (i) shear forces, (ii) the destruc-
tion or prevention of a protective surface layer and (iii) the prevention of micro-alkali-
zation on the surface [7,23]. It is noticeable that a corrosion layer could be identified
considering the flow rate adjusted in this immersion model. Wang et al. compared the
degradation rate of a dynamic system with a flow rate to static conditions with Hank’s
Balanced Salt Solution by weight loss method [25]. An accelerated degradation rate
was reported in this study under dynamic conditions; though the applied flow rate
remains unclear [25].
The EDX analysis of our plates revealed a high amount of the elements Ca, P and O
which indicates the precipitation of calcium phosphates with low solubility which was
reported in previous studies [15,18,26]. The corrosion medium Hank’s Balanced Salt
Solution contains a certain amount of Ca2+ and PO4
3- (Table 1). The most stable cal-
cium phosphate is hydroxyapatite which forms according to the following reaction:
10 Ca2+ + 6 PO3−4 + 2 OH
− → Ca10(PO4)6(OH)2 [27] .
Additional types of calcium phosphates are in order of increasing solubility: Ca2(PO4)
3·nH2O (TCP), Ca8H2(PO4)6·5H2O (OCP) and Ca(HPO4)·5H2O (DCPD) [27]. Hydro-
xyapatite is an essential component of the human bone and therefore the biocompat-
ibility of this precipitation layer can be assumed. In addition, it has been shown that
hydroxyapatite coated carboxymethyl chitosan (CMCS) enhances the proliferation and
differentiation of osteoblasts and stem cells [28]. In a different study Ca3Mg3(PO4)4
was detected on the surface via XRD analysis of a Mg-Mn-Zn alloy immersed in
Waizy et al. BioMedical Engineering OnLine 2012, 11:12
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Hank’s solution [18]. The occurrence of this specific precipitation layer in our study is
not supported by the low Mg content in our EDX analysis. The precipitation layers
protect the magnesium alloy against aggressive ions in the corrosive medium and
therefore reduce the corrosion rate [18]. In corrosive media containing HCO3
-, which
is the case in HBSS and blood plasma, the surface layer might consist of amorphous
carbonated calcium phosphate with a schematic formula as follows: (Mg, Ca)x(PO4)y
(CO3)z(OH)i [29].
An advanced deposition of calcium and phosphate on the surface was determined by
EDX analysis in all specimens. These results are comparable with Huan et al., who
investigated an Mg-Zn-Zr alloy which is comparable to ZEK100 [30]. In this men-
tioned study the atomic content of Mg decreased slightly from 7 days immersion to 24
days while the atomic content of P and Ca increased [30]. The growth of the corrosion
precipitation layer could not be detected in this study by EDX analysis after the differ-
ent immersion time intervals. This let us assume that after 2 weeks the composition
on the surface is stable which might be explained by an equilibrium between precipita-
tion and erosion.
The effect of corrosion on the bending strength of plates with medical geometry has
not been studied previously. In the present work a decreased bending strength of the
plates was determined after 4 weeks in Hank’s Balanced Salt Solution in comparison to
the 2 week and 6 week group. It can be concluded that the change of the bending
Figure 9 Schematic diagram of the reactions on the surface of the magnesium alloy. a) The galvanic
reaction between magnesium and H2O, b) the formation of the magnesium hydroxide film on the surface,
c) the transformation of Mg(OH)2 into soluble MgCl2, d) the formation of hydroxyapatit on the surface due
to consumption of Ca2+ and PO4
3-.
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strength after 4 week and 6 week immersion might be caused by the embrittlement of
the magnesium alloy. As described hydrogen gas evolve as bubbles from the magne-
sium surface in consequence of dissolution. It is also reported that some hydrogen
atoms enter the metal lattice [31,32]. This storage of hydrogen atoms results in hydro-
gen embrittlement of the magnesium alloy which degree is dependent on the immer-
sion time [31]. It is reported that the cohesive strength of a magnesium alloy (AZ31) is
reduced by hydrogen embrittlement [31].
In a previous in vivo study the bending stiffness of ZEK100-implants was determined
via 3 point bending test. The maximum force (Fmax) at the point of breakage of the
explanted implants was decreased by 35% after 3 months and 60% after 6 months.
These in vivo results differ from the results determined in this study. The geometry of
the implant affects the determination of the mechanical properties of the specimen. In
the in vivo study by Hühnerschulte et al. pins were used as implant geometry [17].
Further in vivo evaluations with the dimensions examined in this study would be help-
ful to improve the comparability between the in vivo and in vitro corrosion behavior.
Different biomechanical results may be caused by different corrosion rates in vitro and
in vivo [33,34]. It is reported that the in vitro corrosion rate is faster than in compar-
able in vivo studies [33]. Müller et al. reported that the corrosion rate was in vitro 1.7
times greater than in vivo for LAE442 [33]. Faster corrosion rates should be accompa-
nied with an earlier loss of mechanical strength. A rapid decrease of the bending
strength was determined from week 2 to week 4 in this in vitro study.
In contrast to this, in vivo μCT scans first demonstrate a decrease of the implant
volume until week 4, thereupon an increased volume was determined up to week 8.
After week 8 a continuously reduction of the volume was observed [17]. This increase
of implant volume could be explained by the corrosion products on the surface which
is not differentiated by the contour [17]. We assume that this increase of the volume
caused by precipitation in the first weeks of corrosion affects the bending strength of
the implants at that time. In our study the precipitation of calcium phosphates on the
surface was observed via EDX analysis. This might explain the higher bending strength
in week 6.
Primary bone healing is induced by a stiff construct and secondary bone healing by
limited passive or active dynamization. However the role of mechanical stability in the
fracture healing process is not totally cleared yet. Therefore it is not desirable to pro-
duce a total rigid complex. A mechanical stimulus is essential for bone growth and
consolidation. It is still controversial which tactic would best improve the duration and
strength of the healing fracture. But it is clear that stress shielding occurs as a result of
the different Youngs moduls. The mention benefit of magnesium based implants is the
low Youngs modul, this could avoid stress shielding.
There is a discrepancy between the maximum strength and the optimum strength.
Magnesium plates are able to offer a time depending stability. However, it is important
to define the demanded stability of a specific fracture. The needed stability of fracture
depends on the bone quality, fracture geometry, localization of the fractured bone and
the demand in rehabilitation. Therefore, the first demand should be define. According
to the required implant characteristics the test standards should also be adjusted.
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Conclusion
In the present work the degradation of ZEK100-plates was investigated. The bending
strength increased after 6 weeks immersion compared to the 2 week group and 4 week
group. The characterization of the surface revealed the presence of high amounts of O,
P and Ca on the surface and small Mg content. This indicates the precipitation of cal-
cium phosphates with low solubility on the surface of the ZEK100 plates. The present
in vitro study indicates that ZEK100 is a potential candidate for degradable orthopedic
implants. Further investigations are needed to examine the degradation behavior.
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4	   LDHs	   as	   Tunable	   Implant	   Materials	   with	   Regard	   to	  
Orthopedic	  Application	  
4.1	  	   Preface	  
This	  chapter	  deals	   in	   two	  articles	  with	  the	   in	  vitro	   stability	  of	  Mg-­‐Al-­‐CO3-­‐LDHs	  
(section	  4.2),	  and	  the	  in	  vitro	  and	  in	  vivo	  examination	  of	  Mg-­‐Al-­‐	  and	  Mg-­‐Fe-­‐LDHs	  
(section	  4.3)	  with	  regard	  to	  their	  applicability	  in	  orthopedics.	  Both	  studies	  were	  
performed	   in	   comparison	   with	   magnesium	   hydroxide.	   Examination	   of	  
magnesium	   hydroxide-­‐derived	   compounds	   is	   of	   interest	   due	   to	   the	  
osteoinductive	  properties	  of	  magnesium	  hydroxide,	  which	  holds	  the	  promise	  for	  
enhanced	  implant	  incorporation	  when	  employed	  as	  a	  coating	  on	  the	  implants.	  	  
The	  in	  vitro	  stabilities	  of	  Mg(OH)2	  and	  Mg-­‐Al-­‐LDH	  coatings	  were	  investigated	  by	  
exposing	   the	   substances	   as	   coatings	   on	   titanium	   alloy	   discs	   to	   aqueous	  
conditions	   and	   repeated	   sampling	   from	   the	   medium	   (section	  4.2).	   LDHs	   with	  
varied	   cation	   ratios	   and	   Mg(OH)2	   were	   coated	   using	   a	   semiautomatic	   spray-­‐	  
coating	  chamber,	  comprising	  IR	  heating	  and	  a	  rotating	  sample	  desk.	  This	  device	  
evolved	  from	  simpler	  spray-­‐coating	  techniques	  as	  applied	  for	  the	  LDH	  coatings	  
described	   in	   section	  5.2,	   which	   comprised	   manually	   operated	   airbrush	  
equipment.	  Mg2+	   concentrations	  were	   estimated	  by	   ICP-­‐OES	  measurements	   of	  
the	   samples	   and	   the	   general	   stability	   of	   the	   coatings	   was	   complementarily	  
evaluated	  according	   to	   SEM	  and	  XRD	  data	   collected	  before	   and	   subsequent	   to	  
the	   immersion.	   The	   release	   rates	   and	   the	   according	   general	   stabilities	   of	   the	  
coatings	  were	  shown	  to	  depend	  on	  the	  composition	  of	  the	  coatings	  and	  on	  the	  
processing	  parameters,	  in	  particular	  the	  spray-­‐coating	  temperature.	  The	  results	  
show	   that	  magnesium-­‐containing	  LDHs	  are	  versatile	  Mg2+	   sources,	  which	   is	  of	  
high	  interest	  with	  regard	  to	  osteoinductive	  coatings	  in	  orthopedics.	  
For	  the	   in	  vivo	  evaluation	  of	  Mg-­‐Al-­‐	  and	  Mg-­‐Fe-­‐LDHs	  and	  Mg(OH)2	  with	  regard	  
to	   application	   in	   orthopedics	   (section	  4.3),	   cylindrical	   pellets	   (3x3	  mm)	   were	  
produced	   by	   pressing	   powders	   of	   the	   substances.	   The	   pellets	  were	   implanted	  
into	   femur	   condyles	   of	  New	  Zealand	  White	   rabbits	   and	  were	   examined	   in	   the	  
ex	  vivo	  state	  by	  µCT	  measurements.	  Whereas	  the	  Mg(OH)2	  cylinders	  decreased	  
considerably	  in	  volume,	  the	  LDH	  cylinders	  remained	  intact.	  Host	  response	  was	  
evaluated	  according	  to	  histological	  investigations	  focusing	  on	  the	  implant-­‐bone	  
interface.	  With	   regard	   to	  cell	   compatibility,	   flat	  pellets	  of	   the	  same	  substances	  
were	   tested	   with	   NIH3T3	   fibroblasts	   and	   MG63	   osteosarcoma	   cells	   under	  
standard	  cell	  culture	  conditions.	  It	  was	  found	  that	  cell	  densities	  were	  reduced	  in	  
comparison	  to	  the	  polystyrene	  control	  surfaces;	  however,	  cell	  compatibility	  was	  
judged	  as	  good	  overall.	  According	   to	  both,	   cell	   tests	  and	   in	  vivo	  host	   response,	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the	  Mg-­‐Al-­‐LDH	  system	  emerged	  as	  the	  most	  promising	  biomaterial	  of	  this	  study	  
for	  orthopedic	  applications.	  	  
Furthermore,	   magnesium	   hydroxide	   with	   increased	   surface	   area	   (BET)	   was	  
synthesized	   as	   a	   powder	   and	   processed	   to	   pellets.	   These	  were	   tested	   in	  vitro	  
and	  in	  vivo	  in	  accordance	  with	  the	  experimental	  series	  for	  the	  other	  substances	  
listed	   above.	   Due	   to	   the	   resemblance	   of	   the	   results	   gained	   from	   the	   two	  
magnesium	   hydroxide	   related	   series,	   the	   results	   from	   the	   non-­‐commercially	  
available	   Mg(OH)2	   were	   neglected	   for	   the	   article.	   Nonetheless,	   this	   finding	  
emphasizes	   the	   necessity	   for	   tunable	   magnesium	   hydroxide	   derivates,	   like	  
magnesium	  containing	  LDHs.	  	  
For	  the	  studies	  presented	  in	  sections	  4.2	  and	  4.3,	  differently	  composed	  Mg-­‐LDHs	  
were	  examined	  in	  course	  of	  in	  vitro	  and	  in	  vivo	  studies.	  For	  these,	  Mg-­‐LDHs	  were	  
synthesized	   and	   processed	   into	   pellets,	   nanosuspensions	   and	   coatings.	   The	  
studies	  discussed	  above	  present	  in	  particular	  the	  Mg-­‐Al-­‐CO3-­‐LDH	  as	  a	  versatile,	  
processable	  and	  biocompatible	  LDH	  system,	  with	  high	  potential	  for	  orthopedic	  
application.	  	  
With	   regard	   to	   the	   application	   as	   coatings	   on	   hip	   implants,	   the	   in	  vivo	  
examination	  of	   coated	   implants	  and	   implant	  materials,	   respectively,	   should	  be	  
in	  the	  focus	  of	  future	  investigations.	  Furthermore,	  the	  examination	  of	  drug/LDH	  
mixtures	   or	   intercalation	   compounds	   could	   allow	   for	   the	   evaluation	   of	   the	  
influence	  of	  the	  respective	  drugs	  on	  implant	  incorporation.	  	  
For	   the	   article	   presented	   in	   section	  4.2	   the	   author	   of	   this	   thesis	   is	   the	   first	  
author	  and	  the	  manuscript	  was	  for	  the	  most	  part	  drafted	  by	  him.	  The	  syntheses	  
of	   the	   raw	   LDHs	   and	   Mg(OH)2,	   as	   well	   as	   the	   further	   treatment	   in	   order	   to	  
obtain	  nanosuspensions	  were	  performed	  by	  the	  author.	  All	  XRD	  measurements	  
and	  according	  data	  interpretation	  were	  performed	  and	  contributed	  accordingly	  
to	  the	  publications	  by	  him.	  Immersion	  experiments	  and	  ICP-­‐OES	  measurements	  
in	  this	  study	  were	  performed	  by	  Tim-­‐Joshua	  Pinkvos	  in	  the	  course	  of	  the	  work	  
for	   his	   B.	  Sc.	   thesis:	   “Zum	   Verhalten	   von	   Mg-­‐Al-­‐Carbonat-­‐Hydroxid-­‐
Beschichtungen	   in	   wässrigen	   Medien”	   (“On	   the	   behavior	   of	   Mg-­‐Al-­‐carbonate-­‐
hydroxide	   coatings	   in	   aqueous	   media”,	   2014,	   Leibniz	   Universität	   Hannover),	  
supervised	  by	  the	  author	  of	  this	  thesis.	  SEM	  images	  were	  collected	  by	  Hendrik	  
Fullriede	  and	  Gesa	  Zahn.	  Philip	  Dellinger	  prepared	  the	  metal	  slides,	  in	  particular	  
by	   sandblasting,	   and	   spray-­‐coated	   the	   samples	   with	   the	   nanosuspensions.	  
Susanne	  E.	  Thürer,	  Alexandra	  Satalov	  and	  Sabine	  Behrens	  established	  ICP-­‐OES	  
measuring	   routines	  and	  performed	  maintenance	  of	   the	   ICP-­‐OES	  devices.	  Peter	  
Behrens	   coordinated	   the	   study	   together	   with	   Kai	   Möhwald	   and	   Andreas	  
Weizbauer	   and	   primarily	   revised	   the	   manuscript.	   The	   study	   was	   initiated	   by	  
Peter	  Behrens.	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For	   the	   article	   presented	   in	   section	  4.3	   the	   author	   of	   this	   thesis	   and	   Andreas	  
Weizbauer	   are	   the	   first	   authors,	   who	   contributed	   equally	   to	   this	   study.	   The	  
manuscript	   was	   mostly	   written	   by	   Andreas	   Weizbauer.	   The	   selection	   of	   the	  
applied	  LDH-­‐compositions	  based	  on	  pre-­‐studies	  and	  synthesis	  of	   the	  LDH	  and	  
Mg(OH)2	   as	   well	   as	   their	   characterization,	   in	   particular	   by	   XRD	  means,	   were	  
performed	   by	   the	   author	   of	   this	   thesis.	   LDH	   and	  Mg(OH)2	   pellets	   for	   the	   cell	  
tests	   and	   for	   preliminary	   studies	   were	   fabricated	   by	   him	   or	   under	   his	  
supervision.	  The	  employed	  pressing	  tools	  for	  the	  latter	  pellets	  were	  designed	  by	  
him	   and	   the	   workshop	   of	   the	   Institute	   for	   Inorganic	   Chemistry	   (Leibniz	  
Universität	   Hannover).	   The	   final	   pellets	   for	   the	   main	   in	   vivo	   study	   were	  
fabricated	  by	  the	  Department	  of	   Inorganic	  Chemistry,	  University	  of	  Essen.	  The	  
in	  vitro	   cell	   compatibility	   tests	   were	   performed	   by	   Muhammad	   Imran	   Rahim	  
and	   the	   ICP-­‐OES-­‐analysis	   of	   the	   Mg2+-­‐content	   of	   the	   supernatants	   were	  
performed	  by	  the	  Medical	  Laboratory	  of	  Bremen.	  The	  surgeries	  of	   the	  animals	  
were	   conducted	   alternately	   by	   Thilo	   Flörkemeier	   and	   Stefan	   Budde	   with	  
intraoperative	   assistance	   by	   Andreas	   Weizbauer.	   Anesthesia,	   follow-­‐up	  
examination	   of	   the	   animals	   and	   euthanasia	   were	   done	   by	   Julia	   Diekmann.	  
Sample	   explantation	   was	   conducted	   by	   both	   Julia	   Diekmann	   and	   Andreas	  
Weizbauer.	  The	  ex	  vivo	  µCT	  investigations	  were	  performed	  under	  supervision	  of	  
Gian	  Luigi	  Angrisani	  by	  Andreas	  Weizbauer	  at	  the	  Institute	  of	  Materials	  Science,	  
Leibniz	   Universität	   Hannover,	   and	   histological	   investigations	  were	   performed	  
by	   Elmar	  Willbold	   or	   under	   his	   supervision.	   Andreas	  Weizbauer	   analyzed	   the	  
data	  and	  coordinated	   the	  study.	  Thilo	  Flörkemeier,	  Henning	  Windhagen,	  Peter	  
Paul	   Müller,	   Peter	   Behrens,	   Stefan	   Budde	   initiated	   the	   study	   and	   revised	   the	  
manuscript.	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4.2	  	   Different	  magnesium	  release	  rates	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  hydroxide	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  containing	  layered	  double	  hydroxide	  coatings	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Different magnesium release rates from magnesium hydroxide and magnesium containing layered double 
hydroxide coatings 
 
Marc Kieke ▪ Philip Dellinger ▪ Tim J. Pinkvos ▪ Susanne E. Thürer ▪ Alexandra Satalov ▪ Andreas 
Weizbauer ▪ Henning Windhagen ▪ Sabine Behrens ▪ Kai Möhwald ▪ Peter Behrens 
 
Abstract 
The limitation of the longevity of artificial joint replacements due to aseptic loosening and bacterial infections is 
a key challenge in the field of sustainable implants. Implant coatings that can support the prosthesis fixation and 
that can combat infections by local drug release would be of high interest. For both purposes, controllable 
degradation of the coatings would enable their adjustment for the respective applications. Layered double 
hydroxides (LDHs) are a promising class of biomaterials. Their solubility and their degradation rate can be 
controlled by their exact composition. As both metallic magnesium and magnesium hydroxide have shown 
osteoproliferative properties (possibly connected to the liberation of Mg2+ ions), magnesium-containing LDHs 
appear as a suitable material for the coating of implants. In this study, the in vitro Mg2+ release rate of two such 
LDHs (with a 2:1 ratio and a 4:1 ratio of Mg and Al, respectively) is determined and compared to the behavior of 
Mg(OH)2. For this purpose, suspensions of the LDHs and of Mg(OH)2 were spray-coated on TiAl6V4 slides and 
exposed to aqueous conditions at 37°C. Over the examination time of five days samples were taken repeatedly 
and the Mg2+ concentration was determined by inductively coupled plasma optical emission spectroscopy. In 
addition, the degradation rate of an LDH (with a 2:1 ratio of Mg and Al) coating which was spray-deposited at 
elevated substrate temperatures was examined. The results showed that degradation rates of the magnesium 
containing coatings examined were increased by increased spray coating temperature and as expected by 
increasing the Mg2+ contribution to the coating substance.  
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1 Introduction 
Total hip arthroplasty (THA) is considered as a successful surgical intervention and it is the most frequently 
performed artificial joint replacement procedure. It has a survivorship of more than 80% at 20 years after surgery 
[1]. More than 800,000 THA are performed worldwide every year [2], providing pain relief for many patients. 
These orthopedic devices restore the loss of function of damaged or degenerated structures caused by 
osteoarthritis, avascular necrosis, rheumatoid arthritis, femoral neck fracture, tumours, and developmental 
dysplasia [3]. The reasons for revision of the primary joint replacement are manifold, and include 
instability/dislocation, mechanical loosening, and infection[4]. Integration into the surrounding bone is a primary 
aim in order to enhance implant fixation and prevent infection. For this purpose, (parts of) the shafts of 
commonly used prosthesis are nowadays coated by calcium-containing compounds (hydroxyapatite, brushite).   
Magnesium and its alloys have a long-standing history as degradable biomaterials [5]. Amongst various 
advantages, their osteoinductive properties have gained them increasing interest in the field of degradable 
implant materials [6]. Implants made from magnesium or its alloys are expected to initially provide a suitable 
degree of mechanical stability and then to dissolve while the growth of the surrounding bone is enhanced. 
However, the osteoproliferative properties are not an exclusive feature of metallic magnesium or its alloys. It 
was shown that magnesium hydroxide, which is a dominant corrosion product of magnesium and its alloys under 
various aqueous conditions [7], also has osteoproliferative properties [8]. These could, therefore, be ascribed to 
the release of Mg2+ or OH‒ ions. By applying coatings of magnesium hydroxide (or a similar material) on 
orthopedic prostheses, the osteoproliferative effects could be used on permanent implants, too. However,  
magnesium hydroxide is an individual compound with a fixed stoichiometry and its degradation cannot be 
regulated, except for small variations relying on the size of small particles. 
Layered double hydroxides (LDHs) containing magnesium which have the general formula [Mg1–
xMIIIx(OH)2x+][An–]x/n∙yH2O are a promising class of biomaterials. Their structure can be derived from the layered 
structure of magnesium hydroxide by substituting a certain amount of Mg2+ ions with trivalent cations MIII such 
as Al3+ or Fe3+ [9]. The surplus positive charge on the layers has to be balanced by intercalated anions An–, 
simple ones as Cl‒, NO3–, CO32– [10], or more complex ones as anions of pharmaceutically relevant compounds, 
e.g. ibuprofen and indomethacin [11][12], making this class of material attractive for drug delivery applications. 
Furthermore, drugs can also be simply mixed with LDHs in order to create effective release systems [13]. In a 
former in vivo study, we have shown that a ciprofloxacin/LDH mixture can curb a bacterial infection when 
applied as a coating on middle ear implants in rabbits [14].  
For both purposes, osteoproliferation as well as drug release from drug/LDH mixtures, tunable Mg-LDH 
degradation rates would be of interest. As mentioned, Mg-LDHs can be formed with a variety of trivalent cations 
and anions. Different relative stabilities could be observed for Mg-LDHs with different trivalent cations [15] and 
also with different anions [16]. Furthermore, the variation of the cation ratio Mg:MIII between 2:1 and 4:1 has 
been reported [9]. This variation is in accordance with the general formula and does not fundamentally change 
the LDH structure. However, measureable variations of the interlayer distances depending on the respective 
cation ratios have been reported for Mg-Al-LDHs [17] and Mg-Fe-LDHs [18].  
In the present study, we have focussed on the Mg-Al-LDH system, which has proven suitable for implant 
coatings. Stable nanosuspensions can be obtained via different routes [19]. Since these sols feature a 
homogenous distribution of particles that are considerably smaller than the diameters of nozzles and tubes of 
coating devices, spray coating proved to be a suitable technique for the coating of implants with simple and 
complex geometries. TiAl6V4 was chosen as substrate material, since this alloy is commonly used for hip and 
knee prostheses. Four different types of coatings, three from LDHs and one of magnesium hydroxide, were 
examined for their degradation behavior with regard to the composition of the respective coatings and the 
influence of the substrate temperature during the spray coating.  
 
2 Materials and Methods 
2.1 Preparation of suspensions containing magnesium compounds 
In the present study three different magnesium compounds were investigated: (I) 2:1-Mg-Al-CO3-LDH 
(Mg3.6Al2(OH)11.2(CO3)∙yH2O), (II) 4:1-Mg-Al-CO3-LDH (Mg5.4Al2(OH)14.8(CO3)∙yH2O), and (III) Mg(OH)2. 
The layered double hydroxides (I) and (II) were precipitated from water by adding two solutions, one containing 
MgCl2·6H2O (purum p.a. ≥98.0%, Fluka, Buchs, Switzerland) and the other AlCl3·6H2O (purum p.a. ≥99.0%, 
Fluka) to a vigorously stirred solution of NaOH (reagent grade, anhydrous, ≥98%, Fluka) and Na2CO3·H2O 
(≥99.5%, Fluka). For the preparation of  Mg(OH)2 (III), a solution of MgCl2·6H2O (purum p.a. ≥98.0%, Fluka) 
was added to a vigorously stirred solution of NaOH (reagent grade, anhydrous, ≥98%, Fluka). The respective 
amounts used are listed in Table 1.  
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Table 1 Chemicals and their respective amounts used for the preparation of the suspensions of magnesium 
compounds. 
  Amount of substance / mmol 
  MgCl2·6H2O AlCl3·6H2O NaOH Na2CO3·H2O 
(I) 2:1-Mg-Al-CO3-LDH 100 50 300 60 
(II) 4:1-Mg-Al-CO3-LDH 100 25 200 30 
(III) Mg(OH)2 50 - 100 - 
 
Subsequently to the precipitation, the mixtures were allowed to stand for one hour and the raw products were 
centrifuged repeatedly and washed with deionized water. After three washing cycles the wet materials were 
redispersed in water and exposed to ultrasonication for 30 min. By diluting with deionized water the respective 
solid content of all suspensions was adjusted to 3.5 g∙L–1. All steps were performed at room temperature and all 
chemicals were used as purchased without further purification.  
According to ICP-OES (Spectroflame Ciros Vision CCD, Spektro, Kleve, Germany) measurements the Mg:Al 
ratio of the (I) 2:1-Mg-Al-CO3-LDH was estimated to be 1.8:1 and the cation ratio of the (III) 4:1-Mg-Al-CO3-
LDH was estimated to be 3.7:1. However, the LDHs were named according to their expected cation ratios.  
 
2.2 Spray Coating 
Cylindrical, sandblasted (corundum) TiAl6V4 slides with a diameter of 1 cm and a height of 3 mmwere spray 
coated with the magnesium containing suspension described above, using a semi-automatic spray coating 
chamber. Prior to the coating, the samples as well as the sample holder were heated by four IR lamps (each with 
150 W) to the desired temperature within five minutes. For each coating cycle three samples were placed on the 
rotatable table in order to be coated equally. Accordingly, degradation experiments were performed in triplicate. 
The spraying setup was characterized by a spray angle of 45° and a nozzle-to-sample distance of 10 cm. For each 
coating cycle an amount of 7 mL of the suspensions (3.5 g∙L–1) was used. After each coating cycle the spray gun 
was cleaned. All three suspensions (I)-(III) were sprayed applying a sample temperature of 150°C. The setup 
was repeated with a substrate temperature of 300°C to investigate the influence of the sample temperature.  
In order to determine if the samples were successfully coated with LDH/Mg(OH)2 and if the respective crystal 
structures were maintained, X-Ray diffraction (XRD) measurements were performed on a Theta/Theta 
diffractometer from Stoe (Stoe, Darmstadt, Germany) in reflection mode using Cu Kα radiation (λ = 1.54060 Å). 
The 2Θ range of 5-50° was scanned applying a step size of 0.01° (2.5 s per step). The diffractometer was 
operated at 40 kV and 30 mA. All samples were placed flatly in a sample holder and were rotated during the 
measurement. No further sample preparations were made for the XRD measurements.  
For morphological evaluations, SEM images were collected before and after the immersion studies using a JSM-
6610LV (Jeol, Eching, Germany), operated with an accelerating voltage of 10 kV using the SEI detector. High-
resolution SEM images were collected with a JSM-6700F (Jeol, Eching, Germany), operated with an 
accelerating voltage of 2.0 kV using the SEI-detector.  
 
2.3 Degradation setup 
The coated TiAl6V4 slides were placed into each a reactor of a liquid handling system (LHS) (Liquid Station 
PS-C520, Duratec Analysentechnik, Hockenheim, Germany) using common cable binders (Conrad 
Electronic SE, Hirschau, Germany) for fixation. Three slides were immersed simultaneously, each in an 
individual reactor, containing deionized water (50 mL, 37°C). The sampling process included the extraction of 
1 mL from the medium and the restocking with 1 mL deionized water, keeping the total medium volume in the 
reactors constant. After the extracted samples were transferred to storage vessels, nitric acid (2 N, 400 µL) and 
deionized water (8.600 mL) were added in order to adjust the samples to the ICP-OES calibration. Sampling and 
pH monitoring was performed automatically by the LHS after 0 h, 6 h, 12 h, 18 h, 24 h, 36 h, 48 h, 60 h, 72 h, 
84 h, 96 h, 108 h and 120 h, totaling in 13 samples for each slide. Over the examination period, the medium was 
stirred using a magnetic stirring bar (300 rpm). All devices were rinsed with diluted nitric acid and then 
deionized water before use.  
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2.4 Mg2+ and Al3+ concentration measured with ICP-OES 
Magnesium concentrations of the samples taken and adjusted by the LHS were estimated using a Spectroflame 
Ciros Vision CCD (Spektro, Kleve, Germany), operated with Ar 4.6 (Air Liquide, Düsseldorf, Germany) and a 
plasma power of 1400 W. Calibration for both Mg2+ (279.553 nm) and Al3+ (167.078 nm) was done according to 
the following concentrations: 0.005 mg∙L–1, 0.010 mg∙L–1, 0.020 mg∙L–1, 0.050 mg∙L–1, 0.100 mg∙L–1, 
0.200 mg∙L–1, 0.500 mg∙L–1, 1.000 mg∙L–1 using single-element ICP-standard-solutions by Roth (Carl Roth, 
Karlsruhe, Germany), diluted with an autodiluter microLAB 600 series (Hamilton Company, Reno, USA). 
Correlation coefficients were found to be 0.99994-1.  
 
3 Results 
3.1 Chemical analysis of the coatings 
According to optical evaluation and evaluation of the SEM images Fig. 1 (left), coatings were obtained from all 
three magnesium sources, sprayed at 150°C and 300°C, respectively. The appearances of the coatings sprayed at 
150°C are in accordance with the expectations based on earlier spray coating experiments. Despite the presence 
of cracks, the coatings seem to cover most of the metal slides and were mechanically stable when handled as 
needed for the analyses. The samples sprayed at 300°C appear remarkably patchy at micrometer scale. High-
resolution SEM images are shown in Fig. 2 and reveal no noticeable difference between the samples at 
nanometer scale. The chemical stability of the substances at these temperatures was confirmed by XRD 
measurements of coated samples. As shown in Fig. 3 (left), X-ray diffractograms obtained comprised combined 
XRD patterns of the respective coating materials and the TiAl6V4 slides. In the case of the spray coating at 
300°C the main reflections of the Mg-LDH are broadened, probably due to a deterioration of the 2:1-LDH at 
300°C. All X-ray diffractograms also contain reflections that can be attributed to corundum (Al2O3) presumably 
residing from the sandblasting. 
 
 
Fig. 1 Exemplary SEM images of coatings (1) before and (2) after immersion; (a) 2:1-LDH sprayed at 300°C, 
(b) 2:1-LDH sprayed at 150°C, (c) 4:1-LDH sprayed at 150°C and (d) Mg(OH)2 sprayed at 150°C 
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Fig. 2 Photographs and (3) high-resolution SEM images of (a) 2:1-LDH sprayed at 300°C and (b) 2:1-LDH 
sprayed at 150°C. Scale bars represent 200 nm 
 
3.2 Post-immersion analysis of the coatings 
After the immersion studies, SEM images of the dried samples were collected and compared to the images of the 
un-immersed samples. Fig. 1 (right) shows exemplary SEM images of dried samples from the immersion studies. 
In the case of the 2:1-LDH coating (150°C) only minor signs of alteration can be seen, while the comparison of 
the other series, i.e. 4:1-LDH (150°C), Mg(OH)2 (150°C) and 2:1-LDH (300°C) revealed fundamental changes 
at the samples surfaces. After the degradation studies, the sample surfaces of the latter series resemble uncoated, 
sandblasted TiAl6V4 substrates.  
A selection of XRD patterns of dried samples is shown in Fig. 3 (right). A pronounced decomposition of the 
coating is expected to result in a fundamental decrease of the relative reflection intensities derived from the 
respective compounds. In the case of the 2:1-LDH coating (150°C) the relative intensities did not decrease 
noticeably, which is in accordance with the observations gained from the SEM images. The fading of the 
coatings in the other series is in agreement with the decrease of their relative intensities in the XRD patterns 
shown. In the case of the 4:1-LDH and 2:1-LDH (300°C) series, newly formed Mg(OH)2 can be found according 
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Fig. 3 Exemplary XRD patterns of coatings (1) before and (2) after immersion; (a) 2:1-LDH sprayed at 300°C, 
(b) 2:1-LDH sprayed at 150°C, (c) 4:1-LDH sprayed at 150°C and (d) Mg(OH)2 sprayed at 150°C. Reflections 
of different compounds are marked with: L = layered double hydroxide, A = Al2O3 (cordundum), T = titanium 
alloy, M = Mg(OH)2 (brucite), M* = newly formed brucite 
 
3.3 Mg2+ release  
Mg2+ release from the different coatings was determined by ICP-OES. The magnesium concentrations as a 
function of time are shown in Fig. 4 . In general, burst release behavior was observable for all four release 
systems. After the initial higher release rates, gradients decreased distinctly. In case of the coatings sprayed at 
150°C, the release rates increased with the respective Mg2+ contribution to the substance. Accordingly, the 
degradation rate and final Mg2+ concentrations were lowest for the 2:1-LDH (150°C) coating and highest for the 
Mg(OH)2 coating. The initial release rate of the 2:1-LDH coating sprayed at 300°C resembles the one of the 4:1-
LDH (150°C). Remarkably, the release rate for 2-5 days was the highest in the study. The initial and progressed 
Mg2+ release rates, final concentrations and pH values are listed in Table 2. 
 
 
Fig. 4 Mg2+ ion release from different coatings as a function of time. Error bars are in the scale of the symbols, 
hence neglected for clarity 
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Mg2+ release rate / 
mg∙L−1∙h−1 




  0-12 h 2-5 days   
2:1-LDH  300°C 0.082 0.019 0.388 ± <0.001 8.1 
2:1-LDH  150°C 0.024 <0.001 0.056 ± <0.001 6.9 
4:1-LDH  150°C 0.080 0.008 0.270 ± 0.001 7.4 
Mg(OH)2  150°C 0.101 0.009 0.359 ± 0.002 8.0 
 
 
3.4 pH and Al3+ release 
In accordance with the Mg2+ release curves, pH increased with a burst-like behavior for all coatings. After 12 h 
the increase of the pH was attenuated in the case of the 2:1-LDH coatings, and even decreased in the case of the 
4:1-LDH (150°C) and Mg(OH)2 (150°C) coatings (Fig. 5). The highest pH was found in the medium of the 
Mg(OH)2 coating (8.8 ± 0.3, 12 h).  
 
Fig. 5 PH of the medium of different coatings as a function of time. Error bars are exemplarily shown for the 
2:1-LDH (150°C) series. Data points marked with # had a three to four-fold error due to unresolved reasons 
 
Besides the Mg2+ concentration, also the Al3+ concentration was estimated. Al3+ concentrations released from the 
LDH coatings were noticeably lower than expected, presumably due to the low solubility of Al(OH)3 at 
moderate pH values. Hence, these data were neglected for further considerations. A minor final Al3+ 
concentration around 0.013 mg-L−1 was found in the Mg(OH)2 (150°C) series. Since Al is not present in the 
coating, at higher pH probably Al(OH)4– was formed according to Al2O3/Al(OH)3 + OH– Æ Al(OH)4– on the 
surfaces of the TiAl6V4 substrate or corundum residing from the sandblasting, respectively.  
 
4 Discussion 
4.1 Material stability during spray coating 
Long-term stable suspensions were obtained from all four substances, which proved to be stable under the 
applied spraying conditions. XRD measurements confirm the presence of expected, crystalline substances on the 
TiAl6V4 substrates. However, crystallinity of the 2:1-LDH sprayed at elevated temperatures seemed somewhat 
mitigated. According to the morphologic evaluation, dense coatings could be obtained at 150°C substrate 
temperature, whereas the 2:1-LDH coating obtained at 300°C had a patchy appearance at micrometer scale. 
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4.2 Degradation rates depending on the composition (150°C) 
For the coatings, sprayed at the same substrate temperature, Mg2+ release rates were found to be increased in the 
following order of substances: 2:1-LDH < 4:1-LDH < Mg(OH)2. The findings are in accordance with the XRD 
and SEM post-immersion analyses of the coatings.  
This sequence is in agreement with the increasing Mg2+ contribution to the coating substances, leading to an 
increased concentration gradient and by this an increased release rate. In case of the Mg-Al-CO3-LDHs, the 
decrease of the Al3+ content could also lead to a destabilization of the layer structure, which is stabilized by 
electrostatic interactions. A decrease of the Al3+ content decreases the number of carbonate anions in the 
interlayers, while the layer distances are widely maintained. The sequence of final pH values is in agreement 
with the Mg2+ release sequence. As known, LDH weathering kinetics depend on pH and the strength of the 
cation binding [20]. However, no signs for crystalline aluminium hydroxides were found in this study.  
 
4.3 Degradation rates depending on the substrate temperature (150°C/300°C) 
The 2:1-LDH suspension was spray coated at 150°C and 300°C, respectively. The latter coating showed higher 
release rates at the beginning and at later time points, higher pH throughout the experiment, and higher final 
Mg2+ concentrations. The initial release rate is close to the one of the 4:1-LDH (150°C) coating, while the final 
concentration is close to the one of Mg(OH)2. Remarkably, the gradient of the release curve for the period of 2-
5 days is twice the gradient of the Mg(OH)2 curve.  
According to SEM images no difference at nanometer scale (Fig. 2), but on micrometer scale (Fig. 1) can be 
observed. Due to the patchy texture of the coating a presumably considerable amount of LDH particles are 
exposed to the medium, which might have enhanced degradation [20]. Also XRD results (Fig. 3) indicate a 
change in the properties of the material, which might have caused the increase of the release rates. Structural 
alterations at elevated temperatures were also reported for hydrotalcite, which can be designated as the prototype 
compound for Mg-Al-LDHs. While lattice parameters and orientation of CO32− ions were maintained in course 
of dehydration at 150°C, at 250°C a change of lattice parameters and a grafting of CO32− ions occured [21]. A 
change of local coordination of carbonate ions at elevated temperatures, was also reported for dehydrated Mg-
Al-CO3-LDHs [22]. However, the exact causes and mechanisms that led to the increased release rates or the 
formation of Mg(OH)2 in two series, cannot be derived from the data gained in this study. 
 
4.4 Considerations for further application 
Different Mg2+ release rates, hence, degradation rates were found for different magnesium hydroxide based 
coatings. The possibility to take influence on the degradation rates by the choice of the material and the coating 
parameters could be useful for various release systems such as drug delivery systems. Nonetheless, as known in 
magnesium chemistry, results from in vitro and in vivo setups can differ drastically [23].  
The spray ciating system can be used for different geometric samples such as cylindrical dental implants as well. 
Drug/LDH intercalation compounds have drawn an increasing interest as drug delivery vehicles [24]. It is 
pointed out that, syntheses and processing of intercalation compounds are demanding processes that have to be 
adjusted for every drug/LDH system and not all drugs are suitable for the intercalation. If appropriate and 
compatible with the application, drug molecules could be added to the chosen LDH/Mg(OH)2 suspension in 
order to suit the prostheses coating with the respective functionalization. Alternatively, drugs and LDH/Mg(OH)2 
could be coated in alternating sequences, allowing also for multilayer systems of differently degrading 
hydroxides. In any case, the drugs have to be stable at elevated temperatures. For some drug/LDH systems the 
thermal behavior has been reported, showing that LDH can serve as a protection against thermal decomposition 
[25]. In the case of the drug/LDH intercalation compounds or reactive LDHs such as Cl−- and NO3−-LDHs 
[26][27], also the stability against an anion exchange during the spray coating has to be considered.  
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5 Conclusion 
Water-based suspensions of Mg(OH)2, 2:1-Mg-Al-CO3-LDH and 4:1-Mg-Al-CO3-LDH are suitable materials 
for the spray coating of TiAl6V4 substrates at moderate spraying temperatures. The substances proved 
chemically inert throughout the spraying process and mechanically stable when handled commonly.  
Different degradation behaviors of magnesium hydroxide derived coatings can be realized by increasing the 
spray coating temperature and as expected by increasing the Mg2+ contribution to the coating substance. 
For further applications, the availability of a repertoire of differently degrading, magnesium containing coating 
substances and their combinations, respectively, could be of advantage. 
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Abstract: The total hip arthroplasty is one of the most com-
mon artificial joint replacement procedures. Several different
surface coatings have been shown to improve implant fixation
by facilitating bone ingrowth and consequently enhancing the
longevity of uncemented orthopaedic hip prostheses. In the
present study, two different layered double hydroxides (LDHs),
Mg-Fe- and Mg-Al-LDH, were investigated as potential magne-
sium (Mg)-containing coating materials for orthopaedic appli-
cations in comparison to Mg hydroxide (Mg(OH)2). In vitro
direct cell compatibility tests were carried out using the
murine fibroblast cell line NIH 3T3 and the mouse osteosar-
coma cell line MG 63. The host response of bone tissue was
evaluated in in vivo experiments with nine rabbits. Two cylin-
drical pellets (3 3 3 mm) were implanted into each femoral
condyle of the left hind leg. The samples were analyzed histo-
logically and with l-computed tomography (l-CT) 6 weeks
after surgery. An in vitro cytotoxicity test determined that
more cells grew on the LDH pellets than on the Mg(OH)2-pel-
lets. The pH value and the Mg21 content of the cell culture
media were increased after incubation of the cells on the
degradable samples. The in vivo tests demonstrated the for-
mation of fibrous capsules around Mg(OH)2 and Mg-Fe-LDH.
In contrast, the host response of the Mg-Al-LDH samples indi-
cated that this Mg-containing biomaterial is a potential candi-
date for implant coating. VC 2015 Wiley Periodicals, Inc. J Biomed
Mater Res Part B: Appl Biomater 00B: 000–000, 2015.
Key Words: biomaterial, layered double hydroxides, magne-
sium hydroxide, surface coating, orthopaedic implants,
osteoconductivity
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M€uller PP, Behrens P, Budde S. 2015. Magnesium-containing layered double hydroxides as orthopaedic implant coating
materials—An in vitro and in vivo study. J Biomed Mater Res Part B 2015:00B:000–000.
INTRODUCTION
The usage of orthopaedic devices increased over years with
total hip arthroplasty being one of the most common artifi-
cial joint replacement procedures.1 The number of revision
hip procedures has also grown and is expected to increase
further with greater demand for primary total hip replace-
ment.1,2 Improving the survivability of permanent, unce-
mented orthopaedic hip prostheses is an important
issue that depends on the stable fixation of the implant by
bone ingrowth.
Hip prostheses are made of stainless steel, cobalt
alloy, or titanium alloys.3 Insufficient direct bone adher-
ence to the implant and osteolysis due to released metal-
lic and polymeric particles both may cause premature
implant failure.4 Surface coatings may be a useful
approach for enhancing bone ingrowth. Recently, many
different osteoconductive coatings have been investi-
gated.5 Calcium phosphate coatings (e.g., hydroxyapatite
[HAp]) have been shown to achieve appropriate bone
ongrowth to the implant, which increases biological fixa-
tion.6,7 However, HAp degrades over time due to osteo-
clastic resorption.6,8 A recent analysis of the Swedish Hip
Arthroplasty Register led to the conclusion that HAp
coating does not enhance acetabular cup survival,9 and
concerns about osteolysis induced by HAp wear particles
have been raised.10
*Both authors contributed equally to this work.
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A novel approach is the use of degradable magnesium
(Mg)-containing compounds as surface coatings. Several dif-
ferent implant materials, for example, ceramic and titanium,
have been successfully coated with layered double hydrox-
ide (LDH)-particles.11,12 The release of Mg21 during the
degradation process has been reported to be advantageous
for bone tissue.13 Several in vitro studies have reported
enhanced osteoblast adhesion with Mg21-supplemented
HAp,14 Al2O3-Mg
21,15 or carbonate apatite-containing
Mg21.16 In addition, Mg21 ions are reported to have a pref-
erable effect on proliferation and differentiation of human
mesenchymal stem cells (hMSCs).17 Layered double hydrox-
ides (LDHs) are materials comprising positively charged
layers with intercalated anions and water molecules. A wide
variety of chemical compositions can be produced, with the
general composition described by the formula [M(II)1-
xM(III)x(OH)2(A
n2)x/n ! yH2O], where M(II) represents
Mg21, calcium (Ca21), or zinc (Zn21), and so forth;
M(III) indicates aluminium (Al31), manganese (Mn31), or
iron (Fe31), and so forth; and An2 represents the interlayer
anion.12,18 These compounds have been investigated as a
delivery system for antibiotics12 and different biomolecules
(e.g., DNA, ATP, nucleoside monophosphates),19 as well as a
protective coating material to prevent the corrosion of pure
Mg and its alloys.20,21 Mg-Al-LDH particles exhibited low
toxicity in a rat experiment, and few systemic effects are
observed at doses below 200 mg kg21.22 Furthermore,
LDHs are routinely administered orally as an antacid drug.
In the present study, two different Mg-containing LDHs
were investigated as potential materials for coating of ortho-
paedic implants. In vitro cytotoxicity tests were performed
with mouse fibroblasts (NIH 3T3) and a human osteosar-
coma cell line (MG 63). The biological response was also




We assessed two different LDHs: (i) [Mg4Al2(OH)12](-
CO3)!4H2O with M(III)5Al31, hereafter referred to as Mg-
Al-LDH, and (ii) [Mg4Fe2(OH)12](CO3)!3H2O with
M(III)5 Fe31, hereafter referred to as Mg-Fe-LDH. The
respective LDHs were precipitated in water by adding a
solution of (i) MgCl2!6H2O (100 mmol, purum p.a. "98.0%,
Fluka, Buchs, Switzerland) and AlCl3!6H2O (50 mmol,
purum p.a. "99.0%, Fluka) or (ii) MgCl2!6H2O (100 mmol,
purum p.a. "98.0%, Fluka) and FeCl3 (50 mmol, reagent
grade, >97%, Fluka) to a vigorously stirred solution of
NaOH (300 mmol, reagent grade, anhydrous, "98%, Fluka)
and Na2CO3!H2O (60 mmol, "99.5%, Fluka). The mixtures
were allowed to stand for 1 h before the raw products were
repeatedly centrifuged and washed with deionized water.
After three washing cycles, the LDHs were obtained by cen-
trifugation, and air-dried at 60 #C. Mg(OH)2 powder (purum
p.a. 96%) was used as a reference material. All chemicals
were used as purchased without further purification.
The identities of the LDHs and the Mg(OH)2 were con-
firmed by powder X-ray diffraction (p-XRD) measurements
performed with a Theta–Theta diffractometer by STOE. The
2H range was scanned with a step size of 0.02# (5.0 s per
step, 30 mA, 40 kV) using monochromatized Cu Ka1 radia-
tion (wavelength51.54059 Å).
Pellets with a diameter of 13 mm for the in vitro cell
tests were formed by pressing the respective powders with
5 tons over 5 min. During and prior to processing, all devi-
ces and containers were repeatedly rinsed with ethanol. No
further sterilization methods were applied.
Cylindrical implants (3 3 3 mm) were formed for the in
vivo test with a cold isostatic pressure technique (Depart-
ment of Inorganic Chemistry, University of Essen, Germany)
(Figure 1). The samples used for in vivo testing were
gamma-sterilized with 25–29 kGy cobalt radiation (BBF
Sterilisation Service, Kernen-Rommelshausen, Germany).
In vitro cell compatibility tests with NIH 3T3
and MG 63-cells
We tested the cell compatibility of pellets made from Mg-Al-
LDH, Mg-Fe-LDH, and Mg(OH)2 using the murine fibroblast
cell line NIH 3T3 (ATCC CRL-1685; LGC Standards GmbH,
Wesel, Germany), and the mouse osteosarcoma cell line MG
63 (ATCC CRL-1427; LGC Standards GmbH, Wesel, Ger-
many). They were cultured in Dulbecco’s modified Eagle’s
medium (DMEM; Gibco/Life Technologies, Darmstadt, Ger-
many) supplemented with 1% (v/v) glutamine, 1% (v/v)
penicillin and streptomycin (100 U mL21 penicillin G and
100 mg mL21 streptomycin) and 10% (v/v) foetal calf
serum in a humidified incubator with 5% CO2 at 37 #C. The
cells were detached from the surface of T25 cell culture
flasks using trypsin. The cells were washed in DMEM to
remove trypsin and resuspended in fresh DMEM. Both cell
lines were seeded separately at a density of 1.2 3 104
cells mL21 on the pellets as well as on a polystyrene surface
(control), which is a widely used, cell culture optimized,
standard cell adhesion substrate material.11,23 Pellets
seeded with murine fibroblasts were incubated at 37 #C in
a humidified incubator with 5% CO2 for 48 h, and the
mouse osteosarcoma cell line was incubated for 72 h. After
the incubation period, media and non-adherent cells were
washed off the pellets with 13 phosphate-buffered saline
FIGURE 1. Pictures of the cylindrical implants (3 3 3 mm) used in the
in vivo experiments. Pellets of two different LDHs were investigated:
(a) [Mg4Fe2(OH)12](CO3)!3H2O (Mg-Fe-LDH), (b) [Mg4Al2(OH)12](-
CO3)!4H2O (Mg-Al-LDH). These samples were compared to pellets
made of (c) Mg(OH)2. [Color figure can be viewed in the online issue,
which is available at wileyonlinelibrary.com.]
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(PBS). Both cell lines were then stained with the fluorescent
cell proliferation dye CFSE (5- and 6-Carboxyfluorescein diac-
etate succinimidyl ester; eBioscience, San Diego, CA) to
observe cell adhesion, spreading, and proliferation on the
surface of pellets using an Axio Observer A-1 microscope
(Carl Zeiss Microscopy GmbH, Jena, Germany). The images
were captured with Axiovision Rel. 4.5 software (Carl Zeiss
MicroImaging, Jena, Germany). The samples were tested in
triplicate. The data are presented as mean values6 standard
deviation. The pH values of the cell culture media were
measured with the pellets before seeding the cells and after
48 and 72 h incubation periods for fibroblasts and bone cells,
respectively. The content of magnesium was measured using
inductively coupled plasma optical emission spectroscopy
(ICP-OES, Spectro Arcos, Spectro Analyticals Instruments,
Kleve, Germany) at the Medical Laboratory of Bremen.
Animal study
The animal experiment was conducted under an ethics com-
mittee approved protocol in accordance with German fed-
eral animal welfare legislation (Approval No. 33.9–42502-
04-13/1108). Nine female adult rabbits (New Zealand
White; Charles River Laboratory, Bad Kissingen, Germany),
with a mean body weight of 3.86 0.4 kg and a minimum
age of 6 months were used. For each animal, two implants
were inserted into the femoral condyles of the left hind leg
(one in the medial and one in the lateral condyle).
Surgery was performed under general anaesthesia
induced by an intramuscular (i.m.) injection of ketamine (25
mg kg21; Ketanest, Albrecht, Aulendorf, Germany) and mid-
azolam (5 mg/animal; Dormicum, CuraMED Pharma, Karls-
ruhe, Germany) and a subcutaneous (s.c.) dose of
glycopyrroniumbromid (0.1 mg/animal; Robinul, Riemser
Arzneimittel, Greifswald—Insel Riems, Germany). For anal-
gesia, the rabbits were given meloxicam (0.15 mg kg21 per-
oral (p.o.); Metacam, Boehringer Ingelheim, Ingelheim am
Rhein, Germany) 1 day preoperatively, immediately preoper-
atively, and for the following 2 days. They also received pre-
operative buprenorphine (0.15 mg/animal, s.c.; Temgesic,
Essex Pharma, M€unchen, Germany). During endotracheal
intubation, each animal received an intravenous injection of
propofol (initial 1 mg/kg, Propofol-Lipuro 1%, B. Braun
Melsungen, Germany). After endotracheal intubation, anaes-
thesia was maintained by isoflurane delivered in oxygen
(1.5–2.5 vol % isoflurane; Isofluran CP, CP-Pharma, Burg-
dorf, Germany; oxygen flow: 1.0 L min21). Ringer’s lactate
solution was infused (10 mL kg21 h21) during the entire
surgery to ensure proper cardiovascular function.
A median skin incision was performed to access the lat-
eral femoral condyle, the fascia was split, and a 3-mm wide
hole was drilled where the cylindrical sample was inserted.
Then, the incision was moved to the medial condyle where
another implant was set in an analogous manner. After con-
trol of bleeding and flushing with 0.9% NaCl, the wound
was closed using absorbable suture material (Vicryl5-0;
Ethicon, Norderstedt, Germany). For the first 3 days after
surgery, antibiotic medication was given (enrofloxacin, 10
mg kg21, Baytril 2.5%, p.o., once daily, Bayer Animal Health,
Leverkusen, Germany).
Six weeks after surgery, all animals were sedated with
i.m. ketamine (25 mg kg21) and midazolam (5 mg/animal)
and euthanized by an intravenous overdose of pentobarbital
(release ad us. vet.; WDT, Garbsen, Germany). The femoral
condyles were explanted and fixed in 3.5% commercial for-
malin for 1 week.
l-Computed tomography evaluations
Each sample was scanned with l-computed tomography
(mCT; Micro-CT 80 system, SCANCO MEDICAL, Br€uttisellen,
Switzerland) before implantation and in the explanted bone.
The scan resolution was 36 mm with 55 kV voltage and 72
mA amperage. The integration time was 2 3 500 ms.
The evaluation was performed using the MICRO-CT Eval-
uation Program V6.0 (SCANCO MEDICAL) by manually con-
touring the surface of the cylinders. The volume change of
each implant was determined.
Histology
Bone samples from each animal were processed for histo-
logic analysis. The explanted bones were fixed in formalin
(3.5%), and the samples were dehydrated at room tempera-
ture in increasing concentrations of alcohol: 70% ethanol
for 2 days, two changes of 96% ethanol for 2 days, and two
changes of 2-propanol for 2 days. Samples were degreased
in xylene for 2 days and then embedded in methyl-
methacrylate (Technovit 9100 NewVR , Heraeus Kulzer, Hanau,
Germany) according to the manufacturer’s instructions, that
is, polymerization under vacuum at 22 to 4 !C in the
freezer for 3 days. Then, 40 mm sections of bone were cut
perpendicular to the implants with a cutting–grinding tech-
nique and then polished (Exakt-Apparatebau, Norderstedt,
Germany).24 The samples were stained with toluidine blue
using established protocols.
RESULTS
XRD characterization of the samples
The diffractograms of the two LDHs and Mg(OH)2 are shown
in Figure 2. The patterns are as expected for the substances,
confirming that they were successfully synthesized.
Cell densities following in vitro incubation
We assessed the cytocompatibility of the samples with two
different cell lines. Figures 3 and 4 show the cell densities
after incubation on different samples. The densities for both
cell lines were highest on the control polystyrene surface.
The numbers of cells decreased after incubation on the two
different LDH pellets. The smallest number of living cells
was detected on the Mg(OH)2 samples.
The pH value of DMEM before incubation was
7.956 0.008. After incubation on the control surface, the
medium’s pH value was decreased (Figure 4). The media of
all other tested samples showed a pH increase after incuba-
tion. The highest value was observed with Mg(OH)2 pellets
(pHs of 8.48 and 8.50, respectively). The Mg21 concentra-
tions in the media after incubation with the tested samples
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were higher than for the control surface. The highest
value was found in media incubated with Mg(OH)2 samples
(Figure 4).
Mg-Al-LDH samples showed an appropriate bone
response in vivo
Post-operative clinical monitoring of the rabbits revealed
solid swellings on both sides of the joint of the left hind for
example, which mostly regressed in the 3 weeks after sur-
gery. These swellings were not painful on palpation. Except
for one animal, all rabbits moved without lameness. The
animal with the persistent moderate lameness was eutha-
nized 1 week after surgery because of a patella luxation.
Microscopic evaluation of the histological samples
revealed a thick layer of connective tissue around Mg-Fe-
LDH-samples [Figure 5(d)]. Nearly no direct bone–implant
contact was observed in the samples. We did not observe
alterations of the living bone around the implant site. The
bone adjacent to these implants had an abrasive surface
due to bone resorption. However, non-calcified bone (ncb)
was detected at the implant interface [Figure 5(a)].
The Mg-Al-LDH-samples showed some direct bone–
implant contact and a thin seam of connective tissue around
the implant. The contours of the implant were well defined.
Similar to the Mg-Fe-LDH-implants, the fibrous capsule
was pronounced in bones implanted with Mg(OH)2 samples
[Figure 5(c)]. The implant was covered by a layer of corro-
sion products [Figure 5(f)].
Cylindrical pellet volume loss was determined using l-
CT. The cylindrical implants had an average volume of
21.560.8 mm3 before implantation. After 6 weeks, the vol-
ume of the Mg(OH)2 pellets was decreased by 40%, but the
volumes of the two tested LDH implants remained nearly
unchanged [Figure 6].
DISCUSSION
An ideal orthopaedic implant surface coating should
improve bone ingrowth and in this way support implant fix-
ation. In the present study, we evaluated two different Mg-
containing LDHs as potential coating materials in compari-
son to conventional Mg(OH)2. Several different studies have
reported an osteoconductive effect of Mg-containing
materials.13–15
The in vitro experiments described here revealed a tend-
ency of decreased cell density with an increase in the pH
values of the media to alkaline ranges and higher Mg21 con-
centrations. The degradation of LDH in cell culture media
releases several ions (e.g., Mg21, Al31, OH2, etc), which
alters the pH.19 A direct cytotoxicity test was used in the
present study; other optional in vitro test methods are indi-
rect cytotoxicity tests, where extracts are evaluated or
where there is a barrier between the biomaterial and the
cells (i.e., Millipore filter or agar overlay).25 We assume that
direct contact with the surface of the LDH test items most
closely simulates in vivo conditions. The alkalization of the
media might inhibit cell proliferation and viability. Further-
more, Mg21 accumulation in the media might have addi-
tional adverse effects on cells. It is reported that the
tolerance limit for Mg21 is about 22 mM for the MG 63 cell
line26; it ranges from 20 to 40 mM for other cell lines.26
Furthermore, the accumulation of released ions from the
LDH might negatively impact osmolarity. Increasing the
osmolarity to >500 mOsm can cause apoptosis27; however,
some in vitro studies have investigated LDHs and reported
low cytotoxicity.19,28–30 Human promyelocytic leukemia cells
(HL-60 cells) exposed to various concentrations of [Mg2A-
l(OH)6]NO3 exhibited no cytotoxic effects at concentrations
below 1,000 lg mL21.28 The same LDH was reported to
have no negative effect on the viability of the human tendi-
nous fibroblasts and human osteosarcoma cells (cell line
SaOS-2) at the concentration of 5 lg mL21,29 and 500
lg mL21 was reportedly not toxic for SaOS-2 and MG 63
cells.31 Conversely, inhibited profileration of human embry-
onic kidney cells (HEK293T) was reported at a concentra-
tion of 0.125 mg mL21.30
In the present study, the MG 63 cells grew similarly on
both LDH-pellets; while, the NIH 3T3 cell density was lower
on the Mg-Fe-LDH-pellet. These different results might be
caused by a deviating tolerance and susceptibility of the cell
lines used. Variations in the sensitivities of different cell
FIGURE 3. Numbers of living cells after incubation on different sam-
ples. There were more cells on the LDH pellets than on the degrad-
able Mg(OH)2-pellets. Samples cultured on the polystyrene surface
(control) exhibited the highest number of cells.
FIGURE 2. Powder XRD patterns of a) Mg-Fe-LDH, b) Mg-Al-LDH, and
c) Mg(OH)2. Reflection positions for the LDH and for Mg(OH)2 are
indicated.
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lines were reported previously in a study investigating the
cytotoxicity of rare earth elements.32 The release of alumin-
ium and iron from the LDH-pellet might have an effect on
cells. In a study by Hallab et al. the toxicity of different met-
als was investigated on MG 63 osteoblasts and iron was
rated as one of the most toxic metals.33 A limitation of this
study was that the ion concentrations of Al31 and Fe31
were not quantified in the media of the LDH-samples.
Janning et al. investigated Mg(OH)2 pellets in a rabbit
model for up to 6 weeks.13 Although temporarily enhanced
FIGURE 5. Toludine blue-stained histological samples of Mg-Fe-, Mg-Al-LDH, and Mg(OH)2. (a,d) A thick layer of connective tissue was observed
around Mg-Fe-LDH samples. (b,e) Sparse direct bone–implant contact was found with Mg-Al-LDH samples. (c,f) Fibrous capsule formation was
most pronounced with Mg(OH)2. i, implant; ncb, non-calcified bone; b, bone; ct, connective tissue; cp, corrosion products. [Color figure can be
viewed in the online issue, which is available at wileyonlinelibrary.com.]
FIGURE 4. Cell densities of the murine fibroblast cell line NIH 3T3 and the mouse osteosarcoma cell line MG 63 after incubation for 48 and
72 h, respectively. The cells were seeded directly onto the pellets. A cell culture-optimized polystyrene surface served as a control. The pH val-
ues and the Mg21 contents were determined on the cell culture media at the end of the incubation. [Color figure can be viewed in the online
issue, which is available at wileyonlinelibrary.com.]
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bone growth was reported in the first 4 weeks, the bone
volume/tissue volume (BV/TV) as well as the osteoid sur-
face was decreased at 6 weeks.13 In the present study, we
observed pronounced fibrous capsule formation around the
magnesium hydroxide implants. In vivo the detection of the
pH value near degrading Mg(OH)2 samples showed a shift
toward alkaline environments immediately after implanta-
tion.34 After 14 days, the pH value shifted toward the acidic
range. This was interpreted as the formation of a fibrous
capsule due to a foreign body reaction,34 which is in accord-
ance with the finding in the present study of fibrous capsule
formation after Mg(OH)2-implantation. The foreign body
reaction is a complex host response to biomaterials that
includes the adsorption of different plasma proteins, the
adhesion of macrophages, and the formation of foreign-body
giant cells.35 These adherent cells can secrete proteins that
facilitate the development of a fibrous capsule and may sub-
sequently lead to implant failure.35 Our results demon-
strated fibrous capsule formation around Mg(OH)2 and Mg-
Fe-LDH pellets.
Direct apposition of living bone to the implant without
interposing soft tissue layers is advantageous for the long-
term function of orthopaedic prostheses.36 Stainless steel,
cobalt alloy, or titanium alloys are the primary biomaterials
for modern hip prostheses.3 The formation of thin soft tis-
sue layers around these metal implant devices has been
reported.36,37 Modification of surface topography (e.g.,
roughness) and different coatings (e.g., HAp) have been
investigated to improve the initial implant ingrowth of unce-
mented orthopaedic devices.38 The present study investi-
gated the bone responses to two different degradable LDHs
as potential coating materials for orthopaedic devices. Sev-
eral in vivo studies reported appropriate host responses to
different LDHs.22 Rats injected with suspensions of LDH
particles showed few effects at doses at or below 200
mg kg21, but unwanted systemic effects were observed at
higher doses (300 mg/kg).22 The degradation of LDHs in
vivo and in body fluids may lead to the release of Mg21,
Cl2, Fe31, Al31, CO3
22, and OH2 ions. Fe31 and its chelated
complexes around the implant may be engulfed by macro-
phages,39 and these may lead to Fe31-activated proinflam-
matory TNF (tumor necrosis factor)-a-releasing
macrophages.40 Elevated levels of pro-inflammatory cyto-
kines can stimulate osteoclastic bone resorption, and Fe31-
loaded macrophages can release toxic radicals (i.e., OH•).40
We therefore assume that locally increased Fe31 concentra-
tions, caused by release from the Mg-Fe-LDH coating materi-
als, might have led to the negative effects observed in
our study.
Al31 ions can also have adverse effects on bone forma-
tion and may interfere with bone metabolism. Al31 is
reported to accumulate in calcified bone, consequently alter-
ing mineralization and reducing new bone formation due to
a direct effect on osteoblast metabolism.41 The results
of the present study demonstrated that the Mg-Al-LDH
material led to an appropriate host response, with no
adverse effects on bone remodelling. However, the in vitro
Mg21-release portends of lower degradation rates of Mg-Al-
LDH than Mg-Fe-LDH; which may result in lower local
ion release.
Interestingly, the volumes of the LDH cylinders remained
nearly unchanged after 6 weeks of implantation. The vol-
ume of the Mg-Al-LDH even appears to have increased
which may be due to the intercalation of anionic compo-
nents of the surrounding body fluids. The low volume
change of the Mg-Al-LDH is consistent with the results of a
recent animal study in the middle ear of rabbits, where a
similar Mg-Al-LDH was applied as a coating on BioveritVR II
middle ear prostheses.
The results of this study demonstrate that Mg-Fe-LDH is
not suitable or biomedical applications in bone. In contrast,
the host response to Mg-Al-LDH indicates that this Mg-
containing biomaterial is a potential candidate for implant
coating. Further studies are necessary to evaluate the long-
term effects of this material.
CONCLUSION
In the present study, we evaluated two different Mg-
containing LDHs as potential coating materials and com-
pared them to the simple Mg(OH)2. The in vitro cytotoxicity
test results revealed that more cells grew on the LDH-
samples than on the degradable Mg(OH)2-pellets. The pH
and the Mg21 content of the cell culture media were
increased after incubation of the cells on the degradable
samples. The in vivo findings revealed fibrous capsule for-
mation around Mg(OH)2 and Mg-Fe-LDH, with nearly no
direct bone–implant contact. In contrast, the host response
to the Mg-Al-LDH indicated that this Mg-containing biomate-
rial is a potential candidate for implant coatings.
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5	  	   	  LDHs	   as	   Key	   Components	   in	   Drug	   Release	   Systems	   with	  
Regard	  to	  Application	  in	  the	  Middle	  Ear	  
5.1	  	   Preface	  
This	   chapter	   deals	   in	   three	   articles	   with	   the	   in	  vivo	   and	   in	  vitro	   efficacy	   of	  
coatings	   based	   on	  mixtures	   of	   an	   antibiotic	   drug	   and	   an	   LDH.	   These	   coatings	  
were	   prepared	   with	   the	   aim	   to	   combat	   bacterial	   infections	   directly	   from	   the	  
implant.	  In	  the	  course	  of	  the	  studies,	  it	  appeared	  necessary	  to	  study	  the	  in	  vivo	  
stability	   of	   a	   pristine	   LDH	   coating	   (section	  5.2).	   The	   in	  vivo	   studies	   were	  
performed	   in	   the	   middle	   ears	   of	   New	   Zealand	   White	   rabbits	   (sections	   5.2	  
and	  5.3)	  and	  subcutaneously	  in	  Balb/c	  mice	  (section	  5.4).	  	  
The	  studies	  were	  performed	  considering	  the	  background	  of	  chronic	  middle	  ear	  
diseases	  that	  might	  lead	  to	  the	  loss	  of	  the	  small	  bones	  of	  the	  ossicular	  chain,	  a	  
loss	  which	  has	  to	  be	  repaired	  by	  placing	  a	  total	  ossicular	  replacement	  prosthesis	  
(TORP).	   The	   endowment	   of	   these	   with	   antibacterial	   functionality	   is	   of	   high	  
interest	  due	  to	  the	  problem	  of	  bacterial	  infection	  during	  and	  subsequent	  to	  the	  
surgery.	  
Despite	  numerous	  studies	  on	  biological	  or	  medical	  applications	  of	  LDH,	   in	  vivo	  
assays	   were	   reported	   scarcely	   and	   concentrated	   mostly	   on	   the	   effects	   of	   the	  
LDH	   system	   on	   the	   organism.	   In	   the	   study	   presented	   in	   section	  5.2	   the	  
degradation	   behavior	   and	   biocompatibility	   of	   pure	   LDH	   coatings	   were	   in	   the	  
focus	  of	  the	  investigation.	  For	  this,	  middle	  ear	  implants	  suitable	  for	  New	  Zealand	  
White	   rabbits	   were	   coated	  with	   a	   pure	  Mg-­‐Al-­‐CO3-­‐LDH	   and	   inserted	   into	   the	  
middle	  ears.	  A	  direct	  characterization	  of	   the	  LDH	  coatings	  via	  XRD	  means	  was	  
not	   possible.	   Hence,	   the	   presence	   of	   the	   Mg-­‐Al-­‐LDH	   coating	   was	   indirectly	  
tracked	  by	  EDX	  measurements,	  in	  principle	  based	  on	  the	  detection	  of	  the	  Mg:Al	  
ratios	  on	  the	  surfaces	  of	  the	  implants.	  	  
Animal	  health	  screening	  revealed	  no	  harmful	  effects	  on	  the	  animals,	  implicating	  
an	   overall	   good	   biocompatibility	   of	   the	   pristine	   LDH	   coatings	   under	   the	  
conditions	   applied.	   Hence,	   Mg-­‐Al-­‐LDHs	   proved	   as	   biocompatible	   and	  
processable	  components	  for	  drug	  delivery	  systems.	  	  
In	   the	   course	   of	   complementary	   in	   vitro	   studies,	   similarly	   coated	   middle	   ear	  
implants	   were	   immersed	   under	   conditions	   with	   resemblance	   to	   the	   in	  vivo	  
conditions	   in	   the	   middle	   ear,	   including	   HBSS	   as	   the	   medium	   at	   38	   °C.	   The	  
general	  stability	  of	  the	  LDH	  coatings	  under	  these	  conditions	  was	  confirmed	  by	  
these	  comparably	  simple	  experiments	  according	  to	  EDX	  data	  (not	  shown).	  	  
The	   implants	   used	   in	   this	   study	   were	   endowed	   with	   the	   Mg-­‐Al-­‐CO3-­‐LDH	   by	  
spray-­‐coating	   (using	   a	   commercially	   available	   simple	   airbrush	   equipment),	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which	   allowed	   the	   application	   of	   a	   nebulized	   LDH	   nanosuspension	   on	   heated	  
implants.	   A	   direct	   estimation	   of	   the	   coating	   thickness,	   for	   example	   by	   cross	  
section	   SEM	   and	   ellipsometric	   investigations,	   proved	   unsuitable.	   Hence,	   flat	  
glass	   substrates	   were	   coated	   by	   the	   same	   means	   and	   coating	   thickness	   was	  
estimated	   by	   laser	   scanning	   microscopy.	   Prior	   to	   this	   study,	   dip-­‐coating	   had	  
been	  applied	  as	  an	  alternative	  coating	  technique,	  but	  was	  turned	  down	  due	  to	  
the	  small	  thicknesses	  achieved.	  	  
With	  regard	  to	  the	  bacterial	  infections	  mentioned	  above,	  middle	  ear	  prostheses	  
suitable	   for	   New	   Zealand	   White	   rabbits	   were	   endowed	   with	   a	   coating	   of	   a	  
ciprofloxacin/LDH	   mixture	   (section	  5.3).	   Pseudomonas	   aeruginosa	   infections	  
were	   triggered	   in	   the	   middle	   ears	   of	   the	   rabbits	   either	   during	   or	   one	   week	  
subsequent	   to	   TORP	   insertion	   surgery.	   Clinical,	   microbiological	   and	  
histopathological	   examination	   revealed	   the	   general	   efficacy	   of	   the	  
functionalized	   implants	   against	   the	   infections.	   However,	   the	   effects	   were	  
somewhat	  mitigated	  when	  the	  infection	  was	  triggered	  with	  the	  one	  week	  delay,	  
and	  drug	  release	  appeared	  too	  fast	  with	  regard	  to	  general	  application.	  	  
As	  mentioned	  above,	  for	  direct	  examination	  of	  the	  coated	  implants,	  XRD	  means	  
proved	  unsuitable.	  Hence,	  similar	  mixtures	  were	  applied	  to	  glass	  substrates	  and	  
examined,	  revealing	  the	  identity	  and	  general	  stability	  of	  the	  LDH	  component	  of	  
the	  coatings	  (data	  not	  shown).	  	  
In	  the	  study	  presented	  in	  section	  5.2,	  LDH	  coatings	  were	  shown	  to	  be	  practically	  
biostable	  over	   the	   entire	   application	   time.	  Hence,	   it	   is	   to	  be	   expected	   that	   the	  
LDH	   component	   of	   the	   drug	   delivery	   system	   used	   in	   the	   study	   presented	   in	  
section	  5.3	  was	  stable	  as	  well.	  	  
Further	   investigations	  on	   the	  efficacy	  of	  LDH-­‐based,	  antibiotic-­‐loaded	  coatings	  
on	  titanium	  alloy	  substrates	  comprised	  in	  vitro	  and	  in	  vivo	  studies	  (section	  5.4).	  
In	  the	  course	  of	  the	  in	  vitro	  studies,	  plain	  and	  porous	  titanium	  alloy	  discs	  were	  
coated	   with	   differently	   composed	   ciprofloxacin/LDH	   mixtures	   (via	   drop	  
coating)	  and	  exposed	  to	  phosphate	  buffered	  saline	  (PBS).	  The	  supernatant	  was	  
sampled	  repeatedly	  and	   the	  ciprofloxacin	  concentration	  was	  estimated	  by	  UV-­‐
Vis	   spectroscopy.	  The	  antibacterial	  efficacy	  of	   the	  supernatants	  was	  shown	  by	  
the	   vanishing	   luminescence	   of	   luminescent	   P.	  aeruginosa.	   Prolongation	   of	  
antibiotic	   release	   and	   antibacterial	   efficacy	   were	   found	   for	   all	  
ciprofloxacin/LDH	   mixtures	   investigated.	   In	   the	   course	   of	   the	   in	  vivo	   study,	  
coated	  porous	   titanium	  discs	  were	   implanted	   subcutaneously	   into	  white	  mice	  
and	   infection	   was	   triggered	   seven,	   15	   and	   20	   days	   after	   implantation,	  
respectively.	   It	   could	   be	   shown	   that	   ciprofloxacin/LDH	   coatings	  were	   able	   to	  
combat	  bacterial	  infections	  close	  to	  the	  implantation	  site	  for	  over	  two	  weeks.	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Excellent	   cell	   compatibility	   of	   the	   LDH	   coatings	   was	   confirmed	   by	   tests	   with	  
immortalized	  NIH3T3	   fibroblasts,	  which	  were	   directly	   seeded	   on	   the	   coatings	  
and	   incubated	   under	   standard	   cell	   culture	   conditions.	   Cells	   were	   shown	   to	  
adhere	   to	   the	   coatings	   as	   a	   confluent	   cell	   layer,	   and	   antibiotic	   addition	   to	   the	  
LDH	  coating	  did	  not	  result	  in	  impairment.	  Magnesium	  hydroxide,	  however,	  was	  
shown	   to	  not	   support	   cell	   adhesion	  and	   cell	   survival,	   further	   emphasizing	   the	  
promise	  of	  LDH-­‐based	  coatings.	  	  
Mg-­‐Al-­‐LDH	  based	  coatings	  proved	  biocompatible	  and	  practically	  bioinert	  in	  the	  
middle	   ear	   of	   rabbits.	   Cell	   compatibility	   of	  Mg-­‐Al-­‐LDH	   coatings	  was	   shown	   as	  
well	  with	  NIH3T3	  fibroblasts.	  When	  combined	  with	  antibiotics	  by	  mixing,	  these	  
coatings	  proved	  active	  against	  bacterial	  infections	  (P.	  aeruginosa)	  in	  in	  vitro	  and	  
in	  in	  vivo	  studies.	  Intercalation	  of	  the	  drug	  into	  LDH	  interlayers	  did	  not	  appear	  
to	  be	  necessary	  in	  order	  to	  fabricate	  efficient	  drug	  delivery	  systems.	  	  
With	   regard	   to	   alternative	   application	   sites	   and	   due	   to	   the	   formation	   of	  
resistances	   of	   certain	   bacteria	   towards	   antibiotics,	   further	   development	   and	  
systematic	  investigation	  of	  LDH-­‐based	  drug	  release	  systems	  is	  of	  high	  interest.	  
In	  the	  course	  of	  further	  investigations,	  variation	  of	  antibiotics,	  mixing	  ratios,	  the	  
used	   LDH	   system	   (i.e.	   cation	   ratios)	   and	   coating	   techniques	   could	   be	   in	   the	  
focus.	  	  
For	  the	  article	  presented	  in	  section	  5.2,	   the	  author	  of	  this	  thesis	  and	  Franziska	  
Duda	   are	   the	   first	   authors,	   who	   contributed	   equally	   to	   this	   study.	   The	  
manuscript	   was	   for	   the	   most	   part	   drafted	   by	   both	   the	   first	   authors.	   The	  
syntheses	  of	   the	   raw	  LDH,	   as	  well	   as	   the	   further	   treatment	   in	  order	   to	  obtain	  
nanosuspensions	  were	  performed	  by	  the	  author.	  Spray-­‐coating	  techniques	  and	  
custom-­‐made	   SEM/EDX	   sample	   holders	   for	   this	   study	   were	   developed	   and	  
applied	   by	   him,	   together	   with	   Florian	   Waltz.	   Florian	   Waltz	   and	   Maria	  
Schweinefuß	   collected	   the	  SEM	   images	   and	  EDX	  data,	  which	  were	   interpreted	  
by	  Franziska	  Duda	  and	  the	  author	  of	  this	  thesis.	  Complementary	  in	  vitro	  studies,	  
XRD	  measurements	   and	   according	  data	   interpretation	  were	  performed	  by	   the	  
author	   (data	   not	   shown).	   The	   surgeries	   and	   perioperative	   treatment	   of	   the	  
animals	   in	  the	  course	  of	  the	  animal	  assays	  were	  performed	  by	  Franziska	  Duda	  
and	   Nils	   Prenzler.	   Muhammad	   Badar	   aided	   in	   the	   evaluation	   of	   alternative	  
coating	   techniques	   for	   the	  middle	   ear	   implants.	   Peter	   Paul	  Müller,	   Karl-­‐Heinz	  
Esser,	   Thomas	   Lenarz,	   Peter	   Behrens	   and	   Nils	   Kristian	   Prenzler	   initiated	   the	  
study	  and	  revised	  the	  manuscript.	  
For	  the	  article	  presented	  in	  section	  5.3,	  Daniela	  Hesse	  is	  the	  first	  author,	  and	  the	  
author	  of	  this	  thesis	  is	  a	  co-­‐author.	  All	  XRD	  measurements	  in	  the	  course	  of	  the	  
study	   and	   in	   the	   course	   of	   complementary	   studies,	   and	   according	   data	  
interpretation	  were	  performed	  by	  him	   (data	  not	   shown).	  The	   surgeries	   in	   the	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course	  of	  the	  animal	  studies	  were	  performed	  by	  Nils	  Kristian	  Prenzler.	  Daniela	  
Hesse	   collected	   the	   samples,	   took	   care	   of	   the	   animals	   perioperativley	   and	  
performed	   statistical	   analyses.	   Coating	   of	   the	   middle	   ear	   implants	   was	  
performed	   by	   Muhammad	   Badar.	   Microbiological	   investigations	   were	  
performed	  by	  André	  Bleich,	  Anna	  Smoczek	  and	  Silke	  Glage.	  Peter	  Behrens,	  Peter	  
Paul	  Müller,	  Karl-­‐Heinz	  Esser	  and	  Martin	  Stieve	  initiated	  the	  study	  and	  revised	  
the	  manuscript.	  
For	   the	   article	   presented	   in	   section	  5.4,	   Muhammad	   Badar	   and	   Muhammad	  
Imran	  Rahim	  are	   the	   first	   authors,	  who	   contributed	  equally	   to	   this	   study.	  The	  
author	  of	   this	   thesis	   is	  a	  co-­‐author.	  All	  XRD	  measurements	  and	  according	  data	  
interpretation	  were	   performed	   by	   him	   and	   the	   syntheses	   of	   the	   raw	   LDH,	   as	  
well	  as	  the	  further	  treatment	  in	  order	  to	  obtain	  suspensions	  were	  performed	  by	  
the	   author	   or	   under	   his	   supervision.	   The	   coating	   of	   the	   samples,	   cell	   culture	  
tests,	   the	   estimation	   of	   drug	   release	   kinetics,	   the	   animal	   studies	   and	   data	  
analysis	  were	  performed	  by	  Muhammad	  Badar	  and	  Muhammad	   Imran	  Rahim.	  
The	   titanium	  discs	  were	   custom	  made	   by	  Thomas	   Ebel.	  Manfred	  Rohde	   (SEM	  
imaging),	  Hansjörg	  Hauser,	  Peter	  Behrens,	  Peter	  Paul	  Müller	  initiated	  the	  study	  
and	  revised	  the	  manuscript.	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5.2	  	   	  Highly	  biocompatible	  behavior	  and	  slow	  degradation	  of	  a	  LDH	  
(layered	  double	  hydroxide)-­‐coating	  on	  implants	  in	  the	  middle	  ear	  of	  
rabbits	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Highly biocompatible behaviour and slow degradation of a LDH (layered double hydroxide)-coating on 
implants in the middle ear of rabbits 
 
Franziska Duda ▪ Marc Kieke ▪ Florian Waltz ▪ Maria E. Schweinefuß ▪ Muhammad Badar ▪ Peter Paul 
Müller ▪ Karl-Heinz Esser ▪ Thomas Lenarz ▪ Peter Behrens ▪ Nils Kristian Prenzler 
 
Abstract 
Chronic inflammation can irreversibly damage components of the ossicular chain which may lead to sound 
conduction deafness. The replacement of impaired ossicles with prostheses does not reduce the risk of bacterial 
infections which may lead to loss of function of the implant and consequently to additional damage of the 
connected structures such as inner ear, meninges and brain. Therefore, implants that could do both, reconstruct 
the sound conduction and in addition provide antibacterial protection are of high interest for ear surgery. Layered 
double hydroxides (LDHs) are promising novel biomaterials that have previously been used as an antibiotic-
releasing implant coating to curb bacterial infections in the middle ear. However, animal studies of LDHs are 
scarce and there exist only few additional data on the biocompatibility and hardly any on the biodegradation of 
these compounds. 
In this study, middle ear prostheses were coated with an LDH compound, using suspensions of nanoparticles of 
an LDH containing Mg and Al as well as carbonate ions. These coatings were characterized and implanted into 
the middle ear of healthy rabbits for 10 days. Analysis of the explanted prostheses showed only little signs of 
degradation. A stable health constitution was observed throughout the whole experiment in every animal. 
The results show that LDH-based implant coatings are biocompatible and dissolve only slowly in the middle ear. 
They, therefore, appear as promising materials for the construction of controlled drug delivery vehicles.  
 
Key words: layered double hydroxides, biocompatibility, biodegradation, Bioverit® II, middle ear implant, 
coating, local drug delivery, nanosuspension 
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Chronic otitis media with or without formation of cholesteatoma is often associated with hearing loss due to 
destruction of the ossicular chain, that is the malleus, incus and stapes [1,2]. To treat this conductive hearing loss 
it is usually necessary to insert ossicular replacement prostheses [3]. Despite aseptic conditions throughout 
implantation surgery there is a high risk of re-inflammation and -infection endangering the healing process and 
the function of the prosthesis [4]. For better control of inflammatory and infectious processes after implantation, 
a special pharmaceutically active coating of the prosthesis would be useful in order to complement or replace 
systemic drug applications. This has been shown for the local drug delivery of ciprofloxacin from a nanoporous 
silica coating on a standard total ossicular chain replacement prosthesis (TORP) [5]. As a material for those 
implants Bioverit® II has been proven biocompatible in several studies [6]. Bioverit® II is a bioglass-mica 
composite which is characterized by an easy manufacturing process and high resistance to biodegradation.  
A promising class of material that has been employed recently in drug delivery studies are layered double 
hydroxides (LDHs). LDHs, also known as hydrotalcite-like compounds with the general formula [MII1–
xMIIIx(OH)2x+][An–]x/n ∙ yH2O, are composed of positively and negatively charged layers. MII represents bivalent 
(e.g. Mg2+, Ca2+, Mn2+, Zn2+) and MIII trivalent (e.g. Al3+, Co3+, Cr3+, Fe3+) cations of the main layer [7,8]. The 
structure of magnesium-containing LDHs (Fig. 1) can be derived from the layered structure of brucite 
(Mg(OH)2), in which a certain amount of Mg2+ ions is replaced with trivalent cations; both types of metal ions 
are octahedrally coordinated by hydroxide ions (OH–) in the layers. Resulting surplus positive charges are 
balanced by anions An– placed in the interlayer spaces together with water molecules to fill the increased 
interlayer space [9]. The anions An– can be simple inorganic ones, as CO32- and SO42-, but also more complex 
anionic organic drugs [10–12]. These can then be released, when the LDH is used as a drug delivery system. The 
release of anions (e.g. drugs) from the LDH interlayer spaces can be achieved by anion exchange of the 
persisting LDH or by the dissolution of the LDH itself. Under acidic conditions, the dissolution of the LDH is 
triggered, but LDH will also dissolve slowly under neutral conditions [13]. 
 
 
Fig. 1 Schematic structure of layered double hydroxides with positively charged layers and charge-balancing 
anions and additional water molecules located in the interlayer region (modified from [17]) 
 
In former studies several anti-inflammatory or antibacterial agents were applied in combination with LDHs as 
drug delivery systems. Mostly, only simple release experiments were performed and only few cell culture studies 
have been published. For example, a decrease in cell proliferation was reported by Dagnon et al. for implant 
surfaces covered with LDHs loaded with ibuprofen [14]. Strikingly, only very few in vivo studies have been 
reported so far. Silion et al. explored the in vivo behaviour of ketoprofen-loaded LDH in mice and found that 
intercalated ketoprofen has a better gastrointestinal compatibility and a stronger analgetic effect than the plain 
anti-inflammatory drug [15]. In another mouse study, Li et al. tested the protective potential as well as the 
therapeutic effects of LDHs as a DNA vaccine delivery vector. The LDH served as a suitable adjuvant to carry 
the vaccine and could thus inhibit tumour formation and suppress melanoma growth, respectively [16]. 
In a former study, we have examined the antimicrobial effect of a Mg-Al-SO4-LDH mixed with ciprofloxacin as 
a coating on middle ear prostheses for rabbits. The coating used by Hesse et al. showed excellent activity against 
infection immediately after implantation and persisting attenuated activity when the re-infection was triggered 
one week after surgery [17]. The in vivo studies mentioned above concentrated on the effects of drug loaded 
LDH coatings on the animals [15–17].  
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To our knowledge, our present study is the first to examine the degradation behaviour of pure LDH as an implant 
coating in vivo. The aim of this study was to examine the degradation characteristics of LDH under the complex 
conditions in the middle ear, and by this complement our former investigations. Thorough knowledge on the 
degradation behaviour of LDH is crucial for further examinations and ultimately for the targeted application of 
LDHs as key components of controllable drug release systems, in particular for reconstructive middle ear 
surgery. 
 
2 Materials and methods 
2.1 Implants and coating material 
Bioverit® II implants were purchased from 3di GmbH (Jena, Germany). The bioceramic implants with an 
average weight of 8 mg are composed of a 2.1 mm long shaft with a diameter of 0.9 mm attached to a base plate 
with a diameter of 2.5 mm and a height of 0.5 mm (Fig. 2a.). 
For our study we used a water-based suspension of nanocrystals of a Mg-Al-CO3-LDH with a Mg:Al ratio of 2:1 
as the material to prepare the implant coating. In a typical synthesis the raw LDH was precipitated in water by 
adding a solution of MgCl2·6H2O (20 mmol, purum p.a. ≥ 98.0 %, Fluka, Buchs, Switzerland) and AlCl3·6H2O 
(10 mmol, purum p.a. ≥ 99.0 %, Fluka) to an intensely stirred solution of NaOH (60 mmol, reagent grade, 
anhydrous, ≥ 98 %, Fluka) and Na2CO3·H2O (12 mmol, ≥ 99.5 %, Fluka). After the raw product was aged for 
15 min, the product was collected by centrifugation, and washed twice with deionized water. The remainder was 
redispersed in water and exposed to ultrasonication for one hour. The synthesis was performed at ambient 
conditions and all chemicals were used as purchased without further purification. Information about the 
crystalline structure of the LDH materials was collected by X-ray diffraction (XRD) with a Theta/Theta 
diffractometer from Stoe (Darmstadt, Germany).  
The coating was performed via a spray-coating technique. For this purpose, the implants were heated to 150 °C 
and sprayed with the nebulized LDH nanosuspension using a commercially available air brush equipment 
(Conrad Electronic SE, Hirschau, Germany). Throughout the process the spraying geometry, characterized by an 
angle of 45 ° and a distance of 30 cm (nozzle to implant), was maintained.  
The spraying process and coating thickness were indirectly controlled by energy dispersive X-ray spectroscopy 
(EDX) to map the initial situation for a comparison with the explanted prostheses. All coated prostheses were 
characterized individually. The coating process was judged as complete when the EDX spectrum corresponded 
to the expectation of a high-intensity magnesium peak, a medium-intensity aluminium peak and a low-intensity 
silicon peak (Fig. 2c.). In all cases the silicon peak from the Bioverit® II could be detected, indicating that the 
EDX was able to detect signals from both the Bioverit® II substrate and the silicon-free LDH coating, hence, 
allowing to track even minor degradation. 
For this purpose, the implants were rotated by an angle of 90° around their long axis after five sprays had been 
applied, totalling in 20 sprays for the initial coating. If the EDX spectrum was not satisfactory after 20 sprays, 
one spray on each side was performed in addition and the EDX measurement was repeated. An average LDH 
coating thickness on the middle ear implants of approximately 150 nm was estimated according to laser scanning 
microscopy measurements (VK-9710, Keyence, Neu-Isenburg, Germany) of similarly coated flat glass slides.  
 
 
Fig. 2 a. SEM picture of an uncoated Bioverit® II middle ear implant as produced for the study (EDX sites are 
marked with white rectangles) b. EDX spectrum of an uncoated and c. LDH coated prostheses (before the 
insertion into the ear). The white arrows highlight the intensity sequences of the element peaks of Mg, Al and Si 
for uncoated and LDH coated prostheses 
 
5	  LDHs	  as	  Key	  Components	  in	  Drug	  Release	  Systems	   117	  
	  
 4 
2.2 In vivo setup  
The in vivo study (permitted by the Lower Saxony State Office for Consumer Protection and Food Safety, Dept. 
of Animal Welfare, No. 33.9-42502-04-11/0610, considering the German Animal Welfare legislation) included 
30 approximately six-month-old male New Zealand White rabbits (Charles River Laboratories, Sulzfeld, 
Germany). The animals had an average weight of 3.3 kg and were housed in single cages with an artificial day-
night rhythm of 12 hours in the Institute of Laboratory Animal Science and Central Animal Facility of the 
Hannover Medical School. The rabbits were accordingly divided into three groups (n = 10), each with an 
observation period after surgery of four, 7 and 10 days.  
The anaesthetic management and implantation procedure was performed following the same protocol described 
in the studies by Hesse et al. and Stieve et al. [17,18]. Accordingly, the prostheses were implanted into the right 
middle ear via a retroauricular access, while the left ear was used as control. The implantation procedure is 
documented in Fig. 3. After implantation the animals were supplied with an oral dose of 0.15 mg·kg–1 
meloxicam (Metacam®, Boehringer Ingelheim, Ingelheim am Rhein, Germany) one day pre-surgery and three 
days post surgery for analgesia. Oral antibiotic prophylaxis of 10 mg·kg–1 enrofloxacin (Baytril®, Bayer, 




Fig. 3 Sequence of endoscopic images of the implantation procedure with a. retroauricular acess b. incision of 
ear canal (meatus acusticus externus) c. ear canal with tympanic membrane d. tympanotomy for accessing the 
middle ear e. view on middle ear with  malleus  incus  stapes and  chorda tymani f. extraction of incus g. 
luxation of malleus h. extraction of crura stapes i. insertion of middle ear prosthesis between tympanic 
membrane and remaining base of stapes j. closure of middle ear 
 
After four, 7 and 10 days, respectively, subjects were sedated and euthanized with regard to animal welfare. Both 
middle ears were irrigated with 1.5 mL distilled water with a syringe by piercing the tympanic membrane, 
avoiding damage of the bulla. The rinsing solution was collected immediately and stored in sterile reaction tubes. 
Afterwards, pH values of the samples were estimated with a calibrated PB-20 Basic pH-Meter (Sartorius, 
Göttingen, Germany) by directly immersing the electrode into the respective solutions. The bulla tympanica was 
opened to estimate the middle ear microscopically. Finally the prosthesis was explanted and chemically 
analyzed. 
 
2.3 Clinical evaluation 
To examine the health status of the animals, we observed the behaviour, appetite, defecation and urination, body 
weight and rectal temperature up to four days post implantation. Afterwards, the animals were weighed weekly.  
To detect possible systemic inflammation, blood samples were taken before implantation and at the end of the 
examination periods (per animal 0.5 mL blood in an EDTA micro tube, Sarstedt, Nümbrecht, Germany) and 
analysed with an animal blood counter (scil Vet ABC™ hematology analyzer, scil animal care company, CSF, 
Viernheim, Germany). 
 
2.4 Microscopic examination of the middle ear 
After ventral opening of the bulla tympanica the implant situation in the middle ear was microscopically 
evaluated using light microscopy (Microscope Zeiss®, Jena, Germany / Camera Lumenera®, Ottawa, Canada), 
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whereas, the left middle ear served as control. The main focus was on the position and appearance of the 
prosthesis, the local mucosal reaction, possible inflammation signs e.g. hyper-vascularised mucosa, swelling, 
aggregation of watery, serous, mucous or bloody fluids.  
A JEOL JSM-6700F field-emission scanning electron microscope (Jeol, Eching, Germany) was used for the 
collection of SEM images of the prostheses. The device was operated with an accelerating voltage of 2.0 kV at a 
working distance of 8 mm using the LEI-detector. The SEM was equipped with an INCA 300 energy dispersive 
X-ray (EDX) detector (Oxford Instruments PLC, Abingdon, UK). 
 
2.5 Chemical analyses of the coatings  
The main focus was on the tracking of the element ratios, in particular the Mg:Al ratio, at the implant surfaces 
and the intensities (Ielement) in the respective EDX spectra. To illustrate the course of changes of the coatings, 
each implant was measured before implantation and subsequently in the post-explanted state. The EDX spectrum 
of uncoated Bioverit® II is characterized by a low-intensity magnesium peak, a medium-intensity aluminium 
peak and a high-intensity silicon peak: IMg<IAl<ISi with a Mg:Al ratio of approximately 0.6. When coated with 
Mg4Al2-LDH, the intensities shifted to the expected, vice versa sequence: IMg<IAl<ISi Æ IMg>IAl>ISi (Fig. 2b. and 
2c.) with an average Mg:Al ratio of approximately 1.5, close to the ratio of 1.8 of the Mg4Al2-LDH in the 
suspension.  
Accordingly, the progress of in vivo LDH degradation for each group (four days, 7 days and 10 days) was 
evaluated at the cation ratio and the intensities of the element peaks in the EDX spectra. Hence, an advanced 
degradation of the LDH coating is expected to be characterized by an obvious decrease of the Mg:Al ratio and a 
re-reversion of the peak intensity sequence: IMg>IAl>ISi Æ IMg<IAl<ISi. 
Due to the unique geometry of the implants, customized sample holders were fabricated by drilling the shape of 
the implants into standard graphite blocks suitable for scanning electron microscopy (SEM). EDX measurements 
were performed on each of the prostheses, near to and far away from the base plate. As shown in Fig. 2a., the 
EDX measurements were performed with a 200-fold magnification, totalling in 20 EDX spectra for each group 
(n = 10, four days, 7 days and 10 days). The JSM-6700F was operated in EDX mode with 10 kV (accelerating 
voltage) and 10 µA at a range of 0-10 kV with regard to the prostheses elemental composition at the surface, i.e. 
Mg, Al, Si, O, C, K, F and Na. 
 
3 Results 
3.1 Clinical evaluation 
All 30 rabbits showed a good general health status throughout the experiment without any inflammation signs of 
the wound or fever. Food and water intake as well as urination and defecation behaviour were normal. Two 
animals showed a slight head tilt for not more than three days after implantation, a rare but typical side effect of 
the implantation as described in earlier studies [17].  
All rabbits showed an inconspicuous haematologic status prior to implantation and at the end of the study in 
agreement with the clinical appearance of the animals.  
 
3.2 pH measurements 
After the removal of the implants the pH values were measured in the rinsing solutions taken from the implanted 
right ears as well as from the left ears (control side). A slightly higher pH could be observed in the implanted 
ears (7.3 ± 0.3) than in the control side ears (6.7 ± 0.4). No correlation between the pH and the period of 
application was observed. 
 
3.3 Microscopic examination 
The appearance of the examined ears was in agreement with the expectations of an implanted middle ear after 
respective timepoints. After four days the microscopic view showed a minimal watery-bloody milieu with 
occasional appearance of a mucotympanum. After longer implantation periods, blood clots and mucus were 
resorbed and smooth mucosa became visible (Fig. 4). No signs of inflammation could be observed by 
microscopic means. 




Fig. 4 Representative microscopic views (16x magnification) into the middle ear a. Four days post implantation: 
blood clots surrounding implant b. 7 days post implantation: blood resorbed c. 10 days post implantation: 
mucotympanum surrounding implant d. control side: left middle ear, not implanted 
 
 
3.4 Chemical analysis of the coatings 
The successful synthesis of pure Mg-Al-CO3-LDH was confirmed by XRD measurements of dried material from 
the nanosuspension. Unfortunately, a direct detection of LDH on the implant by XRD was not possible due to 
the geometry and small size of the middle ear implants. Weighing the samples was also not suitable for tracking 
the coating and was considered to be ineffective once the implants were contaminated with organic material after 
explantation. In order to prove the general applicability of the LDH nanosuspension for the spray coating 
process, and to optimize the substrate temperature used in this process (150 °C), flat glass slides were used as 
test substrates and spray-coated using a process similar to the one applied to the middle ear implants. These 
samples could be investigated by XRD. Crystalline LDH coatings were observed in all cases.  
For each group (four days, 7 days and 10 days) 20 EDX spectra were collected and considered for the evaluation 
of the LDH degradation. Over the period of 10 days, no remarkable decrease of the magnesium to aluminium 
ratio determined at the surfaces (Fig. 5) and furthermore no change of the relative intensities of the element 
peaks in the EDX spectra could be observed. This is a sign that the Mg-Al-CO3-LDH coatings are practically 
biostable. As Mg is present with a higher contribution in the LDH coating but occurs with a minor contribution 
in the Bioverit® II substrate, a degradation of the LDH coating would result in a decrease of the Mg:Al ratio. 
Also the SEM images did not show any signs for alterations of the surface structure.  
 
 
Fig. 5 Mg:Al ratio derived from EDX measurements of pre- and post-implantation samples. The Mg:Al ratio at 
the surface of uncoated Bioverit® II is highlighted by the dashed line 




Whereas the carbon content was low before the implantations, as expected, it was considerably increased after 
the in vivo exposition. Organic debris (blood stains, mucus, and cell detritus) with high carbon content was found 
adhering to the implants’ surfaces in varying amounts and could also be seen by eye. Fig. 6 exemplarily shows 
photographical and SEM images of two prostheses explanted four days after implantation. An increasing carbon 
content proportionally decreased the relative contributions of the other elements such as magnesium and 
aluminium, but did not influence their ratio.  
 
 
Fig. 6 a. and c. Pictures of explanted prostheses, shown here by way of example for prostheses which had 
remained in the middle ear for four days. b. and d. SEM images of the samples shown in a. and c., respectively. 
EDX data were taken at the sites indicated by the white rectangles b1., b2., d1. and d2. images with higher 




4.1 Animal health screening and microscopic examination 
No harmful effect of the LDH coatings could be observed for any of the animals studied. All groups presented 
normal behaviour and clinical health status. In addition, the microscopic examination of the middle ear showed 
no pathological findings and no adverse effects of the LDH coating could be detected. This confirms a very good 
biocompatibility of LDHs as an implant coating material in the middle ear.  
 
4.2 pH measurements  
The slight increase of the pH in the operated ears can be assigned to the presence of the layered double 
hydroxide. Mildly alkaline effects are a consequence of a decomposition of the LDH: 
[Mg4Al2(OH)12][CO3]∙yH2O Æ 4Mg2+ + 2Al3+ + 12OH– + CO32– + yH2O 
This reaction probably occurs only to a very small extent which is not detectable in the EDX spectra. Since 
inflammatory reactions commonly acidify the surrounding tissue, the data shown and the post mortem 
microscopic examinations allow the conclusion that no severe inflammatory reaction was present [19,20]. 
 
4.3 In vivo stability of LDH coatings  
The main result from this study, apart from the conclusion that the LDH has a very good biocompatibility, is the 
unexpected stability of the LDH coatings. Except for the mildly alkaline effect, no changes could be observed 
even after 10 days of implantation.  
With regard to the estimated coating thickness of 150 nm, suitable implantation periods had to be chosen. 
Janning et al. examined the dissolution character of magnesium hydroxide (Mg(OH)2), a substance similar to 
magnesium-containing LDHs, in a peri-implant bone environment and found that the volume of implanted 
Mg(OH)2 cylinders was reduced by 7 % after two weeks and by 19 % of its initial volume after 6 weeks of 
implantation [21]. Considering these results, with degradation occurring at the µm scale in the course of several 
weeks, examination periods of four, 7 and 10 days were chosen with regard to the much thinner coating. 
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Additionally, many release systems show burst release behaviour [22], making the early stages of possible 
degradation processes more interesting for this empiric study. 
It has to be emphasized that the middle ear illustrates a special environment for implants. For the first days after 
surgical procedure, the tympanic cavity is liquid-filled, blood and mucus surrounding the implantation site. 
Throughout the healing, liquids are resorbed, ventilation and pressure equalization of the middle ear are restored 
and the fluid is replaced by an air-filled environment. Based on our knowledge gained from earlier studies and 
from human middle ear surgery, our different examination periods seem suitable to include and track the 
extensive reorganization processes.  
It also has to be pointed out that the coated prostheses were implanted under physiological conditions in a 
healthy middle ear. Commonly, prostheses as therapeutic tools will be implanted into inflamed and infected 
surroundings, which might influence the degradation process and by this the drug release behavior. Accordingly, 
examination times have to be adjusted to the indications caused by a corresponding infection model.  
 
4.4 Consequences for LDH-based drug delivery systems  
In our former in vivo drug delivery study, the delivery system consisted mainly of a physical mixture of 
ciprofloxacin with a Mg-Al-SO4-LDH [17]. Considering the results obtained on Mg-Al-CO3-LDH coatings, we 
suppose that the LDH component of the ciprofloxacin / Mg-Al-SO4-LDH mixture used in our earlier 
investigations did not dissolve entirely. Nonetheless, sufficient amounts of drug could be released to suppress 
infection. With the findings presented here we expect that the drug had been released independently from the 
dissolution of the Mg-Al-SO4-LDH. It is likely that the Mg-Al-SO4-LDH matrix served mainly as a physico-
chemical barrier and as a mild pH-balancing agent. Concerning this matter, the biostability of the Mg-Al-CO3-
LDH shown in this study indicates biodegradation characteristics comparable to an analogous Mg-Al-CO3-LDH 
based drug release system. Hence, both LDHs appear promising as key components of drug release systems, in 
particular in the middle ear. However, drug and indication specific demands, exemplarily desired release rates, 
have to be considered. 
Certainly the preparation of simple physical mixtures is an undemanding process, allowing for the facile and fast 
preparation of drug delivery systems including easily producible carbonate-LDHs and many other water-stable 
pharmaceuticals [23]. The LDHs offer a versatile material with regard to their composition and corresponding 
chemical properties. As mentioned above, the choice of the anion can be altered, as well the cations and their 
ratio [24,25], while maintaining the general LDH formula [MII1–xMIIIx(OH)2x+][An–]x/n∙yH2O.  
On the contrary, the preparation of LDH intercalation compounds, where an anionic drug has to be intercalated 
into the LDH structure in order to form to a true common chemical compound, involves a much larger amount of 
work effort [26,27]. Synthesis routes with satisfying yields and purities have to be elaborated and adjusted for 
every individual drug. The release of a drug from a drug-LDH intercalation compound is either accompanied by 
the decomposition of the LDH coating or occurs via anion exchange. These complex processes can be very 
different depending on the type of the drug used. When drug / LDH mixtures (in contrast to intercalation 
compounds) are used, drug release rates can be adjusted by altering the ratio of components and the composition 
of the LDH. Preferably, the adjustments could be included in the respective coating process. In order to promote 
the homogeneity of the coatings and to establish a reproducible process eligible for market authorization, 
automation of the coating techniques, exemplary for our study i.e. controlled spray duration per cycle, humidity 
and substrate temperature, would be of interest. 
 
5 Conclusion 
In the middle ear, Mg-Al-CO3-LDH can serve as a highly biocompatible and practically biostable (at least for the 
timeframe of the current investigation of ten days) coating material which can provide mild pH balance and is 
suitable for the construction of drug release systems, as shown before for Mg-Al-SO4-LDH [17]. Throughout the 
examination, the pure LDH coatings on middle ear implants had no harmful effects on the animals’ health. 
For further drug release applications for which the utilization of sophisticated, pure drug-LDH intercalation 
compounds has been considered to be necessary, simple mixtures of agents with LDH could prove to be 
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Layered double hydroxides as efficient drug delivery system of ciprofloxacin in the middle ear: an animal 
study in rabbits 
 
Daniela Hesse • Muhammad Badar • Andre´ Bleich • Anna Smoczek • Silke Glage • Marc Kieke • Peter 
Behrens • Peter Paul Mu¨ ller • Karl-Heinz Esser • Martin Stieve • Nils Kristian Prenzler 
 
Abstract  
Chronic otitis media is a common disease often accompanied by recurrent bacterial infections. These may lead to 
the destruction of the middle ear bones such that prostheses have to be implanted to restore sound transmission. 
Surface coatings with layered double hydroxides (LDHs) are evaluated here as a possibility for drug delivery 
systems with convenient advantages such as low cytotoxicity and easy synthesis. Male New Zealand White 
rabbits were implanted with Bioverit® II middle ear prostheses coated with the LDH Mg4Al2(OH)12(SO4)2∙6H2O 
impregnated with ciprofloxacin. 12 (group 1) were directly infected with Pseudomonas aeruginosa and another 
12 (group 2) 1 week after the implantation. Clinical outcome, blood counts, histological analyses and 
microbiological examination showed an excellent antimicrobial activity for group 1, whereas this effect was 
attenuated in animals where infection was performed 1 week after implantation. This is the first study to 
demonstrate an efficient drug delivery system with an LDH coating on prostheses in the middle ear. 
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1 Introduction  
Chronic otitis media is a common disease in western civilization and is often associated with local complications 
such as destruction of the ossicular chain, conduction deafness or infectious expansion like in otogenous 
meningitis or cerebral abscess. The most frequently isolated pathogens are Staphylococcus aureus, coagulase-
negative Staphylococcus and Pseudomonas aeruginosa, a gram-negative obligate aerobic rod-shaped germ, 
which prefers a moist environment [1–3]. Recently, the prevalence of multiresistant Ps. aeruginosa stems in 
chronic otitis media has increased [4]. When the ossicular chain is destroyed, its reconstruction with an 
allogeneic prosthesis is the only possibility to restore sound transmission. However, recurrence or progression of 
an inflammation and the development of bacterial biofilms must be avoided. In this context, implants with a drug 
delivery system with antibiotics are a promising approach to combat peri- and postoperative infection and to 
support a cellular colonization of the implant. In recent years, the interest in the development of layered double 
hydroxides (LDHs) as drug delivery systems has strongly increased [5, 6], although only very few in vivo studies 
have been carried out. LDHs are materials with a layered structure, consisting of positively charged metal 
hydroxide layers and charge-balancing anions and water molecules located in the interlayer region, as shown in 
Fig. 1 and described by the general formula [MII1−xMIII(OH)2]x+[An−]x/n∙yH2O, where MII and MIII represent the 
metal cations, x stands for the charge per formula unit of the hydroxide layer, An− means the interlayer anion of 
charge n, and y is the number of the interlayer water molecules. LDHs are also known as hydrotalcite-like 
compounds or anionic clays and are for example applied as antacids for the treatment of heart-burn and gastric 
ulcers. Their flexible composition and the relatively simple synthesis make LDHs interesting materials for a 
variety of other bioapplications. Their chemistry is furthermore enhanced by the possibilities of the exchange of 
the interlayer anions and of the intercalation of larger molecules. 
 
 
Fig. 1 Schematic stucture of LDHs with positively charged layers and charge-balancing anions and additional 
water molecules located in the interlayer region 
 
LDH nanoparticles are mainly transported into cells by clathrin-mediated endocytosis [7], which can be different 
from the cellular uptake mechanism for the pure drugs, as shown in a study about methotrexate-LDHs [8], the 
first example of an LDH-mediated drug delivery which enabled to overcome drug resistance. Choy et al. 
examined folic acid derivatives of LDHs and explained the enhanced drug delivery by the increased permeability 
through the cell membrane and protection of the agent from rapid decomposition [9]. This improved impact was 
also observed in animal studies. The use of LDHs as DNA vaccine delivery vector in the treatment of melanoma 
in mice induced an enhanced serum antibody response at a greater extent than naked DNA [10]. Del Arco et al. 
investigated LDHs with intercalated indomethacin and showed that gastric damage was reduced in comparison 
to oral intake of indomethacin alone [11]. Another important factor of LDHs is the slowed release and the 
subsequent extended presence of the drugs. A study in rabbits on LDHs with intercalated diclofenac for ocular 
delivery revealed a longer detectable time compared with diclofenac only [12]. Moreover, for all therapeutic 
drug delivery systems a low cytotoxicity is required. Gu et al. [13] examined the effect of heparin intercalated 
into LDH nanoparticles on vascular smooth muscle cells in rats as an anti-restenotic drug. The cytotoxicity tests 
showed that LDH itself had a very limited toxicity at concentrations below 50 µg/ml over 6-day incubation. 
For the present study, we have investigated the ability of LDH nanoparticles impregnated with the antibiotic 
ciprofloxacin on Bioverit® II implants to act as a drug delivery system in order to combat an infection with 
Ps. aeruginosa in the middle ear. To our knowledge, this is one of the very few in vivo studies of LDHs and the 
first report of an application of LDHs in the middle ear. For these in vivo experiments, we chose rabbits as the 
animal model. This choice was made due to a favourable surgical approach with similar anatomy to the human 
middle ear [14, 15] and because we have already established an infection model based for the middle ear in this 
species. Here, we have infected one group of animals during surgery and another group 1 week after 




implantation to mimic a recurrent infection and to allow estimation of the duration of the antibacterial efficacy of 
the ciprofloxacin–LDH system. 
 
2 Materials and methods 
2.1 Animals 
For this animal study, we used 24 five-month-old healthy male New Zealand White rabbits from Charles River 
(Sulzfeld, Germany). The rabbits were housed in single cages up to an average weight of 2.4 kg in the Institute 
for Laboratory Animal Science and Central Animal Facility, Medical University of Hannover, Germany. This 
study was conducted in accordance with German law for animal protection and with the European Communities 
Council Directive 86/609/EEC for the protection of animals used for experimental purposes. All experiments 
were approved by the Local Institutional Animal Care and Research Advisory committee and permitted by the 
local government (No. 33.9-42502-04-11/0355). 
 
2.2 Implants 
The bioceramic Bioverit® II, from 3di GmbH (Jena, Germany), was used as basic implant material for the 
ossicular reconstruction. The prostheses, with a weight of 8 mg, consisted of a 2.5 mm long cylinder with a 
diameter of 1 mm and with, at one end, an orthogonal plate 3 mm of diameter. A nanoparticle stock suspension 
(~ 3.5 g/l) of the LDH with the chemical formula Mg4Al2(OH)12(SO4)0∙6H2O was concentrated by centrifuging 
the suspension @ 3,000 rpm for 5 min at room temp. Half of the supernatant was removed and the pellet was 
resuspended in the remaining liquid. This concentrated suspension of LDH was mixed with 1 mg/ml suspension 
of ciprofloxacin (Fluka Chemie GmbH, Deisenhofen, Germany) in H2O in a 3:1 ratio. Bioverit® II middle ear 
implants were individually placed in reaction tubes of 0.2 ml volume and 100 µl of the LDH and ciprofloxacin 
mixture was added to each tube. The tubes were then placed overnight at 37 °C to evaporate the liquid from the 
tubes. This left the Bioverit implants coated with the mixture of LDH and ciprofloxacin. In vitro experiments on 
the release kinetics of ciprofloxacin out of the LDH/ciprofloxacin mixture in phosphate buffered saline showed a 
continuous stable release of the drug for about 2 weeks before the release began to decrease (data not shown, to 
be published elsewhere). 
 
2.3 Bacteria 
The Ps. aeruginosa strain “PAO1” was used for this experiment; the sensitivity to ciprofloxacin was confirmed. 
In previous studies (data not shown) a clinical strain of Ps. aeruginosa was tested but found to be too harmful for 
the rabbits; the PAO1 strain proved to be clinically relevant in this context but did not cause such a high 
mortality. The bacteria were cultured on blood agar and incubated at 37 °C for 24 h. Afterwards, they were 
suspended in sterile saline solution and set to an optical density of 0.6 (OD = 0,6) measured at 578 nm, 
corresponding to a concentration approximately of 106 colony forming units (CFU)/200 µl. 
 
2.4 Middle ear surgery 
All rabbits were sedated with an intramuscular injection of 25 mg/kg ketamine (Ketamin Gräub®, Albrecht, 
Aulendorf, Germany) and 1.25 mg/kg midazolam (Midazolam 5 mg, Cura-Med, Hameln, Germany). Both eyes 
were given a protective ophthalmic ointment (Bepanthen® Augen- und Nasensalbe, Bayer, Leverkusen, 
Germany) to prevent desiccation. Subsequently, as subcutaneous injections were given of 0.1 mg/kg of the 
anticholinergic agent Robinul® (Riemser, Insel Riems, Germany), 0.05 mg/kg of the analgesic buprenorphin 
(Buprenovet®, Bayer, Leverkusen, Germany) and 4 mg/kg carprofen (Rimadyl®, Pfizer, Karlsruhe, Germany) to 
inhibit inflammation and pain. Anesthesia was induced with 1 mg/kg of 1% propofol (Propofol-® Lipuro, B. 
Braun, Melsungen, Germany) intravenously. After endotracheal intubation, narcosis was maintained using a mix 
of Isofluran® (Baxter, Unterschleißheim, Germany) and oxygen (1.5%/1.5 l/min). During surgery the rabbits 
were laid in a thoracic-abdominalposition and a heated mat was used to stabilize the bodytemperature. 
Additionally, 10 ml/kg/h electrolyte solution (Sterofundin HEG-5®, B. Braun, Melsungen, Germany) was used to 
stabilize the animals’ circulatory systems. Breathing, lid reflex, body-temperature and pulse rate were monitored 
consistently. The prostheses were implanted in the right middle ear cavity. After shaving, disinfection (Braunol®, 
B. Braun, Melsungen, Germany) and sterile covering of the operational site, a retroauricular incision of 5 cm 
length was made and the external acoustic meatus was opened between the cartilage- bone junction. 
Subsequently, a tympanomeatal flap was created to get access to the middle ear. The ossicular chain was 
removed, partially with the help of a laser microscope (OPMI® Twin ER, Carl Zeiss AG, Oberkochen, 
Germany), and the prosthesis was placed between the tympanic membrane (with the plate), the remaining 
malleus and the stapes. Afterwards, the tympanomeatal flap was replaced and a tamponade (Gelita®, B. Braun, 
Tuttlingen, Germany) was used to support the eardrum. The approach was closed using absorbable surgical 
suture material (Vicryl®; 4/0, SH-1 plus; Ethicon GmbH, Norderstedt, Germany) and non-absorbable surgical 
suture material (Supolene®; 4/0; RESORBA Wundversorgung, Nürnberg, Germany) for the skin. Prior to 
surgery, the animals were split into two groups: one was infected with Ps. aeruginosa suspension during the 
implantation, the other group 1 week after the implantation. Group 1 (n = 12) received 0.2 ml of the bacterial 




suspension (106 CFU/200 µl) directly into the middle ear before replacing the tympanomeatal flap. The retarded 
infection was placed through the tympanic membrane. For this purpose, the animals of group 2 were narcotized 
with an intramuscular injection of 25 mg/kg ketamine, 1.25 mg/kg midazolam and 0.1 ml medetomidin 
(Domitor®, Janssen, Neuss, Germany) 1 week after the implantation. Both eyes were given a protective 
ophthalmic ointment. 0.1 mg/kg of the anticholinergic agent Robinul® and 4 mg/kg carprofen (Rimadyl®, Pfizer, 
Karlsruhe, Germany) were administered subcutaneously to inhibit inflammation and pain. 
 
2.5 Evaluation of the clinical condition 
To evaluate the clinical general condition, we assessed behaviour, feed intake, defecation and urination, body 
weight and rectal temperature and created a scoring system (Table 1) for the first four parameters. The daily 
scores of each animal were added to a total clinical score and this was averaged to give the means of the two 
groups. During the first week after infection rectal temperature was assessed daily. Body weight alterations, 
compared to the initial weight before infection, was documented for 7 days after infection and additionally prior 
to euthanasia. The animals received carprofen (Rimadyl®, 4 mg/kg s.c., Pfizer, Berlin, Germany) as an anti-
inflammatory and analgesic drug for 2 days after infection and if they showed remaining fever after 2 days, 
carprofen treatment was continued. Rabbits that did not eat properly were fed a blended special powder for 
herbivore (Critical Care®, Albrecht, Aulendorf, Germany). Blood samples from the auricular artery were taken 
daily throughout the first seven days after infection. Samples were put in ethylenediamintetraacetic acid (EDTA) 
tubes and leukocytes were counted using Vet ABC® Animal Blood Counter (Scil Animal Care Company GmbH, 
Viernheim, Germany). To evaluate the clinical neurological condition, we additionally noted head tilt, 
nystagmus, imbalance, circling in cage and rotation around the longitudinal axis with the aid of a scoring system. 
Score 0 indicates no symptom; a possible score of 5 is obtained if an animal showed all symptoms at the same 
time. 
 
Table 1 Classification of the total clinical score 
Clinical parameters  Score 
Behaviour Lively, attentive, 
 typical movement 
Calm, attentive, 
 reduced movement 
Apathetic, weak, 
















Total clinical score  0-5 
 
 
2.6 Euthanasia and necropsy 
Animals were euthanised three weeks after infection. To this end, they were sedated with an intramuscular 
injection of 25 mg/kg ketamine (Ketamin Gräub®, Albrecht, Aulendorf, Germany) and 1.25 mg/kg midazolam 
(Midazolam 5 mg, Cura-Med, Hameln, Germany). Propofol (1%, 1 mg/kg) (Propofol-® Lipuro, Braun, 
Melsungen, Germany) was administered i.v. to deepen the narcosis before the rabbits were euthanised with 600 
mg/kg i.v. pentobarbital (Release®, WDT, Garbsen, Germany). The animals were dissected and organ alterations 
were documented. Tissue samples of lung, liver, spleen, and kidney and a blood sample were taken for 
microbiological examination and lung and heart were prepared for histology. Subsequently, the external acoustic 
meatus was removed and the middle ear was examined and irrigated with 1,000 µl saline solution which was 
used for further microbiological examination. Afterwards, the bulla was opened from the ventral side and the 
implant was obtained and rinsed with 100 µl saline solution to determine the growth of Ps. aeruginosa. Finally, 
the skullcap was opened, swab samples of the brain were taken for microbiological examination and the brain 
was removed and examined histopathologically to detect inflammatory lesions, based on a procedure published 
by the RITA and NACAD groups [16]. 
 
2.7 Microbiological examination 
Tissue or swab samples of brain and ear were cultured in Thioglycolat (TG) medium (Thioglycolat Medium 
U.S.P., Oxoid Deutschland GmbH, Wesel, Germany). Irrigation fluids of implant and middle ear were cultured 
on standard blood agar (Blood Agar Base No. 2, Oxoid Deutschland GmbH, Wesel, Germany), Gassner agar 
(Oxoid Deutschland GmbH, Wesel, Germany) and in TG medium. Bacterial growth on blood and Gassner agar 




was evaluated for a maximum of 48 h, in the TG medium for 1 week. The evidence for the presence of Ps. 
aeruginosa was ensured by oxidase tests and the API-system (API® 20NE, bioMe´vieux Deutschland GmbH, 
Nürtingen, Germany). Quantification of Ps. aeruginosa from the irrigations of middle ears and implants was 
achieved by using plating out dilution series and the result is given as CFU/10 µl. 
 
2.8 Statistical methods 
GraphPad Prism 5.0 was used for statistical analysis. The parameters of the clinical general examination were 
analyzed using the unpaired t test. The Fisher‘s exact test was applied to evaluate the neurological examination, 
the results of the necropsy and the qualitative microbiological examination. The quantitative microbiological 
results and the neurological score were analyzed by the Mann– Whitney test. Differences with the value of 
P < 0.05 were considered statistically significant. 
 
3 Results 
One animal of each group died in the course of theimplantation due to cardiopulmonary failure. In addition, 
one animal of group 2 was euthanised preterm on day four after infection due to its poor health condition. 
 
3.1 Clinical examination 
Only two rabbits, one of each group, showed behavioural syndromes at the clinical general examination. The 
animal of group 1 showed reduced food intake and mild diarrhea and decreased defecation throughout the first 4 
days. It was also calm but attentive and showed a reduced movement from day one to day four. The rabbit of 
group 2 showed reduced feed intake on day three and four and a decreased defecation on day four after infection 
and was also calm, with reduced movement throughout the first 4 days. Both rabbits were allocated to score 3. In 
total, there was no significant difference between the groups. Furthermore, both above-mentioned animals lost 
11% of their initial body weight to day four. In summary, there was only one significant difference for the body 
weight: animals of group 2 gained more weight than animals of group 1 (P = 0.04 Mann–Whitney test, Fig. 2). 
One rabbit of group 1 showed fever (body temperature > 40 °C) on day one after surgery and the rabbit of group 
2, that was euthanised preterm, developed fever on day three and four after infection, despite treatment with 
carprofen. All in all, there was no significant difference between the groups, Fig. 3. The clinical neurological 
examination showed that in group 1, one rabbit developed mild imbalance and mild to severe head tilt 
throughout the whole examination period after infection. It also showed circling in cage for the last 4 days and 
rotated around its longitudinal axis for the last 3 days. In group 2, vestibular signs were shown by three animals. 
Two suffered from mild head tilt, one for 2 days after surgery and the second for 2 days after infection. The 
rabbit, which was euthanised preterm, showed moderate imbalance on day three and a severe imbalance on day 
four, Fig. 4. Adding and comparing the total neurological score, no significant differences were seen between the 
groups. Leukocytosis was seen in two rabbits of group 1, and in three animals of group 2, i.e. no significant 
difference between the groups was found, Fig. 5. 
 
 
Fig. 2 Relative body weight: means of both groups (N = 22). Statistically significant differences (P < 0.05) 
between the groups are marked with asterisks. #The preterm death of one rabbit of group 2 
 





Fig. 3 Body temperature: means of both groups (N = 22) in the first 7 days after surgery. #Signifies the preterm 
death of one rabbit of group 2 
 
 
Fig. 4 Total neurological score. Score 0 means no neurological symptoms; score 5 corresponds to the display of 
five neurological symptoms at the same time as described in the text. This results in the means of both groups 
(N = 22) 
 
3.2 Microbiological examination 
The qualitative microbiological examination proved the presence of Ps. aeruginosa in two rabbits of group 1: the 
first rabbit had the germ on blood- and Gassner agar in the implant and middle ear irrigations. For the second 
animal, the germ was detected on blood- and Gassner agar in the middle ear irrigation. In group 2, 
Ps. aeruginosa was found in five subjects. In the first four animals, Ps. aeruginosa was detected on blood- and 
Gassner agar of the implant and middle ear irrigations. In the fifth, the germ could only be detected in the blood 
agar of the implant irrigation. The quantitative microbiological examination (CFU) of the implant irrigation 
showed a much higher value for the animals which were infected 1 week after implantation (P = 0.03), Fig. 6. 




Fig. 5 Number of leukocytes: means of both groups (N = 22) in the first 7 days after surgery. #Signifies the 
preterm death of rabbit of group 2 





Fig. 6 Quantitative microbiological examination (CFU): means of both groups (N = 22). Statistically significant 
differences (P < 0.05) between the groups are marked with asterisks 
 
3.3 Histopathological examination 
Pulmonary oedema was found in all animals. Only the rabbit of group 2, which was euthanised preterm, had 
developed a severe meningoencephalitis with an accumulation of neutrophils, Fig. 7. The remaining rabbits of 
both groups showed no inflammation of the brain. 
 
 
Fig. 7 Histological examination of the rabbit of group 1 which was euthanised preterm: the image shows a severe 
meningoencephalitis with an accumulation of neutrophils (arrows) 
 
4 Discussion 
LDH nanoparticles can serve as a local drug delivery system as shown in previous studies of different medical 
applications. Due to their favourable properties in terms of low cytotoxicity and easy synthesis, they can be a 
promising agent in the environment of the middle ear. Newly inserted prostheses, especially after various 
infections, are likely to become covered with bacteria, which prevents proper integration of the prostheses. To 
test the antimicrobial effect of a formulation comprised of a mixture of an LDH compound and ciprofloxacin as 
an effective drug against Ps. aeruginosa [17, 18], we coated this mixture on Bioverit® II prostheses which show 
an excellent biocompatibility [19, 20]. In order to mimic a recurrent infection, animals were infected at two 
different timepoints as explained before. There was no control group due to ethical considerations, as in 
preliminary studies animals without any antibiotic treatment had a very poor outcome and several of them had to 
be euthanised preterm (data not shown). Concerning the general condition only minor differences could be 
observed between the two groups, but it seems that animals that were infected 1 week after implantation had a 
slightly worse outcome: here, one animal had to be euthanised preterm. The reduced defecation of two animals, 
one of each group, can be explained by the reduced feed intake, because the stomach of rabbits transports the 
food only mechanically by permanent feed intake and not actively by muscle contraction. Therefore, they have 
to eat continuously. Furthermore, the gastrointestinal tract of rabbits is very fragile. Especially, in stress 
situations associated with surgical operations, gastrointestinal disorders can be observed [21–23]. Some rabbits 
developed fever and leukocytosis, which is both unusual in rabbits [22, 24, 25]. The most common reason for 
fever is heat stroke as well as septicaemia and viraemia. Even in the case of an abscess, pyrexia is rare. Also 
leukocytosis, in the context of an acute infection, occurs rarely in rabbits. For the first days after infection the 
high leukocyte number could be seen as the result of the immune system to combat the high concentration of 
bacteria, but also other factors such as pain, anxiety or excitement can play a role [26]. The neurological 




examination showed that only one rabbit of group 1 and three rabbits of group 2 suffered from neurological 
symptoms, including the two animals which showed alterations in the general condition. One rabbit of group 2 
showed mild head tilt for only 2 days after surgery without infection. So this observation is not only caused by 
otitis media or interna, but also by the surgical operation which involved pain and irritation of the vestibular 
system. Especially, head tilt and nystagmus are signs for a peripheral vestibular disturbance [24, 27]. However, 
also imbalance, circling and rotation around the longitudinal axis could be a reason for peripheral vestibular 
lesions. Besides, rolling seems to correlate with head tilt, because rabbits with increased head tilt showed rolling 
more often, which was recognized likewise in an examination about Encephalitozoonosis in rabbits [28]. The 
histology of the rabbit of group 2, which was euthanised preterm, revealed a severe meningoencephalitis, which 
is an indication for the spreading infection of Ps. aeruginosa. The qualitative microbiological examination 
showed a clear difference between the two groups. In group 1, Ps. aeruginosa was proven only in two rabbits in 
a very low concentration. Although only a few animals showed clinical alterations, the microbiology showed a 
positive detection for Ps. aeruginosa in five rabbits of group 2, partially in a very high concentration. However, 
the quantitative microbiological examination (CFU) showed a statistically significant difference between the 
groups for the irrigations of the implants (P = 0.03 Mann–Whitney test), though there was no significance 
concerning the irrigations of the middle ear. These results demonstrate the ability of impregnated LDH 
nanoparticles as a drug delivery system for ciprofloxacin to combat a local bacterial infection in the middle ear 
of rabbits. In comparison to animals that were implanted without any antibiotic agents (preliminary studies, data 
not shown), both groups reached excellent results regarding microbiological and clinical outcome. Nevertheless, 
in case of a recurrent otitis media (group 2) this drug delivery system showed an attenuated efficiency. The 
reason could be a gradient release of ciprofloxacin accelerated by the bloody and fluid environment in the middle 
ear after surgery. In this context, further research on the decomposition kinetics of the LDHs in the environment 
of the middle ear have to be performed in order to establish this drug delivery system as a possible component of 
middle ear prostheses for a clinical use. 
 
5 Conclusion 
This is the first study of LDHs used in the middle ear and one of the few in vivo studies of this material class. It 
was demonstrated that LDH nanoparticles impregnated with a medical drug can be used as an effective drug 
delivery system for antibiotics to combat a forced infection of the middle ear of rabbits. However, animals which 
were concomitantly infected during the implantation of the prostheses showed a better outcome in 
microbiological examination than subjects which underwent infection 1 week after implantation, so the drug 
release and the efficiency is proven, but—at least for some application cases—faster than desirable. Further 
research has to be performed on the decomposition kinetics and the antibiotic release rate in the attempt to 
establish this new drug delivery system as a therapeutic tool in middle ear surgery.  
 
Acknowledgments  
This work was supported by the German Research Foundation (DFG, Collaborative Research Centre SFB 599, 
work packages D1 and DR1). The authors would like to thank Susanne Häussler from Helmholtz Centre for 
Infection Research (Braunschweig, Germany) for the kind provision of the Ps. aeruginosa strain “PAO1”. 
Moreover, Muhammad Badar was supported by the Higher Education Commission (HEC) and German 
Academic Exchange Service (DAAD). 
 
References 
1. Madana J, Yolmo D, Kalaiarasi R, Gopalakrishnan S, Sujatha S. Microbiological profile with antibiotic 
sensitivity pattern of cholesteatomatous chronic suppurative otitis media among children. Int J Pediatr 
Otorhinolaryngol. 2011;75(9):1104–8. 
2. Choi HG, Park KH, Park SN, Jun BC, Lee DH, Yeo SW. The appropriate medical management of 
methicillin-resistant Staphylococcus aureus in chronic suppurative otitis media. Acta Otolaryngol. 
2010;130:42–6. 
3. Hwang JH, Chu CK, Liu TC. Changes in bacteriology of discharging ears. J Laryngol Otol. 
2002;116:686–9. 
4. Hirakawa Y, Sasaki H, Kawamoto E, Ishikawa H, Matsumoto T, Aoyama N, Kawasumi K, Amao H. 
Prevalence and analysis of Pseudomonas aeruginosa in chinchillas. BMC Vet Res. 2010;6:52. 
5. Williams GR, O’Hare D. Towards understanding, control and application of layered double hydroxides 
chemistry. J Mater Chem. 2006;16:3065–74. 
6. Del Hoyo C. Layered double hydroxides and human health: an overview. Appl Clay Sci. 2007;36:103–
21. 
7. Choi S-J, Oh J-M, Choy J-H. Human-related application and nanotoxicology of inorganic particles: 
complementary aspects. J Mater Chem. 2008;18:615–20. 
8. Choi S-J, Choi GE, Oh J-M, Oh Y-J, Park M-C, Choy J-H. Anticancer drug encapsulated in inorganic 
lattice can overcome drug resistance. J Mater Chem. 2010;20:9463–9. 






9. Choy J-H, Jung J-S, Oh J-M, Park M-C, Jeong J, Kang Y-K, Han O-J. Layered double hydroxide as an 
effective drug reservoir for folate derivatives. Biomaterials. 2004;25:3059–64. 
10. Li A, Qin L, Wang W, Zhu R, Yu Y, Liu H, Wang S. The use of layered hydroxides as DNA vaccine 
delivery vector for enhancement of anti-melanoma immune response. Biomaterials. 2011;32:469–77. 
11. Del Arco M, Cebadera E, Gutierrez S, Martin C, Rives V, Rocha J, Sevilla MA. Mg, Al layered double 
hydroxides with intercalated indomethacin: synthesis, characterization and pharmacological study. J 
Pharm Sci. 2004;93:1649–58. 
12. Cao F, Wang Y, Ping Q, Liao Z. Zn-Al-NO3-layered double hydroxides with intercalated diclofenac for 
ocular delivery. Int J Pharm. 2011;404:250–6. 
13. Gu Z, Rolfe ER, Xu ZP, Thomas AC, Campbell JH, Lu GQM. Enhanced effects of low molecular 
weight heparin intercalated with layered double hydroxide nanoparticles on rat vascular smooth muscle 
cells. Biomaterials. 2010;31:5455–62. 
14. Stieve M, Hedrich HJ, Battmer RD, Behrens P, Mu¨ller PP, Lenarz T. Experimental middle ear surgery 
in rabbits: a new approach for reconstructing the ossicular chain. Lab Anim. 2009;43:198–204. 
15. Stieve M, Schwab B, Winter M, Lenarz T. Titanium oxide ceramic as an implantation material in 
otosurgery: animal experimental results and surgical technique. Laryngorhinootologie. 2006;85:635–9. 
16. Morawietz G, Ruehl-Fehlert C, Kittel B, Bube A, Keane K, Halm S, Heuser A, Hellmann J. Revised 
guides for organ sampling and trimming in rats and mice - Part 3. Exp Toxic Pathol. 2004;55:433–49. 
17. Stange G. Lokale Therapie von Pseudomonasinfektionen des Ohres. Laryngo-Rhino-Otol. 
1989;68:653–6. 
18. Drehobl M, Guerrero JL, Lacarte PR, Goldstein G, Mata SF, Luber S. Comparison of efficacy safety of 
ciprofloxacin otic solution 0.2% versus polymyxin B-neomycin-hydrocortisone in the treatment of 
acute diffuse otitis externa. Curr Med Res Opin. 2008;24(12):3531–42. 
19. Vogt JC, Brandes G, Ehlert N, Behrens P, Nolte I, Mueller PP, Lenarz T, Stieve M. Free Bioverit_ II 
implants coated with a nanoporous silica layer in a mouse ear model: a histological study. J Biomater 
Appl. 2009;24:175–91. 
20. Vogt JC, Brandes G, Krueger I, Behrens P, Nolte I, Lenarz T, Stieve M. A comparison of different 
nanostructured biomaterials in subcutaneous tissue. J Mater Sci. 2008;19:2629–36. 
21. Koetsche W, Gottschalk C. Krankheiten der Kaninchen und Hasen. 4rd ed. Jena: Gustav Fischer 
Verlag; 1990. p. 18, 105. 
22. Zinke J. Ganzheitliche Behandlung von Kaninchen und Meerschweinchen. Stuttgart: Sonntag Verlag; 
2004. p. 4–5. 
23. Brooks DL. Nutrition and gastrointestinal physiology. In: Quesenberry K, Carpenter J, editors. Ferrets, 
rabbits and rodents. 2nd ed. St. Louis: Saunders; 2004. p. 157. 
24. Saunders R, Davies R. Notes on rabbit internal medicine. Oxford: Blackwell Publishing; 2005. p. 57. 
25. Harcourt-Brown F. Textbook of rabbit medicine. Oxford: Butterworth- Heinemann; 2002. p. 145, 211. 
26. Nelson R, Couto C. Innere Medizin der Kleintiere. 2nd ed. Mu¨nchen: Urban & Fischer Verlag; 2010. 
p. 69, 1281. 
27. Keeble E. Nervous and musculoskeletal disorders. In: Meredith A, Flecknell P, editors. Manual of 
rabbit medicine and surgery. 2nd ed. Quedgeley, Gloucs: BSAVA; 2006. p. 106. 
28. Kuenzel F, Joachim A. Encephalitozoonosis in rabbits. Parasitol Res. 2010;106:299–309. 
134	   5	  LDHs	  as	  Key	  Components	  in	  Drug	  Release	  Systems	  
	  
5.4	   	  Controlled	  drug	  release	  from	  antibiotic-­‐loaded	  layered	  double	  
hydroxide	  coatings	  on	  porous	  titanium	  implants	  in	  a	  mouse	  model	  
Muhammad	   Badar*,	   Muhammad	   Imran	   Rahim*,	   Marc	   Kieke,	   Thomas	   Ebel,	  
Manfred	  Rohde,	  Hansjörg	  Hauser,	  Peter	  Behrens,	  Peter	  P.	  Müller	  	  
	  
*These	  authors	  contributed	  equally	  to	  this	  study.	  
	  




The	  final	  publication	  is	  available	  at	  
http://onlinelibrary.wiley.com/doi/10.1002/jbm.a.35358/full	  
	  





5	  LDHs	  as	  Key	  Components	  in	  Drug	  Release	  Systems	   135	  
	  
	  
	   	  
Controlled drug release from antibiotic-loaded layered double
hydroxide coatings on porous titanium implants in a mouse model
Muhammad Badar,1,2* Muhammad Imran Rahim,1* Marc Kieke,3 Thomas Ebel,4 Manfred Rohde,1
Hansj€org Hauser,1 Peter Behrens,3 Peter P. Mueller1
1Helmholtz Centre for Infection Research, Inhoffenstrasse 7, 38124 Braunschweig, Germany
2Gomal Center of Biochemistry and Biotechnology (GCBB), Gomal University, Dera Ismail Khan, Pakistan
3Institute for Inorganic Chemistry, Leibniz University of Hannover, Callinstrasse 9, 30167 Hannover, Germany
4Department of Powder Technology, Helmholtz Center Geesthacht, Centre for Materials and Coastal Research, Max-Planck-
Strasse 1, 21502 Geesthacht, Germany
Received 5 September 2014; revised 16 October 2014; accepted 21 October 2014
Published online 00 Month 2014 in Wiley Online Library (wileyonlinelibrary.com). DOI: 10.1002/jbm.a.35358
Abstract: As an alternative to degradable organic coatings the
possibility of using layered double hydroxides (LDHs) to gen-
erate implant coatings for controlled drug delivery was eval-
uated in vivo and in vitro. Coatings prepared from LDH
suspensions dissolved slowly and appeared compatible with
cultured cells. LDH coatings loaded with an antibiotic resulted
in antibacterial effects in vitro. The LDH coating prolonged the
drug release period and improved the proliferation of adher-
ent cells in comparison to pure drug coatings. However, dur-
ing incubation in physiological solutions the LDH coatings
became brittle and pieces occasionally detached from the sur-
face. For stress protection porous titanium implants were
investigated as a substrate for the coatings. The pores pre-
vented premature detachment of the coatings. To evaluate the
coated porous implants in vivo a mouse model was estab-
lished. To monitor bacterial infection of implants noninvasive
in vivo imaging was used to monitor luminescently labeled
Pseudomonas aeruginosa. In this model porous implants with
antibiotic-loaded LDH coatings could antagonize bacterial
infections for over 1 week. The findings provide evidence that
delayed drug delivery from LDH coatings could be feasible in
combination with structured implant surfaces. VC 2014 Wiley Peri-
odicals, Inc. J Biomed Mater Res Part A: 00A:000–000, 2014.
Key Words: implant infection, local drug delivery, degradable
implant coating, bacterial biofilm, layered double hydroxides
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INTRODUCTION
Various materials, including plain, structured or coated tita-
nium are commonly used as implant materials.1–3 The abil-
ity of pathogenic bacteria to colonize such implants and
form biofilms that are resistant to conventional therapies
poses a major clinical problem.4,5 Frequently, the only effec-
tive treatment is to first remove the implant and then eradi-
cate the infection.6,7 Even though device infections may
occur even years after implantation, a most risky time
period appears to be during the surgery and the subsequent
convalescence. After the wound healing is completed
implants are protected by a fibrous capsule that is thought
to restrict the risk of infection.8 Due to the limited efficacy
of systemic antibiotic treatments various alternative strat-
egies have been devised to prevent bacterial colonization of
implants during this critical period.9 Local drug delivery
from degradable implant coatings could be of advantage to
temporarily achieve highly efficacious antibiotic concentra-
tions at the site where they are needed while systemic drug
levels and side effects could be reduced.10–13 Polymeric
materials can be used as drug carriers but acidic break-
down products have been associated with inflammatory tis-
sue responses.14–19 Alternatively, inorganic biodegradable
coatings could avoid such undesirable byproducts. In this
study layered double hydroxides (LDHs) were investigated
as a class of inorganic biodegradable materials that have
gained considerable interest as potential drug delivery sys-
tems.20 These hydrotalcite-type anionic clays are biocompat-
ible and are certified for human use as antacids.21 The aim
of this study was to demonstrate the feasibility of controlled
drug delivery from LDH coatings. Importantly, due to differ-
ences between experimental biofilms in vitro and in vivo a
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mouse model was established to verify in vitro observa-
tions.22–24 Antibacterial effects of ciprofloxacin as an effica-
cious model antibiotic were monitored using a luminescent
Pseudomonas aeruginosa strain.25–28 Since LDH coatings
appeared fragile on plain surfaces porous titanium discs
were used as implants. In this setup, ciprofloxacin-loaded
LDH coatings were gradually degraded and biocompatible
while showing antibacterial activity.
MATERIALS AND METHODS
Titanium discs
Plain titanium discs were custom made, 7 mm in diameter
and 1 mm in height (3di GmbH; Jena, Germany). Porous tita-
nium discs were manufactured from Ti–6Al–4V microbeads
grade 23 by metal injection molding of 90% (w/w) beads
with a diameter from 125 to 180 mm and 10% Ti–6Al–4V
powder with a grain diameter of less than 45 mm. The mix-
ture was sintered at 1100!C for 2 h under high vacuum
without further processing. The porous discs were 7 mm in
diameter and 2 mm thick and the average weight was
265.56 2.4 mg.
LDH coatings
A suspension of LDH microparticles with the chemical com-
position Mg4Al2(OH)12(SO4)2"yH2O (LDH) was prepared as
described.29 Briefly, the Mg–Al–SO4–LDH was obtained by
NaOH-induced coprecipitation from a sterile precursor solu-
tion containing MgSO4"7H2O and Al2(SO4)3"18H2O. The pre-
cipitate was washed with and then resuspended in sterile
distilled water at a concentration of 7 mg/mL. Drug-
containing coatings were prepared from a mixture of
5.3 mg/mL LDH suspension with either 2.5, 0.25, or
0.025 mg/mL ciprofloxacin (Fluka Chemie GmbH, Deisenho-
fen, Germany) as indicated. 1 mL per cm2 cell growth area
of the respective suspension was transferred to 6-well cell
culture plates (Nunc, Denmark) for cell compatibility testing
or to 48-well plates for coating titanium discs. The suspen-
sions were air dried for 3 days at 37!C. Titanium discs were
autoclaved before coating and coating manipulations were
done using a sterile laminar flow hood.
X-ray diffraction analysis
X-ray diffraction (XRD) measurements were performed with
a STOE Theta/theta Diffractometer (STOE & Cie GmbH,
Darmstadt) operated at 40 kV and 30 mA. The samples were
scanned in reflection geometry at a step width of 0.02! with
2.0 s counting time per step, employing monochromatized
CuKa1 radiation with a wavelength of 1.54060 Å.
Cell culture methods
The biocompatibility of LDH coatings was tested in mamma-
lian cell cultures as described previously.25 Briefly, immortal-
ized murine NIH3T3 fibroblasts (ATCC CRL-1685) were
cultured in Dulbecco’s modified Eagle’s medium (DMEM;
Gibco/BRL, supplemented with 1% (v/v) glutamine, 1% (v/v)
penicillin and streptomycin (100 U/mL penicillin G and 100
mg/mL streptomycin), and 10% (v/v) fetal calf serum) at 37!C
in a humidified atmosphere with 5% CO2. Subconfluent cells
were detached from tissue culture flasks using trypsin. The
cells were washed in DMEM with 10% (v/v) fetal calf serum
to inactivate trypsin and then the cells were resuspended in
fresh supplemented DMEM medium as above. The cells were
seeded at a density of 12,000 cells per cm2 of a 9.6-cm2 LDH-
coated well of a 6-well plate. The plates were incubated at
37!C in a humidified incubator with 5% CO2 until the cells
reached confluence in untreated control wells. All samples
were prepared and evaluated in triplicates. Cell adhesion,
spreading and proliferation was observed using Axio Observer
A-1 microscope (Zeiss, Germany). The images were recorded
by using the Axiovision software, release 4.5 (Carl Zeiss Micro-
Imaging, Germany).
Electron microscopy
Porous titanium discs with or without coatings were exam-
ined using a Merlin field emission scanning electron micro-
scope (Zeiss, Oberkochen, Germany) using an acceleration
voltage of 5 kV with the Everhart-Thornley SE-detector and
Inlens SE-detector ratio set to 25:75.
Drug release kinetics
Coated wells with a surface area of 1.9 cm2 each or coated
titanium discs with an exposed surface of 0.38 cm2 in indi-
vidual wells of 24-well cell culture plates (Nunclon Delta
Surface, Thermo Scientific) were overlaid with 0.25 mL of
phosphate-buffered saline (PBS) incubated at 37!C. The
plates were incubated at 37!C in a humidified atmosphere
with 5% CO2. Supernatants were collected and replaced
daily unless indicated otherwise. The ciprofloxacin concen-
tration in supernatants was determined by measuring the
light absorption at a wavelength of 272 nm using a
Nanodrop ND-1000 UV-Vis Spectrophotometer (Nanodrop
Technologies, Wilmington). An OD272 of 0.1 corresponded to
1 mg/mL ciprofloxacin.30,31
Luminescent P. aeruginosa (PAO1 CTX:lux) were used for
monitoring the bacteria.32,33 The antibacterial activity of
ciprofloxacin in supernatants was tested by transferring 50
mL of the supernatants to individual wells of a black 96-well
plate (Nunc, Denmark). 50 mL of bacterial cultures in LB
medium with an OD600 of 0.1 was added to the 50 mL of
the supernatants. The bacterial luminescence was deter-
mined using an IVISVR 2200 in vivo imaging system (Xeno-
gen) before and after 4 h incubation at 37!C. The
luminescence was recorded with the Living Image
softwareVR , version 2.6 (Xenogen) and the average radiation
intensity (p/s/cm2/r) determined.25 Bacterial cultures were
prepared in triplicates and the data shown correspond to
the mean values and the standard deviation.
Animal handling and in vivo imaging
The 10-week-old female Balb/c mice (Harlan-Winkelmann,
Borchen, Germany) were kept in cages with individual fil-
tered aeration and fed with a standard diet with water ad
libitum. Before implantation, the animals were anesthetized
by intraperitoneal injection of ketamine (10 mg/kg) and
xylazine (4 mg/kg). The implantation site was shaved and
sterilized with 70% ethanol in a sterile laminar flow hood.
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Porous titanium discs were implanted subcutaneously and
the wound closed by simple interrupted wound sutures
(Vicryl Ethicon, Johnson and Johnson). The luminescently
labeled strain of P. aeruginosa (PAO1 CTX::lux) was used to
infect implants.32,33 Bacteria were grown in LB to an optical
density (OD600) of 0.5, pelleted by centrifugation and resus-
pended in PBS to an OD600 of 0.1. Mice with implants were
anesthetized with ketamine (10 mg/kg) and xylazine
(4 mg/kg). Bacterial suspension of 5 mL was injected on top
of each implant. Each animal was infected once only at the
time point indicated and each implant was infected with a
single injection. Subsequently, the bacterial luminescence
was monitored at predetermined time points and quantified
using an In Vivo Imaging System (IVISVR 2200; Xenogen, Ala-
meda, CA). The luminescence intensity was determined
using the Living Image softwareVR Version 2.6 (Xenogen). For
each type of implant, three samples were used and all ani-
mals used in a given experiment were treated in parallel.
All animal experiments were done in accordance with the
regulations and with the approval from the local authorities
Lower Saxony State Office for Consumer Protection and
Food Safety (LAVES), permission number 33.42502/07–10.5.
RESULTS
Manufacturing of coatings by evaporation of LDH
suspensions
To investigate if LDH coatings on plain implant material
surfaces were feasible, titanium discs were submerged in
aqueous LDH suspensions that were subsequently dried
under ambient conditions. For comparison a suspension of
pure magnesium hydroxide was used. The resulting LDH
coatings appeared homogeneous, smooth and semi-
transparent and firmly adhered to the titanium while in
comparison pure magnesium hydroxide formed a white opa-
que layer [Fig. 1(A–C)]. Ciprofloxacin additions to LDH sus-
pensions lead to a concentration-dependent formation of
visible precipitates in the resulting coatings [Fig. 1(D–G)].
The performance of LDH coatings was evaluated by incuba-
tion in a physiological salt solution for 2 weeks [Fig. 1(H–
K)]. LDH coatings dissolved more slowly than the ciprofloxa-
cin and were still visible after the incubation. However, the
coatings appeared brittle after the incubation and became
fragmented in part. The LDH coatings containing the highest
amounts of ciprofloxacin appeared to be dissolved more
quickly and fewer remnants could be detected after the
incubation [Fig. 1(K)]. Therefore, apart from the brittleness,
the lower antibiotic additions to LDH were deemed to be
more promising to obtain lowly soluble coatings and to
achieve prolonged drug release.
XRD analysis was used to obtain evidence for the pres-
ence of LDH structures in the coatings [Fig. 1(L,M)]. In pure
ciprofloxacin coatings two minor reflections in the region of
6–7! 2h were noted without further characterization. The
broad diffraction peaks of LDH coatings with or without
antibiotic at the 2h scattering angles of 11 and 22! were
typical for Mg–Al LDH films.34 Therefore the LDH structure
was apparently preserved in the coatings.
Compatibility of LDH coatings with cultured cells
Cultured fibroblast cells were used as a representative cell
type since in vivo fibroblasts can form capsules around
implants. Cells seeded on LDH coatings adhered and prolif-
erated to confluency after incubation for 3 days (Fig. 2). In
comparison, cells did not form a confluent layer on pure
ciprofloxacin coatings [Fig. 2(CFX)]. However, when cipro-
floxacin was added to LDH coatings the formation of a
confluent cell layer was not impeded [Fig. 2(LDH CFX)]. As
expected, magnesium hydroxide did not support cell adhe-
sion or cell survival (data not shown). The quantitative anal-
ysis confirmed that cell densities on LDH layers were higher
than on pure ciprofloxacin coatings whereas ciprofloxacin
additions to LDH did not lead to reduced cell densities.
These findings showed that LDH coatings with or without
ciprofloxacin additions could be used as a cell adhesion sub-
strate whereas the lower cell density obtained on pure
ciprofloxacin was in line with the reported effects of exces-
sively high ciprofloxacin concentrations.35–37
Porous carrier improves the stability of LDH coatings
Since exposure to aqueous solutions rendered LDH coatings
brittle it appeared essential for the envisioned applications
to protect them from mechanical stress. To this end, porous
titanium discs were prepared and used as a substrate for
coatings. Loose precipitates that accumulated during the
coating procedure were pressed into the pores. The amount
of LDH on the porous discs was approximately twice of that
on the plain discs (Table I). It was attempted to completely
fill all pores to achieve a homogenous surface to improve
the comparison with the coatings on the flat titanium surfa-
ces. In effect, this resulted in an increased mass of all coat-
ings on porous substrates (Table I, coatings on porous
titanium). Minor variations in the coating mass on individ-
ual samples may be due to the fact that during the manufac-
turing process not all of the suspension applied ended up
as coating on the titanium samples. With respect to the
comparatively smooth coatings on plain surfaces, the coat-
ings on the porous substrates had a rougher surface appear-
ance, with occasional pores or crevices and with platelets in
the range from 10 to 200 mm in diameter [Fig. 3(A)]. Antibi-
otic additions did not lead to noticeable changes in the
appearance of the LDH surface whereas in the absence of
LDH pure ciprofloxacin suspensions yielded a minor precipi-
tate [Fig. 3(B,C)]. As intended, when incubated in aqueous
buffer the LDH layers gradually dissolved without larger
chunks breaking loose [Fig. 3(D–K), compare to Fig. 1].
Therefore, LDH coatings were effectively protected by the
pores present in the titanium support and appeared more
stable during the incubation in aqueous buffer solutions.
Controlled antibiotic release from LDH coatings and
from porous carriers
The antibiotic release kinetics from LDH coatings in the
presence of a physiological salt solution (PBS) were deter-
mined by measuring the UV light absorption. As expected,
initial release rates were highest from pure ciprofloxacin
coatings and lower when ciprofloxacin was imbedded in
ORIGINAL ARTICLE
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH A | MONTH 2014 VOL 00A, ISSUE 00 3
138	   5	  LDHs	  as	  Key	  Components	  in	  Drug	  Release	  Systems	  
	  
LDH coatings (Fig. 4). In addition, the release from LDH
coatings was prolonged, such that after 4 h of incubation
the release from the antibiotic supplemented LDH coatings
was equal or higher than that from the pure antibiotic coat-
ing for all LDH to ciprofloxacin ratios investigated [Fig. 4(A–
C)]. The antibiotic release rate from LDH coatings gradually
declined over time. Ciprofloxacin could be detected for over
15 days in supernatants from LDH coatings with the highest
antibiotic content and for 7 days from the coating with the
lowest antibiotic content until the levels reached the detec-
tion limit of the instrument. As expected, no antibiotic
release could be detected in the supernatants after incuba-
tion with plain LDH coatings. The ciprofloxacin release rates
from ciprofloxacin-containing LDH coatings or from pure
ciprofloxacin coatings, respectively, were mostly propor-
tional to the total amounts of ciprofloxacin deposited. The
FIGURE 1. Generation of coatings by slow evaporation of LDH suspensions. Titanium discs with a diameter of 7 mm (used here in place of a
scale bar) were coated with LDH in individual wells of 24-well tissue culture plates and overlaid with precursor suspensions that were left to dry
for 3 days at 37!C at atmospheric pressure. Titanium discs coated with the LDH Mg4Al2(OH)12 (SO4)2"6H2O (A), with magnesium hydroxide (B) or
left without coating (C). LDH coatings with increasing ciprofloxacin additions (left to right) in individual wells of 24-well tissue culture plates:
LDH (D); LDH with ciprofloxacin at a ratio of 210:1 (w/w; E); LDH:ciprofloxacin 21:1 (w/w) ratio (F) and with a LDH:ciprofloxacin 2.1:1 (w/w) ratio
(G). Each illustration of the coatings is shown (D–G), the same type of coating was pictured after incubation in PBS buffer for 14 days under
standard cell culture conditions (37!C and a humidified atmosphere with 5% CO2; H–K, respectively). L: X-ray diffraction (XRD) analysis of cell
culture plastic (CCP), ciprofloxacin coatings (CFX), LDH coatings (LDH), and LDH coatings with ciprofloxacin at a ratio of 21:1 (LDH CFX), with all
three coatings on cell culture plastic. M: XRD of microscope glass coverslip (Glass), ciprofloxacin coatings (CFX), LDH coatings (LDH), and LDH
coatings with ciprofloxacin at a ratio of 21:1 (LDH CFX), all three coatings on glass coverslips. I, relative X-ray reflection intensity, 2h, diffraction
angle.
4 BADAR ET AL. ANTIBIOTIC-LOADED LAYERED DOUBLE HYDROXIDE COATINGS
5	  LDHs	  as	  Key	  Components	  in	  Drug	  Release	  Systems	   139	  
	  
ciprofloxacin present in the coatings on cell culture wells
with the highest quantity of the drug was completely recov-
ered in the first three extractions and undetectable at later
time points, amounting to 19 mg ciprofloxacin with the
pure ciprofloxacin coating [Fig. 4(A)]. As expected, coatings
containing lower amounts of antibiotic yielded proportion-
ally reduced concentrations of ciprofloxacin in the extracts
[Fig. 4(B,C)]. The ciprofloxacin release from LDH layers
became undetectable before the coating was dissolved. This
finding indicated that ciprofloxacin dissolved more rapidly
than LDH and without concurrent destruction of the
remaining LDH coating. As expected, the release kinetics
from plain titanium discs were similar to those from coated
cell culture wells [Fig. 4(D) compared to (B)]. Interestingly,
the release from the porous surface indicated that even
though there was an initial burst release from the pure
ciprofloxacin coating, at later time points the release
FIGURE 2. LDH coatings are biocompatible in cell culture assays.
Polystyrene cell culture plates coated with suspensions of LDH par-
ticles or mixtures of LDH and ciprofloxacin were incubated with
NIH3T3 murine fibroblasts under standard cell-culture conditions for 3
days when cells on the tissue culture polystyrene substrate reached
confluence. The density of adherent and spread out cells was deter-
mined by manual counting cells. The bars correspond to the average
of three independent material sample assays, each relative to the cell-
counts on tissue culture polystyrene (CCP) surfaces that were arbitra-
rily set to 100%. The error bars correspond to the standard deviation
of the three independent assays. The coatings used as cell adhesion
substrate were as follows: CCP coated with LDH (LDH); ciprofloxacin
(CFX); LDH combined with ciprofloxacin at a 21:1 (w/w) ratio (LDH
CFX); CCP without coating (CCP).












LDH 1 CFX 5.9 6 0.5 9.4 6 0.6 0.4 6 0.03
LDH 4.7 6 0.3 12 6 1.2 –
CFX 0.3 6 0.2 1.2 6 0.2 1.2 6 0.2
FIGURE 3. Porous titanium substrates can stabilize LDH-ciprofloxacin coatings. Reflection electron microscopy pictures of porous titanium discs
coated with LDH (A and D) LDH:ciprofloxacin at a ratio (w/w) of 21:1 (B and E) with pure ciprofloxacin coatings (C and F). The samples were
incubated for 15 days in PBS buffer that was replaced daily unless indicated otherwise (see Fig. 4). Pictures were taken before (A–C) or after the
incubation (D–F). For comparison, untreated porous titanium discs are shown (G). The scale bar represents 200 mm. Light microscopic pictures
of a porous titanium disc before (H) and after coating with LDH and ciprofloxacin (I) and after 2 weeks subcutaneous mouse implant residence
time period (K). The diameter of the discs shown corresponds to 7 mm.
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appeared to be retarded in comparison to the coated plain
surfaces [Fig. 4(E)]. This finding was consistent with the
notion that the pure ciprofloxacin exposed on the surface
was quickly dissolved but subsequently the remaining cipro-
floxacin buried in the pores was released more gradually.
Overall, the data indicated that the initial drug release burst
could be dampened by the incorporation into LDH and that
the release period could be extended by both, the combina-
tion with LDH or, somewhat less efficacious, by filling it into
pores.
FIGURE 4. Controlled antibiotic release from LDH coatings on plain and porous surfaces. LDH coatings containing ciprofloxacin were prepared
on plain and porous surfaces incubated with PBS buffer under standard cell culture conditions. If not indicated otherwise the supernatant was
collected daily and replaced with fresh PBS. The ciprofloxacin concentration of each supernatant was determined by measuring the UV light
absorption at a wavelength of 270 nm. The mean values of three independent experiments and the standard deviations are indicated in the
graph. The following materials were coated: 24-well cell culture wells (A–C), plain titanium discs (D), and porous titanium discs (E). Ciprofloxacin
release (squares) were determined from coatings containing the following LDH:ciprofloxacin ratios (w/w): 2.1:1 (A), 21:1 (B, D, and E), and 210:1
(C), respectively. Pure ciprofloxacin coatings (triangles) were deposited at concentrations of 10 mg / cm2 (A); 1 mg / cm2 (B, D, and E) and
0.1 mg/cm2 (C) and pure LDH coatings (x marks in C, D, and E).
FIGURE 5. Prolonged antibacterial efficacy of antibiotic-loaded LDH coatings on plain and porous substrates. The supernatants from the coated sam-
ples described in the legend of Figure 4 were added at a 1:1 (v/v) ratio to cultures of luminescent P. aeruginosa and the luminescence was determined.
Then the cultures were incubated at 37!C for 6 h followed by a second reading of the luminescence. The data is presented as average luminescence of
three independent assays after incubation of the cultures relative to the average luminescence before the incubation. For each data point the lumines-
cence of the corresponding cultures with pure LDH coating extracts (A–C) or the luminescence of cultures with supernatants from uncoated titanium
discs (D and E) was arbitrarily set to 100%. The graphic representation, numbering and symbols are as specified in the legend of Figure 4.
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Efficacy of antibiotic-loaded LDH coatings
The antibacterial efficacy of ciprofloxacin-loaded LDH coat-
ings against P. aeruginosa was examined in vitro. When
supernatants collected after incubation with antibiotic-
loaded LDH coatings were added to bacterial cultures the
luminescence was reduced (Fig. 5). Depending on the total
amount of ciprofloxacin in the coatings antibacterial effects
of pure ciprofloxacin coatings on plain surfaces lasted from
1 to 5 days, whereas the activity of ciprofloxacin-loaded
LDH coatings lasted for over 10 days [Fig. 5(A–C)]. The
activity of extracts from ciprofloxacin-coated plain titanium
discs lasted 1 day and over 5 days from ciprofloxacin-
loaded LDH coatings [Fig. 5(D)]. The slightly shorter active
time period could be explained by the smaller diameter of
the coated titanium discs compared to coated cell culture
wells. In comparison, the antibacterial efficacy from porous
discs extended for over 15 days for both, pure ciprofloxacin
coatings and ciprofloxacin-loaded LDH. These results were
consistent with the optical ciprofloxacin determinations and
suggested that the ciprofloxacin in the LDH coatings
remained active over the entire course of the experiment.
This showed that porous titanium substrates could stabilize
the coatings and the antibiotic release from LDH coatings
was controlled such that bacterial growth could be antago-
nized for a clinically relevant time period. Overall, it was
concluded that from the appearance of the coatings and
from the time period during which antibacterial activities
could be observed, the LDH:ciprofloxacin ratio (w/w) of
21:1 appeared most promising for the subsequent charac-
terization in vivo.
In vivo antibacterial efficacy of antibiotic-loaded LDH
coatings
To evaluate antibacterial activity of LDH-ciprofloxacin coat-
ings under in vivo conditions a mouse model was estab-
lished. Based on the in vitro results, coated porous titanium
discs were employed as implants. To allow noninvasive in
vivo monitoring of the time course of the bacterial infection,
the discs were implanted subcutaneously into white mice.
Seven days after implantation, luminescent P. aeruginosa
bacteria were injected on top of the implants and the lumi-
nescence was determined (Fig. 6). Both, ciprofloxacin and
LDH–ciprofloxacin-coated discs reduced the bacterial lumi-
nescence very efficiently [Fig. 6(A1,A2)]. In comparison, in
the absence of antibiotic the bacterial luminescence was
diminished to a lesser degree [Fig. 6(A3,A4)]. 1 day after
FIGURE 6. Prolonged in vivo antibacterial activity of porous implants
with antibiotic-loaded LDH coatings. Three porous titanium discs
coated with ciprofloxacin and LDH (1); ciprofloxacin (2) or LDH (3);
and for comparison, porous titanium discs without coatings (4),
respectively, were implanted subcutaneously in Balb/c mice (A–E).
After the period indicated the implants were infected by subcutaneous
injection of 5 mL of luminescent P. aeruginosa bacteria suspension on
top of the implanted discs. The antibacterial efficacy of the implants
is depicted graphically as the difference between the bacterial lumi-
nescence of infected implants determined directly after infection and
the luminescence 4 h later. Implants were infected 1 week after
implantation (A), 15 days (B), or 20 days after implantation (C),
respectively. The average luminescence of the infected bare implants
(4) was arbitrarily set to 1. The false color luminescence images of
implants infected 15 days after implantation (D) and 4 h after infection
(E) are shown. [Color figure can be viewed in the online issue, which
is available at wileyonlinelibrary.com.]
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inoculation no luminescence could be detected from any of
the infected implants, suggesting that given sufficient time
the immune system of the mouse could also control the
infection (data not shown). When infected 15 days after
implantation, two of the three LDH–ciprofloxacin-coated
discs still showed antibacterial effects while pure ciprofloxa-
cin coatings were somewhat less efficacious [Fig. 6(B)]. 20
days after implantation, only one out of three implants
showed some activity [Fig. 6(C)]. Tissue responses to pure
ciprofloxacin coatings 2 weeks or more after implantation
were noted while all LDH coatings appeared well-tolerated
[Fig. 6(D,E); data not shown]. This finding was in agreement
with previous data indicating cytotoxic effects of excessive
ciprofloxacin concentrations.35–38 Therefore, in this mouse
model, LDH–ciprofloxacin-coated porous implants were bio-
compatible and could curb bacterial infections for over 2
weeks.
DISCUSSION
The structure, biocompatibility, stability and drug delivery
potential of LDH coatings prepared from particle suspen-
sions were characterized in vitro. When used as implant
coatings, the biocompatibility of LDH was confirmed.29,39,40
Only a brief burst of antibacterial activity at the time of
implantation in rabbits in a previous investigation suggested
that plain LDH coatings are not suitable for controlled drug
delivery.29 This is in line with the results in this study that
indicate that LDH coatings become fragile after exposure to
aqueous liquids. Consequently, porous implants improved
the stability and a prolonged antibiotic activity was
achieved. Several animal models have previously been uti-
lized for noninvasive monitoring of bacterial infections and
antibiotic efficacy.41,42 In this study the inoculated number
of bacteria in this infection assay was deliberately high to
permit immediate visualization. However, while the effica-
cious drug release period of 2 weeks appeared clinically
useful it could even be underestimated.
CONCLUSION
LDH coatings were generated to demonstrate as a proof of
principle that prolonged and efficacious drug delivery from
biodegradable inorganic implant coatings could be feasible.
Porous implants could protect fragile antibiotic-loaded LDH
coatings and prolong the efficacious drug release period in
a mouse implant infection model. Therefore, these results
may warrant more detailed investigations.
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